[ { "id": 499, "name": "MedXT", "slug": "medxt", "former_names": [ "Clariso" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/4d244dae097f5be7af6d767af0db5cf4f74fbd57.png", "website": "http://medxt.com", "all_locations": "San Francisco, CA, USA", "long_description": "MedXT is the easiest way to manage medical images online. We make it easy for medical professionals to access and share their medical data safely and securely. We provide specialty tools such as RIS, PACS, and HL7 connectivity. The MedXT platform will power your imaging center, hospital radiology department, or radiology group. Learn more at https://www.medxt.com", "one_liner": "Radiology in the cloud. X-rays, CAT scans, MRI's, and…", "team_size": 2, "industry": "Healthcare", "subindustry": "Healthcare -> Healthcare IT", "launched_at": 1354492839, "tags": [ "Health Tech", "Medical Devices" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2013", "status": "Acquired", "industries": [ "Healthcare", "Healthcare IT" ], "regions": [ "United States of America", "America / Canada" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/medxt", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2013/medxt.json", "year_founded": null, "city": "San Francisco", "country": "US", "linkedin_url": "", "x_url": "", "fb_url": null, "cb_url": "https://www.crunchbase.com/organization/medxt", "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/4d244dae097f5be7af6d767af0db5cf4f74fbd57.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 57511, "full_name": "Reshma Khilnani", "title": "Founder", "founder_bio": "Reshma is CEO of Medplum. In the recent past she was a Visiting Group Partner at YC. Reshma Khilnani was co-founded of MedXT (YC W13 acquired by Box) and Droplet (now Kit.com). Early in her career she held roles at Facebook and Microsoft. Reshma has a BS and MEng from MIT in EECS. She lives in San Francisco and owns reshma.com \n", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/reshmakhilnani/", "x_url": "https://twitter.com/ReshmaKhilnani", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/e591d608ff7220ba79784a18d0d8c2736ea37975.jpg" } ], "jobs": [], "news": [], "launches": [] }, { "id": 785, "name": "Shift Labs", "slug": "shift-labs", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/2246133183bed9d3422eac6444861816329babc9.png", "website": "http://shiftlabs.com", "all_locations": "Seattle, WA, USA", "long_description": "Shift Labs makes medical devices that place technology and design on equal footing to create affordable solutions. We emphasize simplicity and create devices that serve the fastest growing healthcare markets in the world.\r\n\r\nWe believe that every person in the world deserves quality healthcare -- whether they are receiving care in the home, in an outpatient infusion center, or in an emerging market. \r\n\r\nWe're a for-profit company committed to doing well, and doing good.\r\n\r\nWe believe Simple Saves Lives.\r\n___\r\n\r\nIn true startup fashion, we have a strategy that emphasizes early revenue. So check out our first product DripAssist, a low-cost IV fluid monitor and alarm. Get precision monitoring of blood transfusions or fluid delivery at a fraction of the cost of an infusion pump. Purchase at http://www.shiftlabs.com/purchase-dripassist", "one_liner": "Makers of simple, affordable medical devices. Our award-winning…", "team_size": 6, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1416221710, "tags": [ "Hardware", "Medical Devices" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2015", "status": "Acquired", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/shift-labs", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2015/shift-labs.json", "year_founded": 2012, "city": "Seattle", "country": "US", "linkedin_url": "https://www.linkedin.com/company/5313123", "x_url": "https://twitter.com/ShiftLabs", "fb_url": "https://www.facebook.com/ShiftLabs", "cb_url": "https://www.crunchbase.com/organization/shiftlabs", "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/2246133183bed9d3422eac6444861816329babc9.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 4444, "full_name": "Beth Kolko", "title": "Founder/CEO", "founder_bio": "Founder, Shift Labs\nInvestor, Pioneer Fund and Pack Ventures\nProfessor, University of Washington", "is_active": true, "linkedin_url": "http://www.linkedin.com/pub/beth-kolko/2/1b/364/", "x_url": null, "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/7b9ee2d9673a446e0482506aba9f1a95c88d5d76.jpg" } ], "jobs": [], "news": [], "launches": [] }, { "id": 834, "name": "Zenflow", "slug": "zenflow", "former_names": [ "ZenFlow" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/39dafe5a7c09ff15739f0bf0dfb5ef1902393913.png", "website": "http://zenflow.com", "all_locations": "San Francisco, CA, USA; South San Francisco, CA, USA", "long_description": "Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign prostatic hyperplasia (BPH). The majority of men will experience symptoms of this disease at some point in life. BPH, also known as prostate enlargement, leads to urinary straining, frequency, urgency, and sleep disruption. Despite the high prevalence and significant quality of life burden of BPH, established treatments are limited to drugs, which have limited effectiveness, and surgery, which carries a high risk of sexual side effects. The Zenflow Spring is a small implant delivered in the urologist's office in a simple procedure that provides quick and long-lasting symptom relief.", "one_liner": "Medical device that provides a more effective, less invasive…", "team_size": 18, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1416311220, "tags": [ "Medical Devices" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2015", "status": "Active", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "United States of America", "America / Canada" ], "stage": "Growth", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/zenflow", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2015/zenflow.json", "year_founded": 2014, "city": "San Francisco", "country": "US", "linkedin_url": "https://www.linkedin.com/company/torix-medical", "x_url": "https://twitter.com/zenflowinc", "fb_url": "https://www.facebook.com/zenflowinc/", "cb_url": "https://www.crunchbase.com/organization/zenflow", "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/39dafe5a7c09ff15739f0bf0dfb5ef1902393913.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 11736, "full_name": "Shreya Mehta", "title": "Founder/CTO", "founder_bio": "", "is_active": true, "linkedin_url": "https://www.linkedin.com/pub/shreya-mehta/5/57/49a", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/672fe3205896fd9d313d3295ab075cda0e30dc28.jpg" } ], "jobs": [], "news": [], "launches": [] }, { "id": 840, "name": "X-Zell", "slug": "x-zell", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/3fafbc0fbed91c91e5664f3b665740b3a037febe.png", "website": "http://www.x-zell.com", "all_locations": "Bangkok, Thailand; Düsseldorf, NRW, Germany", "long_description": "X-ZELL™ is a global start-up specialising in rare cell detection technology. \r\n\r\nBacked by Y Combinator and various high-profile angel investors from around the globe – among them Gmail creator Paul Buchheit – X-ZELL™ has developed a world-first platform technology capable of isolating and visualizing rare and abnormal cells such as Circulating Endothelial Cells (CEC).\r\n\r\nX-ZELL™’s platform technology is based on four core modules covering the entire spectrum from blood processing through to cell analysis and reporting – with every step performed in-house using patented and proprietary technology.\r\n\r\nBy combining the wisdom of 4,000 years of pathologic research with X-ZELL™’s own, cutting-edge technology, \r\nX-ZELL™ ensures robust results and maximum clinical utility across a broad range of medical applications – from research through to medication management, companions diagnostics, relapse control and diagnostic decision-making.\r\n\r\nMore information on www.x-zell.com and @XZELLInc", "one_liner": "Early, pain-free cancer detection. ", "team_size": 19, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1416312163, "tags": [ "Medical Devices" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2015", "status": "Active", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "Thailand", "Germany", "Southeast Asia", "Europe", "Remote", "Partly Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/x-zell", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2015/x-zell.json", "year_founded": 2014, "city": null, "country": "TH", "linkedin_url": "https://www.linkedin.com/company/xzell", "x_url": "https://twitter.com/XZELLInc", "fb_url": null, "cb_url": "https://www.crunchbase.com/organization/x-zell", "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/3fafbc0fbed91c91e5664f3b665740b3a037febe.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 8648, "full_name": "Sebastian Punyaratabandhu Bhakdi", "title": "Founder", "founder_bio": "Sebastian started out as a physician at the University Hospital of Freiburg, Germany and earned a Degree in International Health at the Autonomous University of Barcelona, Spain, which made him realize that health services have to be accessible for all. A Research Fellowship from the German Research Foundation helped him to create his first patent which he used to found X-ZELL. He remains its CEO and Principal Investigator, growing the company to solve the world's cancer screening challenge.", "is_active": true, "linkedin_url": "https://www.linkedin.com/pub/sebastian-chakrit-punyaratabandhu-bhakdi/4a/357/8a3", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/21502453739200d02d1cc4addb93587a8578017b.jpg" }, { "user_id": 9916, "full_name": "Prapat Suriyaphol", "title": "Founder", "founder_bio": null, "is_active": true, "linkedin_url": "http://th.linkedin.com/pub/prapat-suriyaphol/17/5b0/3b2", "x_url": null, "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/e76c0210b5ecdef4337b186bee4ae8bf0d2642aa.jpg" } ], "jobs": [], "news": [], "launches": [] }, { "id": 853, "name": "Spire Health", "slug": "spire-health", "former_names": [ "Spire" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/03822a77bc23b29ebe750d7df159399111392ed8.png", "website": "https://spirehealth.com/", "all_locations": "San Francisco, CA, USA", "long_description": "We are a B2B medical device and data company passionate about providing remote monitoring solutions for the proactive care of chronic disease patients.\r\nOur core expertise and IP is in continuous respiratory sensing. Spire Remote Patient Monitoring is used by pulmonologists and patients throughout the United States. To date our sensors have been worn by more than 150,000 people.", "one_liner": "Remote patient monitoring for lung disease patients.", "team_size": 52, "industry": "Healthcare", "subindustry": "Healthcare -> Consumer Health and Wellness", "launched_at": 1419817218, "tags": [ "Telehealth", "Medical Devices", "Digital Health" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2015", "status": "Acquired", "industries": [ "Healthcare", "Consumer Health and Wellness" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Growth", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/spire-health", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2015/spire-health.json", "year_founded": 2013, "city": "San Francisco", "country": "US", "linkedin_url": "https://www.linkedin.com/company/spire-inc-/", "x_url": "", "fb_url": null, "cb_url": "https://www.crunchbase.com/organization/spire-3", "github_url": "https://github.com/spire-inc", "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/03822a77bc23b29ebe750d7df159399111392ed8.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 70861, "full_name": "Neema Moraveji", "title": "Founder/Chief Scientist", "founder_bio": "Founder of Spire Health. Stanford Ph.D. ", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/moraveji", "x_url": "https://twitter.com/moraveji", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/839345e415e3ff424ed187fd2d17d2fb771d557a.jpg" } ], "jobs": [], "news": [], "launches": [] }, { "id": 908, "name": "Bodyport", "slug": "bodyport", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/9af59cfe2253d45b23519fa9644441358b95d382.png", "website": "http://bodyport.com", "all_locations": "San Francisco, CA, USA", "long_description": "Bodyport’s cardiovascular sensing weight scale and predictive algorithms detect early changes in cardiac function to help prevent avoidable hospitalizations. Bodyport is initially targeting heart failure, a chronic condition affecting over 6M Americans and a leading cause of hospitalizations (1M/year) and healthcare spending ($35B/year).\r\n\r\nBodyport’s novel scale measures cardiac output, congestion, heart rate, and other leading indicators of cardiovascular health — all in the same step patients already take to weigh themselves. Companion algorithms and software empower care teams to quickly identify at-risk patients and remotely optimize their therapy to prevent deterioration.", "one_liner": "Predicting and preventing heart disease.", "team_size": 19, "industry": "Healthcare", "subindustry": "Healthcare -> Consumer Health and Wellness", "launched_at": 1430156121, "tags": [ "Medical Devices", "Healthcare", "Telemedicine" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2015", "status": "Active", "industries": [ "Healthcare", "Consumer Health and Wellness" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Growth", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/bodyport", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2015/bodyport.json", "year_founded": 2015, "city": "San Francisco", "country": "US", "linkedin_url": "https://www.linkedin.com/company/bodyport-inc./", "x_url": "https://twitter.com/bodyport", "fb_url": null, "cb_url": "https://www.crunchbase.com/organization/bodyport", "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/9af59cfe2253d45b23519fa9644441358b95d382.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 3250, "full_name": "Corey Centen", "title": "Founder/CEO", "founder_bio": "Biomedical engineer developing medical devices to improve cardiac health.", "is_active": true, "linkedin_url": "http://ca.linkedin.com/in/coreycenten/", "x_url": "http://twitter.com/bodyport", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/de537faff102086033a6f32a82f1847f9708a89c.jpg" }, { "user_id": 14473, "full_name": "Sarah Smith", "title": "Founder", "founder_bio": null, "is_active": true, "linkedin_url": "https://www.linkedin.com/in/sarahannsmith", "x_url": null, "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/416294f8c3b65a91f6ec16de8e06c5f1106a3f33.jpg" } ], "jobs": [], "news": [ { "title": "Bodyport Receives FDA Clearance for the Bodyport Cardiac Scale - Bodyport", "url": "https://bodyport.com/2022/08/09/bodyport-receives-fda-clearance-for-the-bodyport-cardiac-scale-2/", "date": "Aug 09, 2022" } ], "launches": [] }, { "id": 955, "name": "Klarismo", "slug": "klarismo", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/9b735035a5d3492fb1057eb5b35bd5b80ee018df.png", "website": "http://klarismo.com", "all_locations": "San Francisco, CA, USA", "long_description": "Fully-automated Quantitative MR Image Analysis.\r\n\r\nOur software converts a user’s full body magnetic resonance scan (MRI) into a 3D virtual model of their body in the cloud. The model is annotated with explanatory information so they can easily explore and learn about different parts of their body.\r\n\r\nKlarismo is the only provider of MR analytics that can offer truly scalable analysis for large data collections. Cloud-based processing allows 1000s of acquisitions to be analyzed simultaneously. Machine learning techniques utilize Klarismo’s proprietary collection of labelled MRI data and eliminate the need for manual processing to produce precise volumetric measurements.\r\n\r\nKlarismo specializes in the detailed analysis of body composition, including volumetric measurements of different muscle and fat tissues, from whole-body acquisitions.", "one_liner": "Klarismo turns your body into an interactive experience. We built a…", "team_size": 10, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1430435618, "tags": [ "Health Tech", "Medical Devices" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2015", "status": "Inactive", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "United States of America", "America / Canada" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/klarismo", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2015/klarismo.json", "year_founded": 2014, "city": "San Francisco", "country": "US", "linkedin_url": "", "x_url": "", "fb_url": null, "cb_url": "https://www.crunchbase.com/organization/klarismo", "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/9b735035a5d3492fb1057eb5b35bd5b80ee018df.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 71690, "full_name": "Marcus Foster", "title": "Founder/CEO", "founder_bio": "Founder and CEO at KAYMO and Klarismo (S15)\nPreviously led product teams at Google, Apple, GRAIL, Yahoo, and Q Bio.", "is_active": false, "linkedin_url": "https://www.linkedin.com/in/mafoster/", "x_url": "https://x.com/schlunzi", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/7f3d4cdd32ead30d6424f4233fdab8b4b87d66e6.jpg" } ], "jobs": [], "news": [], "launches": [] }, { "id": 962, "name": "Cofactor Genomics", "slug": "cofactor-genomics", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/0138772cf18d9846bdac1578f7edd2288e7e4142.png", "website": "http://cofactorgenomics.com", "all_locations": "St. Louis, MO, USA", "long_description": "Cofactor uses RNA and Predictive Immune Modeling to build better biomarkers and improve patient outcomes.\r\n\r\nLed by Jarret Glasscock and a group of expert human genome scientists,Cofactor has built a new category of diagnostic technology powered by unique and powerful RNA data models built on terabytes of data. \r\n\r\nThe team recently had their technology validation peer-reviewed by the organizations that set standards for diagnostic technology (CAP, AMP) and is publishing in the Journal of Molecular Diagnostics. In addition, the team made news when Cancer Physicians who sit on the committee for patient treatment guidelines (NCCN) presented a clinical study using Cofactor’s technology showing superiority in predicting the patients who will respond to immunotherapy. This initial application is an acute problem recognized widely in the rapidly developing immunotherapy industry and represents north of a billion dollar TAM. \r\n\r\nAfter a number of recent key milestones, the team is taking the technology more broadly to 50% of cancers diagnosed in the US. \r\n\r\nCurrent investors include Menlo Ventures, DCVC, and Ascension Ventures (this last investor representing the funding arm for 13 National U.S. Healthcare Systems).", "one_liner": "Cofactor closes the precision medicine gap with predictive diagnostics", "team_size": 13, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1433394319, "tags": [ "Medical Devices", "Biotech", "Diagnostics" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2015", "status": "Active", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Growth", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/cofactor-genomics", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2015/cofactor-genomics.json", "year_founded": 2015, "city": "St. Louis", "country": "US", "linkedin_url": "https://www.linkedin.com/company/cofactorgenomics/", "x_url": "https://twitter.com/cofactorgenomic", "fb_url": null, "cb_url": "https://www.crunchbase.com/organization/cofactor-genomics", "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/0138772cf18d9846bdac1578f7edd2288e7e4142.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 93360, "full_name": "Dave Messina", "title": "Founder/COO", "founder_bio": "Dr. Dave Messina has over 25 years of experience in healthcare and has been leading healthcare investments at Pioneer Fund since 2019. He has led 100+ deals including top portfolio companies like Gilgamesh ($1B exit to Abbvie) and Assort Health ($500M+ valuation). Previously he founded the RNA and machine learning company Cofactor Genomics (YC S15) and led it to national Medicare reimbursement. Dr. Messina also worked on the Human Genome Project.", "is_active": false, "linkedin_url": "http://linkedin.com/in/davemessina", "x_url": "https://twitter.com/davemessina", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/ab073e2e48634af8f85e9039dd8a789ce8bfdee7.jpg" }, { "user_id": 93113, "full_name": "Jarret Glasscock", "title": "Founder/CTO", "founder_bio": null, "is_active": true, "linkedin_url": "https://www.linkedin.com/in/jarretglasscock", "x_url": null, "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/e79cc3d931002836ab378b3f801270df9fc3504c.jpg" } ], "jobs": [], "news": [], "launches": [] }, { "id": 988, "name": "iSono Health", "slug": "isono-health", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/d92dab4a543fbdafaf35d8ee128bd09f103d392c.png", "website": "http://www.isonohealth.com", "all_locations": "San Francisco, CA, USA", "long_description": "The iSono Health platform combines automated 3D ultrasound technology with cloud computation and artificial intelligence to empower women and their physicians with early detection and monitoring of breast cancer. Our patented compact ultrasound scanner captures 3D images through automatic scanning of whole breast volume in 1 min. The device connects to a smartphone/tablet/laptop and is controlled by our mobile app. The data is transferred to a secure cloud for image processing and storage. Our machine learning algorithm uses acoustic biomarkers to identify abnormal masses. Our platform’s automated operation and software expands ultrasound use in point-of-care diagnostics as well as monitoring of breast health at home, walk-in and mobile clinics. \r\n\r\niSono Health offers women and healthcare providers :\r\nSafety: No Radiation\r\nActionable Feedback with AI\r\nFast: 2min Scan\r\nEasy to Use", "one_liner": "AI-powered platform for Accessible and Personalized Breast Health…", "team_size": 9, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1447279515, "tags": [ "Consumer Health Services", "Medical Devices", "AI" ], "tags_highlighted": [], "top_company": false, "isHiring": true, "nonprofit": false, "batch": "Winter 2016", "status": "Active", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/isono-health", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2016/isono-health.json", "year_founded": 2016, "city": "San Francisco", "country": "US", "linkedin_url": "https://www.linkedin.com/company/isono-health/", "x_url": "https://twitter.com/isonohealth", "fb_url": null, "cb_url": "https://www.crunchbase.com/organization/isono-health", "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/d92dab4a543fbdafaf35d8ee128bd09f103d392c.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 108694, "full_name": "Shadi Saberi", "title": "Founder/CTO", "founder_bio": "", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/ssaberig", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/09a1d524539aba6e1ad008a5cbe6e4fe901b857d.jpg" } ], "jobs": [ { "id": 15943, "title": "Computer Vision/Deep Learning Scientist", "url": "https://www.ycombinator.com/companies/isono-health/jobs/HXMO4gGEt-computer-vision-deep-learning-scientist", "location": "South San francisco, CA / Remote (US)", "type": "Full-time", "role": "Engineering", "role_type": "Machine learning", "salary_range": "", "equity_range": "", "experience": "3+ years", "visa": "US citizen/visa only", "skills": [ "Python", "TensorFlow", "Machine Learning", "Computer Vision" ] }, { "id": 16148, "title": "Senior Software Engineer - Cloud", "url": "https://www.ycombinator.com/companies/isono-health/jobs/oNuuvEXnq-senior-software-engineer-cloud", "location": "South San francisco, CA / Remote", "type": "Full-time", "role": "Engineering", "role_type": "Full stack", "salary_range": "$90K - $160K", "equity_range": "", "experience": "6+ years", "visa": "US citizenship/visa not required", "skills": [ "Google Cloud", "JavaScript", "Kubernetes", "Node.js", "PostgreSQL", "Python", "Docker", "Data Warehousing" ] }, { "id": 71761, "title": "Manufacturing Engineer", "url": "https://www.ycombinator.com/companies/isono-health/jobs/QzLjpZG-manufacturing-engineer", "location": "South San Francisco", "type": "Full-time", "role": "Engineering", "role_type": "Mechanical", "salary_range": "$70K - $140K", "equity_range": "", "experience": "3+ years", "visa": "US citizen/visa only", "skills": [ "Assembly", "CAD Design" ] } ], "news": [], "launches": [] }, { "id": 1011, "name": "InnoVein", "slug": "innovein", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/c016740aa024bde1b822a68eb9c3bd126cc85975.png", "website": "http://Innoveinmedical.com", "all_locations": "San Francisco, CA, USA; San Carlos, CA, USA", "long_description": "", "one_liner": "We cure intractable leg wounds with a replacement valve for veins. ", "team_size": 5, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1447311916, "tags": [ "Medical Devices" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2016", "status": "Inactive", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Growth", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/innovein", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2016/innovein.json", "year_founded": 2015, "city": "San Francisco", "country": "US", "linkedin_url": "", "x_url": "", "fb_url": null, "cb_url": "https://www.crunchbase.com/organization/innovein", "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/c016740aa024bde1b822a68eb9c3bd126cc85975.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 110534, "full_name": "Austin Walker", "title": "Founder/CEO", "founder_bio": "", "is_active": false, "linkedin_url": "https://www.linkedin.com/in/rhonevc/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/31b4d58b82219670165b408b74f92a140dcffea3.jpg" }, { "user_id": 113101, "full_name": "Al Chin", "title": "Founder", "founder_bio": null, "is_active": false, "linkedin_url": "https://www.linkedin.com/pub/albert-k-chin-m-d/16/2b8/371", "x_url": null, "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/667097ee274655249325e0e4987088069fc575e6.jpg" }, { "user_id": 113256, "full_name": "Tom Kramer", "title": "Founder", "founder_bio": null, "is_active": false, "linkedin_url": "https://www.linkedin.com/pub/tom-kramer/7/a2a/582", "x_url": null, "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/daf03b4921759652a4872296408d0736376b84b8.jpg" } ], "jobs": [], "news": [], "launches": [] }, { "id": 1014, "name": "Luminist Labs", "slug": "luminist-labs", "former_names": [ "Luminist" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/b2a824d7b13f5cb87d6f2567fb9307570a0c1d46.png", "website": "http://luministlabs.com", "all_locations": "New York City, NY, USA", "long_description": "Luminist developed a non-invasive diagnostic test for the early detection and staging of liver fibrosis and non-alcoholic steatohepatitis (NASH). Luminist was acquired in 2020 by DiscernDx.", "one_liner": "Diagnostic platform for early detection of liver disease", "team_size": 2, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1447311916, "tags": [ "Medical Devices", "Diagnostics", "Genomics" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2016", "status": "Acquired", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "United States of America", "America / Canada" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/luminist-labs", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2016/luminist-labs.json", "year_founded": 2015, "city": "New York City", "country": "US", "linkedin_url": "", "x_url": "", "fb_url": null, "cb_url": "https://www.crunchbase.com/organization/luminist", "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/b2a824d7b13f5cb87d6f2567fb9307570a0c1d46.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 103004, "full_name": "Storm Stillman", "title": "Founder/CEO", "founder_bio": "Co-founder and CEO of Luminist Labs (Acquired by DiscernDx)\nCurrently CEO @ Curebase (S18)", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/ecoa", "x_url": "https://twitter.com/StormStillman", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/e18d2a6b6c07645bafa74bc626b5d56b949ed009.jpg" } ], "jobs": [], "news": [], "launches": [] }, { "id": 1074, "name": "UroDev Medical", "slug": "urodev-medical", "former_names": [ "Spinal Singularity" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/c7fb5021631c4122b74a0ad76af1b47537325bac.png", "website": "https://www.urodevmedical.com/", "all_locations": "San Clemente, CA, USA", "long_description": "Spinal Singularity designs connected medical devices to improve the quality of life for people with Spinal Cord Injury and Disease (SCI/D).\r\n\r\nOur first product, the Connected Catheter, will revolutionize the way people deal with Neurogenic Bladder and Urinary Incontinence.", "one_liner": "Devices to improve the quality of life for people with Spinal Cord…", "team_size": 4, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1447748416, "tags": [ "Medical Devices" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2016", "status": "Acquired", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "United States of America", "America / Canada" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/urodev-medical", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2016/urodev-medical.json", "year_founded": 2015, "city": "San Clemente", "country": "US", "linkedin_url": "", "x_url": "", "fb_url": null, "cb_url": "https://www.crunchbase.com/organization/spinal-singularity", "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/c7fb5021631c4122b74a0ad76af1b47537325bac.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 94496, "full_name": "Derek Herrera", "title": "Founder/CTO", "founder_bio": "Medical Device Entrepreneur", "is_active": false, "linkedin_url": "https://www.linkedin.com/in/derekherrera", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/32f2f5cb25bb002c80de1c3156d6534132e9c7df.jpg" }, { "user_id": 104138, "full_name": "Zach McKinney", "title": "Founder/Chief Science Officer", "founder_bio": null, "is_active": false, "linkedin_url": "https://www.linkedin.com/profile/view?id=AAMAAAPVReMBqUtDVGMlJiVo9OKZeKGUxM6J8rc&trk=hp-identity-photo", "x_url": null, "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/1eece139e48057ad3d80521f93169db2fac25963.jpg" } ], "jobs": [], "news": [], "launches": [] }, { "id": 1236, "name": "Clip Health", "slug": "clip-health", "former_names": [ "Luminostics" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/e24ad91e84232c8d13fc0c0a73e4d5987b4c64de.png", "website": "http://www.cliphealth.com", "all_locations": "San Francisco, CA, USA; Fremont, CA, USA", "long_description": "At Clip Health, we are relentlessly executing on the vision to enable accessible, personalized, and actionable health testing, with immediate follow-up, across infectious, metabolic, endocrine, and chronic diseases and conditions. The Clip Platform brings our proprietary glow-in-the-dark nanochemistry in combination with connected easy-to-use hardware and delightful-to-use mobile apps to at-home, point-of-care, and enterprise settings. ", "one_liner": "Testing & treatment at home, in minutes, for chronic & acute disease", "team_size": 10, "industry": "Healthcare", "subindustry": "Healthcare", "launched_at": 1461244816, "tags": [ "Hard Tech", "Hardware", "Health Tech", "Medical Devices" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2016", "status": "Inactive", "industries": [ "Healthcare" ], "regions": [ "United States of America", "America / Canada" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": true, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/clip-health", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2016/clip-health.json", "year_founded": 2015, "city": "San Francisco", "country": "US", "linkedin_url": "", "x_url": "", "fb_url": null, "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/e24ad91e84232c8d13fc0c0a73e4d5987b4c64de.png", "app_video_url": null, "dday_video_url": "https://bookface-images.s3.us-west-2.amazonaws.com/video_event/31/1471906230450-6s1kaldbzt71ooui-4a9a51ca8b212f7c0a010695b3461664/2a0c415849ecade0f46075d5c0949f4a.mp4?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIAQC4NIECABPQ2AHNW%2F20261020%2Fus-west-2%2Fs3%2Faws4_request&X-Amz-Date=20261020T022633Z&X-Amz-Expires=3600&X-Amz-SignedHeaders=host&X-Amz-Signature=681d0390ecaa9a2a2467855e2263da4d92f9ecf68c36e3093e2cf1f40341a302", "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 94470, "full_name": "Bala Raja", "title": "Founder/CEO", "founder_bio": "Now: \n1. arden.bio/service - precision R&D service for unresolved chronic immune-disorder patients\n2. tempusirb.com - fast (same-day IRB reviews for research/clinical trials) \n\n2014 to 2023, I was cofounder/CEO of Clip Health (YCS16), a Khosla Ventures and NIH-funded startup. Raised $54M, built a HW/bio/chem rapid diagnostics platform, launched 1st product that shipped >1m units but failed to parlay into sustainable growth. Pre-2014 I got a PhD in bio/chem engg (microfluidics/bacterial dx). ", "is_active": false, "linkedin_url": "https://linkedin.com/in/balaraja", "x_url": "https://twitter.com/balavraja", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/53f98d872421231e9f2076bbe5e4ec0be88a1fa0.jpg" }, { "user_id": 123977, "full_name": "Andrew Paterson", "title": "Founder/CTO", "founder_bio": "I'm a scientist and engineer at heart. I love any and all things science from fundamental physics to chemistry and materials science to biology. My passion in life is to help drive scientific and technological progress by shepherding innovative technologies based on hard science and engineering out of the R&D lab and onto the commercial marketplace.\n\nI have 12+ years of experience working at the intersection of biology, chemistry, nanotech, hardware, and software.", "is_active": false, "linkedin_url": "https://linkedin.com/in/aspaterson", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/95352f80971a47b050fea10322b6ace07b12eb62.jpg" } ], "jobs": [], "news": [], "launches": [] }, { "id": 1485, "name": "Volt Health", "slug": "volt-health", "former_names": [], "small_logo_thumb_url": "/company/thumb/missing.png", "website": "https://www.volthealth.com/", "all_locations": "San Francisco, CA, USA", "long_description": "Volt is an electrostimulation wearable to treat diseases like incontinence. The founder has already taken six medical devices to market, including the Cool Sculpting device that sold for billions. Incontinence affects 25 million people and is a $25 billion market. The device stimulates the muscles to get them the give feedback to receptors. This helps those suffering from incontinence to not pee when they don’t want to. The device can also target other conditions like migraines and comes with proprietary technology.", "one_liner": "Volt Health is developing medical devices that deliver electrical…", "team_size": 1, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1478224834, "tags": [ "Medical Devices" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2017", "status": "Inactive", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "United States of America", "America / Canada" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/volt-health", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2017/volt-health.json", "year_founded": null, "city": "San Francisco", "country": "US", "linkedin_url": "", "x_url": "", "fb_url": null, "cb_url": "https://www.crunchbase.com/organization/volt-health", "github_url": null, "logo_url": null, "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 169024, "full_name": "Scott Wolf, MD", "title": "Founder/Founding CEO", "founder_bio": "Scott founded Aerin Medical to create non-surgical therapies to treat nasal airway problems, including nasal obstruction. Scott was also a founder of Zeltiq Aesthetics, the maker of CoolSculpting. Scott was previously a partner at Prospect Venture Partners and a vice-president at Frazier Healthcare Ventures, both leading life science venture capital firms. Scott received his M.D. from George Washington University and his B.A. from the University of Pennsylvania.", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/sjwolf", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/a6e55558c8ed9d4c8c2ffa661bd8365c30a51094.jpg" } ], "jobs": [], "news": [], "launches": [] }, { "id": 1532, "name": "Delee", "slug": "delee", "former_names": [ "Semka Technologies" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/badd1b077ec76be8053aae9a5daf9d6f1afd8d56.png", "website": "http://www.delee.co ", "all_locations": "Monterrey, N.L., Mexico", "long_description": "Delee is a medical device company that developed a blood-testing device for early diagnosis of cancer and treatment monitoring through the isolation and analysis of the circulating tumor cells. ", "one_liner": "Blood testing device for early diagnosis of cancer and treatment…", "team_size": 18, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1478742617, "tags": [ "Medical Devices", "Diagnostics" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2017", "status": "Active", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "Mexico", "Latin America" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/delee", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2017/delee.json", "year_founded": 2017, "city": "Monterrey", "country": "MX", "linkedin_url": "https://www.linkedin.com/company/35691474", "x_url": "https://twitter.com/deleecorp", "fb_url": "https://www.facebook.com/DeleeCorp/", "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/badd1b077ec76be8053aae9a5daf9d6f1afd8d56.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 146653, "full_name": "Liza Velarde", "title": "Founder", "founder_bio": "Co-Founder and acting CEO at Delee Corp. Velarde has been responsible for the development and execution of the company's strategic plans. Velarde's outstanding work has been highly regarded by international institutions such as Cartier Women's Initiative Awards and WeXchange (from the Inter-American Development Bank). She also lead and supervised the development of the Zen FluidicsTM scientific line, a group of products that enables researchers to develop their own microfluidic applications. ", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/lizavelarde/", "x_url": "https://twitter.com/liza_velarde21", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/3fc7f37e65c672c0830a8b4317008838a8ddebde.jpg" }, { "user_id": 162876, "full_name": "Alejandro Abarca-Blanco", "title": "Founder", "founder_bio": null, "is_active": true, "linkedin_url": "https://linkedin.com/in/alejandroabarca", "x_url": null, "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/5cb50dbc32e479e507c7d69201bd6b7bf5c9ed56.jpg" }, { "user_id": 161991, "full_name": "Juan Felipe Yee De León", "title": "Founder", "founder_bio": null, "is_active": true, "linkedin_url": "https://mx.linkedin.com/in/juan-felipe-yee-55107a5b", "x_url": null, "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/85a63ebcc27be009e3e88f32a8a52c7ade4a94e9.jpg" } ], "jobs": [], "news": [ { "title": "52 Women-Led Startups Driving The Future Of HealthTech And FemTech", "url": "https://www.forbes.com/sites/allysonkapin/2021/06/24/52-women-led-startups-driving-the-future-of-healthtech-and-femtech/?sh=53aee317107c", "date": "Oct 06, 2021" } ], "launches": [] }, { "id": 1538, "name": "Voodoo Manufacturing", "slug": "voodoo-manufacturing", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/4c33c9540f1c00495e765aa3154b28d4b9e15ac6.png", "website": "http://www.voodoomfg.com", "all_locations": "New York City, NY, USA; Brooklyn, NY, USA", "long_description": "AWS for manufacturing. Founded in 2015 and based in Brooklyn, NY, Voodoo operates a robotic 3D printing factory with over 250 3D printers, capable of making thousands of parts faster than traditionally possible. Voodoo has worked with thousands of customers to date, from engineers and entrepreneurs to companies such as Microsoft, NBCUniversal, Mattel, and Intel. Visit www.voodoomfg.com to learn more.", "one_liner": "AWS for manufacturing.", "team_size": 19, "industry": "Industrials", "subindustry": "Industrials -> Manufacturing and Robotics", "launched_at": 1478748019, "tags": [ "Medical Devices", "3D Printing", "Manufacturing" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2017", "status": "Inactive", "industries": [ "Industrials", "Manufacturing and Robotics" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/voodoo-manufacturing", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2017/voodoo-manufacturing.json", "year_founded": 2015, "city": "New York City", "country": "US", "linkedin_url": "", "x_url": "", "fb_url": null, "cb_url": "https://www.crunchbase.com/organization/voodoo-manufacturing", "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/4c33c9540f1c00495e765aa3154b28d4b9e15ac6.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 36828, "full_name": "Max Friefeld", "title": "Founder/CEO", "founder_bio": "Max is the co-founder and COO of Ultra. \n\nHe studied Computer and Electrical Engineering at Harvey Mudd College ('13), and founded two YC-backed companies, Layer By Layer (S13) and Voodoo Manufacturing (W17).\n\nImmediately prior to starting Ultra, Max led teams at Boston Consulting Group optimizing operations for the largest logistics networks in the world and developing go-to-market strategy for private equity backed robotics companies.", "is_active": false, "linkedin_url": "https://www.linkedin.com/in/mfriefeld", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/d8216f62957dfd9a799bdefaf861c60b0774a844.jpg" }, { "user_id": 36827, "full_name": "Jon Miller Schwartz", "title": "Founder/CPO", "founder_bio": "Robotmaxxing at Ultra. Prev Arena AI, Voodoo Manufacturing (YC W17), Body Labs, and Layer By Layer (YC S13).\n", "is_active": false, "linkedin_url": "https://www.linkedin.com/in/jmschwartz11", "x_url": "https://twitter.com/JMSchwartz11", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/4175a41b7ddfb0a9f80aaa87d7b4354f003a0842.jpg" }, { "user_id": 36829, "full_name": "Oliver Ortlieb", "title": "Founder", "founder_bio": "Oliver is the co-founder and CTO of Ultra.\n\nBefore co-founding Ultra, Oliver Ortlieb was the Co-founder & CTO at Voodoo Manufacturing where he built the software and systems to support one of the largest 3D printing factories in the world. Prior to that, he co-founded Layer By Layer, a secure marketplace for 3D-printable products. He holds multiple patents in the field of 3D printing, and received his BS in Computer Science from Harvey Mudd College.", "is_active": false, "linkedin_url": "https://www.linkedin.com/in/oliverortlieb", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/c3fc0be0545afe2d8211c303677994e8a2952daa.jpg" }, { "user_id": 165427, "full_name": "Patrick Deem", "title": "Founder/CFO / Head of Business Development", "founder_bio": "", "is_active": false, "linkedin_url": "https://www.linkedin.com/in/patrick-deem-7851511?trk=nav_responsive_tab_profile_pic", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/9ef3577b6d9873a2bd368db7a09c723421ac35e6.jpg" } ], "jobs": [], "news": [], "launches": [] }, { "id": 1759, "name": "Sepsis Scout", "slug": "sepsis-scout", "former_names": [ "Patch'd Medical", "Patchd Medical", "Sepsis Scout (Formerly Patchd Medical)" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/6e203795c935dfa82049aa5e5236b3db6130851e.png", "website": "https://sepsisscout.com", "all_locations": "San Francisco, CA, USA", "long_description": "Formerly known as Patchd Medical, now acquired by Cytovale.\r\n\r\nWearable technology and AI to predict and prevent sepsis outside of hospital.\r\n\r\n", "one_liner": "Wearables and AI to predict and prevent sepsis outside the hospital", "team_size": 5, "industry": "Healthcare", "subindustry": "Healthcare -> Healthcare IT", "launched_at": 1509599012, "tags": [ "Deep Learning", "Health Tech", "Medical Devices" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2018", "status": "Acquired", "industries": [ "Healthcare", "Healthcare IT" ], "regions": [ "United States of America", "America / Canada" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/sepsis-scout", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2018/sepsis-scout.json", "year_founded": null, "city": "San Francisco", "country": "US", "linkedin_url": "", "x_url": "", "fb_url": null, "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/6e203795c935dfa82049aa5e5236b3db6130851e.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 210888, "full_name": "Robert Quinn", "title": "Founder/CEO", "founder_bio": "", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/biomechrobert/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/bca3ae0f46f12e50968b2fbad684eacdd18d58df.jpg" }, { "user_id": 213790, "full_name": "Wei-Jien Tan", "title": "Founder/CTO", "founder_bio": "I have a background in EE and Physiology. I worked in a neuroscience lab applying ML to electrophysiological measurements from rat and monkey brains to predict visual stimulus, then worked in implantable medical devices as an engineer where I wrote firmware and did electronic design. I met my cofounder Rob there and we started Patchd Medical which became Sepsis Scout which was then acquired by Cytovale.", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/wei-jien-tan/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/4b2c3e724e7d8757bdda29919f298a0c25b8a99d.jpg" } ], "jobs": [], "news": [], "launches": [] }, { "id": 1777, "name": "AesculaTech", "slug": "aesculatech", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/558039f3c75c85d7f5fa8ce2aeb0ec091cf0ec1f.png", "website": "https://www.aesculatech.com/", "all_locations": "Los Angeles, CA, USA", "long_description": "AesculaTech believes in building better lives through smart chemistry. We design custom smart materials for a range of biomedical, commercial, and industrial applications. Our platform technology, AesculaGel offers adaptive response to a wide range of stimuli and can be tailor-made for biocompatibility, material strength, and a range of other attributes. \r\n\r\nFounded by one of MIT's 35 under 35 Innovators, AesculaTech is the shared vision of scientists, engineers, and medical experts. Our cornerstone product, Humidifeye, is an ophthalmic platform to treat dry eye disease. Dry eye affects more than 25 million Americans and the global treatment market is projected higher than $6 Billion within the next decade. Our thermally responsive, form-fitting materials are suitable for sustained yet reversible occlusion across a range of treatment times. In contrast to existing technologies, our product will not extrude, or cause discomfort as it adapts to patients. Though Humidifeye is not yet FDA approved, expect to hear about it soon!\r\n\r\nIn coordination with partners across several sectors, we have a variety of groundbreaking technologies in the works that live up to our vision. This work has already been recognized. AesculaTech was named a Rosenman Innovator, received a National Science Foundation I-Corps grant, was a finalist in the 2019 Octane High Tech Awards, and is a graduate of both the Y Combinator and TMCx accelerator programs. In short, Y-Combinator was only the beginning. \r\n\r\n", "one_liner": "Responsive materials, better lives. ", "team_size": 6, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1509678251, "tags": [ "Medical Devices", "Consumer Products" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2018", "status": "Active", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "United States of America", "America / Canada" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/aesculatech", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2018/aesculatech.json", "year_founded": 2016, "city": "Los Angeles", "country": "US", "linkedin_url": "", "x_url": "", "fb_url": null, "cb_url": "https://www.crunchbase.com/organization/aesculatech", "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/558039f3c75c85d7f5fa8ce2aeb0ec091cf0ec1f.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 214533, "full_name": "Niki Bayat", "title": "Founder/CEO", "founder_bio": "I am co-founder and CEO of AesculaTech, a biotechnology company designing innovative smart materials to change the way health and consumer products interact with the human body. I am also a chemical engineer with 10+ years of experience in organic chemistry with a PhD from the University of Southern California. \n\nI was included in MIT's 2018 35 Innovators Under 35. My company participated in YCombinator 2018.", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/niki-bayat-1ba52b4b/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/5d09c1b3a0a05124d62b75b17cd65913aa3a7d4f.jpg" } ], "jobs": [], "news": [], "launches": [] }, { "id": 1842, "name": "AlgoSurg Inc", "slug": "algosurg-inc", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/4c9c6f9649c3dcfc12e8cb14536660a83da8adcb.png", "website": "http://www.algosurg.ai", "all_locations": "MH, India; Remote", "long_description": "AlgoSurg builds surgical AI for medical device companies: anatomy AI and planning software that runs inside their robots, navigation systems and patient-specific devices. Our knee planning AI is licensed to leading implant OEMs and in commercial use on the robotic knee platform across India (200+ robots). Partners hold the clearances; we supply the software and its documentation. Hip, TAVR, bone tumor, shoulder, spine, CMF and IntraOp are in pilot/partner-testing/commercial/in-development.", "one_liner": "Surgical AI for medical device companies: Patient scan to robot-ready…", "team_size": 3, "industry": "Healthcare", "subindustry": "Healthcare -> Healthcare Services", "launched_at": 1510247000, "tags": [ "Robotic Surgery", "Medical Devices", "Healthcare IT", "AI" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2018", "status": "Active", "industries": [ "Healthcare", "Healthcare Services" ], "regions": [ "India", "South Asia", "Remote", "Fully Remote" ], "stage": "Early", "app_video_public": true, "demo_day_video_public": true, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/algosurg-inc", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2018/algosurg-inc.json", "year_founded": 2018, "city": null, "country": "IN", "linkedin_url": "https://www.linkedin.com/company/10368877/admin/dashboard/", "x_url": "", "fb_url": null, "cb_url": "https://www.crunchbase.com/organization/algosurg", "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/4c9c6f9649c3dcfc12e8cb14536660a83da8adcb.png", "app_video_url": "https://bookface-images.s3.us-west-2.amazonaws.com/bf-public_profile/1849/app_video.mp4?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=ASIAQC4NIECAPVLLM2EU%2F20261020%2Fus-west-2%2Fs3%2Faws4_request&X-Amz-Date=20261020T022638Z&X-Amz-Expires=60&X-Amz-Security-Token=IQoJb3JpZ2luX2VjEHEaCXVzLXdlc3QtMiJGMEQCIERmcK8Cf9%2Btw509DI59PWqE38RRTAlvZa4J3JDwHNfvAiAayM%2BKkNtOvjgd758WgPB4q6%2BUu3dhFEeIBKJdEEYmHirlAwg5EAAaDDAwNjIwMTgxMTA3MiIMT2KDc6%2BsqQRelJt7KsIDHKXozlWP2zRm6TyaI63cZu7UdMNJI84LhfrBVoBzKOZrazhBds2e6DhqALWGgEHuhaH96sBW1vGKF0SZPA8JEf%2FhnbI%2B0LPups6efXBWO1aKfnU6HWjkfPemBseL1V1dBRWh3MHmM%2BS0wsfJmaYaFWTcHaaVraOkFgeuvtIGQt%2FnimlcxYe9MQMOeYiPnm5yfGLPkCnGOvHZGDepzR19xj6ZjRi9QZRcX734o%2BDyXGZIQOACA5etqDAXBP7fbW8udzjKK9cHEGPamT7IlaTLAWBWnDjL2T9zw8ZCXoeolYzeaw3DTEK0tdnm9pXjkPGWxrNUNlecD6CiG7M3gr2Lm8eody0o9pj5Ec9BIcJ09i9djYQp%2F9Qt3RQagWspbZEm0RIM98ukXmmQO%2Br5NwFl2BqP7h04EVZMR4%2FxuoUkyMfNGipkzTdDAKGOV2wo7LqFqinznpZBKbguQ%2Fg6wWy40kCNyoPguBPf8GYzzIvusP5x6bf1QHvMlXyb8ElzS4lScRKm7v5GhARAJq%2BveXuxU3aR2lwL84TF9HIpOZ6loG5wOggyMO5KqHtaunl14wjKV3M6InDmt6%2F5NLTGbL6N0P36MOn92tYGOqYB%2B%2FclWb0gxQJ%2FmXWJ%2FID3oboHUM%2BqcRMUObsJl1yosDN9kekbLFwXPJS0wjujDnQuGXhjbEK0yPyr8Dgq35lBDPMlxWRQ8upAxHpp%2F0cruekkJPyONG5qpVv25DqS52YxtylQ0pbERuY6rX1AFi5Hwd5%2FQJgU8TuncKO5FjbC0OPiim0nrZjMnv3t4R3u06MVK4%2FRj2yhCS4qwhYGeOsJdP79%2BCqZqQ%3D%3D&X-Amz-SignedHeaders=host&X-Amz-Signature=6d1e5c77ae7f0d4d5867e187fb6083583900f24160560f8c819078e242d6fa36", "dday_video_url": "https://bookface-images.s3.us-west-2.amazonaws.com/video_event/39/1521500921274-gr6xtmkyqxc-5a087676afc16da77fa2c1444ac176be/f2f0ddb634f04beaa053a3b931c29db3.mp4?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIAQC4NIECABPQ2AHNW%2F20261020%2Fus-west-2%2Fs3%2Faws4_request&X-Amz-Date=20261020T022638Z&X-Amz-Expires=3600&X-Amz-SignedHeaders=host&X-Amz-Signature=06eb7de7c66d3715930ae2f816b591330818c16ca12a8ff61c5cfb9cc30ccc56", "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 207276, "full_name": "Vikas Karade", "title": "Founder", "founder_bio": "I am the Founder and CEO of AlgoSurg, where I lead the development of AI-driven surgical planning and intelligence platforms for robotic surgeries, orthopedics, cardiac care, and beyond. My vision is to build the ultimate AI surgical assistant that improves precision, reduces workflow inefficiencies, and supports surgeons from pre-op planning to future real-time guidance.", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/vikaskarade/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/c0296df8aeea172036964db34a078df3d495c02d.jpg" }, { "user_id": 217557, "full_name": "Amit Maurya", "title": "Founder", "founder_bio": "I am an innovator, entrepreneur and technology enthusiast. Y-combinator backed startup company founder with more than 10 years of experience in medical software development, AI/ML based medical image processing, surgical simulations (AR/VR), robotics, medical software, FDA, etc. (https://scholar.google.com/citations?user=EtBY6MQAAAAJ)", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/amitdmaurya/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/1d4142cec04ca98715d3b6bee8d65996cea7f81d.jpg" } ], "jobs": [], "news": [], "launches": [] }, { "id": 1847, "name": "ArchForm", "slug": "archform", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/611850d9929ff8231ea7f5c72b6f4d2500375fbe.png", "website": "http://archform.com", "all_locations": "San Francisco, CA, USA", "long_description": "Archform is teeth aligner software startup that lets orthodontists create, design and 3D print aligners within their own offices.\r\n\r\nThe idea is to provide orthodontists with a way to better compete against some direct-to-consumer teeth aligner startups and cut down on the cost of Invisalign.", "one_liner": "Replacing orthodontic braces with our clear aligner and software", "team_size": 23, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1510365747, "tags": [ "Robotics", "Health Tech", "Medical Devices", "3D Printing" ], "tags_highlighted": [], "top_company": false, "isHiring": true, "nonprofit": false, "batch": "Winter 2018", "status": "Active", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/archform", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2018/archform.json", "year_founded": 2013, "city": "San Francisco", "country": "US", "linkedin_url": "https://www.linkedin.com/company/archform", "x_url": "https://x.com/archform", "fb_url": "https://www.facebook.com/ArchFormCo", "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/611850d9929ff8231ea7f5c72b6f4d2500375fbe.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 74663, "full_name": "Andrew Martz", "title": "Founder/CEO", "founder_bio": "", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/martzandrew/", "x_url": "https://twitter.com/martz_andrew", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/c4811f35fcecf7be044f269ff5d81e352f69907e.jpg" } ], "jobs": [], "news": [], "launches": [] }, { "id": 1866, "name": "Vena Medical", "slug": "vena-medical", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/fa541d38f62009703cadf97964bc4d1769849376.png", "website": "https://www.venamed.ca/", "all_locations": "Kitchener, ON, Canada", "long_description": "Pre-clinical results published in the Journal of Neuro-Interventional Surgery. Technology presented at the World Live Neurovascular Conference. Technology selected as a top 3 finalist for Innovator of the Year by the Congress of Neurological Surgeons. Raised a Series A to fund commercialization (FDA Clearance, Health Canada, ISO 13485, First-in-man and early revenue).", "one_liner": "Vena Medical is providing physicians with the world's smallest camera…", "team_size": 7, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1513130572, "tags": [ "Hardware", "Medical Devices" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2018", "status": "Active", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "Canada", "America / Canada" ], "stage": "Growth", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/vena-medical", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2018/vena-medical.json", "year_founded": 2016, "city": "Kitchener", "country": "CA", "linkedin_url": "https://www.linkedin.com/company/venamedical", "x_url": "https://twitter.com/vena_medical", "fb_url": null, "cb_url": "https://www.crunchbase.com/organization/vena-medical", "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/fa541d38f62009703cadf97964bc4d1769849376.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 222643, "full_name": "Michael Phillips", "title": "Founder", "founder_bio": "Graduated from University of Waterloo with a Bachelor of Applied Science (B.A.Sc.) focused in Mechanical Engineering with an Entrepreneurship Option. Michael co-founded Vena Medical during the final year of his undergraduate degree and went full-time immediately after graduating. Attended TMCx Accelerator and Y Combinator in the year following. Published author in the Journal of Neuro-Interventional Surgery and the American Journal of Neuroradiology, and inventor on 5 granted patents.", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/m4philli/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/5a162162ef37aa1e365e6dc3f851e0aa78bcba39.jpg" }, { "user_id": 222644, "full_name": "Phillip Cooper", "title": "Founder", "founder_bio": null, "is_active": true, "linkedin_url": "http://www.linkedin.com/in/phillip-cooper-95b06810b", "x_url": null, "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/2e75416da1948afd1900a7d22b51ec6dfffa684d.jpg" } ], "jobs": [], "news": [ { "title": "The Ottawa Hospital uses breakthrough stroke technology to improve patient care", "url": "https://www.ottawahospital.on.ca/en/newsroom/the-ottawa-hospital-uses-breakthrough-stroke-technology-to-improve-patient-care/", "date": "Jan 24, 2024" }, { "title": "Vena Medical’s Balloon Distal Access Catheter Investigated in Canada With First-Ever Procedures - Endovascular Today", "url": "https://evtoday.com/news/vena-medicals-balloon-distal-access-catheter-investigated-in-canada-with-first-ever-procedures", "date": "Aug 16, 2022" } ], "launches": [] }, { "id": 1883, "name": "Allotrope Medical", "slug": "allotrope-medical", "former_names": [], "small_logo_thumb_url": "/company/thumb/missing.png", "website": "http://www.allotropemed.com", "all_locations": "Houston, TX, USA", "long_description": "Allotrope Medical is a Houston-based medical device company founded and run by the surgeon that created the technology.\r\n\r\nOur platform stimulation technology gives physicians control over the natural movements of the urinary and digestive systems. This control over smooth muscle tissues allows the surgeon to identify hidden anatomic structures (ureters, sphincters and others), determine tissue health, and even assist in diagnosing disease states. The technology is delivered through the surgeon's existing instruments (which have remained unchanged in over 30 years) giving a completely new capability to the surgeon while maintaining seamless workflow integration.\r\n\r\nWith an $600M (and growing) initial market, the technology is future-proof and is readily able to be integrated into the continued advancements in the surgical space.", "one_liner": "Advancing surgical precision through safe electrical stimulation. ", "team_size": 2, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1524535492, "tags": [ "Hardware", "Robotic Surgery", "Medical Devices" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2018", "status": "Acquired", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/allotrope-medical", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2018/allotrope-medical.json", "year_founded": 2016, "city": "Houston", "country": "US", "linkedin_url": "", "x_url": "", "fb_url": null, "cb_url": "https://www.crunchbase.com/organization/allotrope-medical", "github_url": null, "logo_url": null, "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 247294, "full_name": "Albert Huang", "title": "Founder/CEO", "founder_bio": "", "is_active": false, "linkedin_url": "http://www.linkedin.com/in/albertyhuang", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/37c75f40f64b5fc5e02e42c85bc00d22e6213089.jpg" } ], "jobs": [], "news": [ { "title": "Northgate® Technologies Inc Announces Acquisition of Allotrope Medical™ Inc. | NTI Northgate Technologies", "url": "https://www.ntisurgical.com/news/northgate-technologies-inc-announces-acquisition-allotrope-medical-inc", "date": "Apr 05, 2023" } ], "launches": [] }, { "id": 1885, "name": "Penta Medical", "slug": "penta-medical", "former_names": [], "small_logo_thumb_url": "/company/thumb/missing.png", "website": "http://pentavo.com", "all_locations": "Waterloo, ON, Canada", "long_description": "At Penta Medical we are dedicated to providing an innovative solution to injury management. We work with the top athletic teams and doctors to help them reduce injury rates and improve healing times. While working with our team you will have access to up to date information on all of your athletes, preventative statistics benchmarked across the field, and customized treatments.", "one_liner": "Smart hardware for injury recovery. \r\n\r\n", "team_size": 5, "industry": "Healthcare", "subindustry": "Healthcare -> Consumer Health and Wellness", "launched_at": 1524535495, "tags": [ "Hardware", "Medical Devices" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2018", "status": "Inactive", "industries": [ "Healthcare", "Consumer Health and Wellness" ], "regions": [ "Canada", "America / Canada" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/penta-medical", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2018/penta-medical.json", "year_founded": null, "city": "Waterloo", "country": "CA", "linkedin_url": null, "x_url": "http://twitter.com/@penta_medical", "fb_url": null, "cb_url": "https://www.crunchbase.com/organization/penta-medical", "github_url": null, "logo_url": null, "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 158431, "full_name": "Alexa Roeper", "title": "Founder/CEO", "founder_bio": "", "is_active": true, "linkedin_url": "http://ca.linkedin.com/in/alexaroeper", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/3ea09b2e139ab719351a2f30b6e932dcbb21b27e.jpg" } ], "jobs": [], "news": [], "launches": [] }, { "id": 1926, "name": "Medinas Health", "slug": "medinas-health", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/08678e1bf47fc014ad5d6837aa4efa17273ae185.png", "website": "https://www.medinas.com/", "all_locations": "San Francisco, CA, USA; Remote", "long_description": "We're a cloud-based asset management and remarketing platform for hospitals.", "one_liner": "Medinas helps hospitals manage their inventory and buy and sell their…", "team_size": 15, "industry": "Healthcare", "subindustry": "Healthcare -> Healthcare Services", "launched_at": 1524715382, "tags": [ "Medical Devices", "Healthcare", "Supply Chain" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2018", "status": "Inactive", "industries": [ "Healthcare", "Healthcare Services" ], "regions": [ "United States of America", "America / Canada", "Remote", "Fully Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/medinas-health", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2018/medinas-health.json", "year_founded": 2017, "city": "San Francisco", "country": "US", "linkedin_url": "", "x_url": "http://www.twitter.com/medinashealth", "fb_url": "http://www.facebook.com/medinashealth", "cb_url": "https://www.crunchbase.com/organization/medinas", "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/08678e1bf47fc014ad5d6837aa4efa17273ae185.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 88930, "full_name": "Chloe Alpert", "title": "Founder/CEO", "founder_bio": "Former CEO @Medinas Health turned Investor. ", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/chloealpert", "x_url": "http://www.twitter.com/chloealpert", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/055c48e3306bedeac3976ac1261064fa87b45c8a.jpg" }, { "user_id": 27840, "full_name": "Jesse Avshalomov", "title": "Co-Founder, CPO/Marketing", "founder_bio": "Product/Growth at Athelas (S16), founder Medinas (S18), and early team at Teespring (W13). Guess I've got a YC startup addiction. Taking some decompression time before the next thing. Likely aiming for a frontier lab, or possibly making the jump to full stack builder (Claude Code is borderline miraculous).", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/jesseavshalomov/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/f822d98fc6c8d15c7011265089871a6cb00d41a7.jpg" }, { "user_id": 242893, "full_name": "Tim Growney", "title": "Founder/CTO at Medinas", "founder_bio": "", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/tim-growney/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/5dff401f5a03fd5a04445c666ffc4c28a46523cd.jpg" } ], "jobs": [], "news": [], "launches": [] }, { "id": 11977, "name": "MedCrypt", "slug": "medcrypt", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/f83d9fea6258d4ade4828219ac97951e9aabc969.png", "website": "https://www.medcrypt.co", "all_locations": "San Diego, CA, USA", "long_description": "MedCrypt has developed a security toolkit that allows medical device developers to focus on diagnosing and treating disease, while ensuring their devices comply with security regulations and best practices. And since each installation of our software communicates with our MedCrypt network, we can use machine learning-based transaction monitoring algorithms to detect anomalous behavior, thwarting attacks in real time. This centralization of transaction data allows us to facilitate \"Threat Sharing\" between device vendors, helping build a community of device vendors offering the most secure devices possible.\r\n\r\n\r\n\r\nMedCrypt protects medical devices against malicious hacking. Each installation of our software communicates with our MedCrypt network, allowing us to use machine learning-based transaction monitoring algorithms to detect anomalous behavior, thwarting attacks in real time. This centralization of transaction data allows us to facilitate \"Threat Sharing\" between device vendors, helping build a community of device vendors offering the most secure devices possible.\r\n\r\n\r\nIf someone hacks your connected thermostat, you’re uncomfortable. If someone hacks your pacemaker, you could be dead. MedCrypt is bringing modern software security technologies to an important, but underserved technology sector.\r\n", "one_liner": "MedCrypt gives medical device vendors cybersecurity features in a few…", "team_size": 16, "industry": "Healthcare", "subindustry": "Healthcare -> Healthcare IT", "launched_at": 1541131379, "tags": [ "Medical Devices", "Healthcare", "Cybersecurity" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2019", "status": "Active", "industries": [ "Healthcare", "Healthcare IT" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Growth", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/medcrypt", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2019/medcrypt.json", "year_founded": 2016, "city": "San Diego", "country": "US", "linkedin_url": "", "x_url": "", "fb_url": null, "cb_url": "https://www.crunchbase.com/organization/medcrypt", "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/f83d9fea6258d4ade4828219ac97951e9aabc969.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 118980, "full_name": "Mike Kijewski", "title": "Founder", "founder_bio": "", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/mkijewski", "x_url": "https://www.twitter.com/mikekijewski", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/0fa44d073e5547897cf82c6606566e712e4c4d3c.jpg" }, { "user_id": 147762, "full_name": "Eric Pancoast", "title": "Founder", "founder_bio": null, "is_active": true, "linkedin_url": "https://www.linkedin.com/in/epancoast", "x_url": null, "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/dd8f001e25df8ad3630e00497773ad0645b950d4.jpg" } ], "jobs": [], "news": [ { "title": "MedCrypt lands $25M injection to secure vulnerable medical devices • TechCrunch", "url": "https://techcrunch.com/2022/11/01/medcrypt-security-medical-device/", "date": "Nov 01, 2022" } ], "launches": [] }, { "id": 12012, "name": "Atomic Alchemy", "slug": "atomic-alchemy", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/f78037132844f2c28f0e50e7d2c311cbf1101d6a.png", "website": "https://atomicalchemy.us", "all_locations": "Idaho Falls, ID, USA", "long_description": "Atomic Alchemy is building a bank of reactors to produce the nuclear material that goes into nuclear medicine. Radiopharmaceuticals are vitally important in biological tracers, diagnostic imaging, and cancer treatments.\r\n\r\nCurrently, the world's supply of Molybdenum-99, the cornerstone of 80% of all nuclear medicine procedures, is sourced from just six government-run, scientific research reactors abroad. Five of these reactors are 45-65 years old and are quickly coming to the end of their operational life. This has cultivated a fragile and lengthy supply chain, at odds with the nature of radioactive material.\r\n\r\nThis issue and its implications do not just effect molybdenum, but any other reactor-based isotope. Many promising cancer therapies are stuck in clinical trials, unable to secure enough material in a timely manner. Research doesn’t even happen because of the difficulty of sourcing any new isotopes.\r\n\r\nIt doesn't have to be this way. Atomic Alchemy is working to solve this by building the world's first scalable radioisotope production facility. This facility will contain the world’s first privately-owned nuclear reactors dedicated to radioisotope production.", "one_liner": "We produce cancer-curing materials used in nuclear medicine.", "team_size": 8, "industry": "Industrials", "subindustry": "Industrials -> Manufacturing and Robotics", "launched_at": 1541478882, "tags": [ "Hard Tech", "Small Modular Reactors", "Medical Devices" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2019", "status": "Acquired", "industries": [ "Industrials", "Manufacturing and Robotics" ], "regions": [ "United States of America", "America / Canada" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/atomic-alchemy", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2019/atomic-alchemy.json", "year_founded": 2018, "city": "Idaho Falls", "country": "US", "linkedin_url": "https://www.linkedin.com/company/atomic-alchemy-inc/", "x_url": "https://twitter.com/isotopefactory", "fb_url": "https://www.facebook.com/AtomicAlchemyInc/", "cb_url": "https://www.crunchbase.com/organization/atomic-alchemy", "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/f78037132844f2c28f0e50e7d2c311cbf1101d6a.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 247802, "full_name": "Thomas Eiden", "title": "Founder", "founder_bio": "Former reactor engineer/core designer at the Advanced Test Reactor at Idaho National Laboratory. Performed next-generation nuclear fuels research at the University of Wisconsin-Madison. Built a nuclear reactor in 11 months with Oklo.\n\n", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/thomaseiden", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/766aa58ab7ba8890026018e19010ae572c04d26c.jpg" } ], "jobs": [], "news": [ { "title": "Oklo Closes Acquisition of Radioisotope Producer Atomic Alchemy", "url": "https://oklo.com/newsroom/news-details/2025/Oklo-Closes-Acquisition-of-Radioisotope-Producer-Atomic-Alchemy/default.aspx", "date": "Mar 05, 2025" }, { "title": "Atomic Alchemy and Zeno Power to provide fuel for radioisotopes - Nuclear Engineering International", "url": "https://www.neimagazine.com/news/atomic-alchemy-and-zeno-power-to-provide-fuel-for-radioisotopes/?cf-view", "date": "Dec 03, 2024" }, { "title": "Oklo’s $25M Move into Radioisotope Production to Expand Advanced Nuclear Revenue Stream", "url": "https://www.powermag.com/oklos-25m-move-into-radioisotope-production-to-expand-advanced-nuclear-revenue-stream/", "date": "Nov 14, 2024" }, { "title": "Oklo Signs MOU with Atomic Alchemy to Collaborate on Isotope Production | Business Wire", "url": "https://www.businesswire.com/news/home/20240513678894/en/", "date": "May 13, 2024" } ], "launches": [] }, { "id": 12067, "name": "PNOĒ", "slug": "pnoe", "former_names": [], "small_logo_thumb_url": "/company/thumb/missing.png", "website": "", "all_locations": "Athens, Greece; Miami, FL, USA", "long_description": "PNOĒ enables health professionals to provide science-backed bio-optimization through breath analysis. For 100+ years, breath analysis (AKA metabolic testing, VO2max) has been the gold standard in anti-aging quantification, nutrition prescription, and evaluation of most critical systems, including the heart, lungs, cells, and nervous system. Until recently, it was only available in sophisticated clinics and regarded as the most valuable but underutilized assessment in medicine. PNOĒ changed that through the first easy-to-use clinical-grade breath analysis device, proprietary software package, and dedicated metabolic expert support. Through a non-invasive 10 min breath test, PNOĒ analyzes the human breath and prescribes a personalized nutrition, exercise, breathwork, and bio-optimization (i.e., red light therapy, hyperbaric chamber, IV therapy, etc.) program based on one’s biological limitations. 3,000+ health professionals trust PNOĒ because it personalizes the clients’ journey through their clinics, builds retention by quantifying progress, and enables the upsell of personalized nutrition and breathwork. All this without any effort, time commitment, or upfront cost. PNOĒ has been independently validated by Georgetown University, VA in Maryland, and Rutgers University and is trusted by leading institutions including Cenegenics, Dais Cove, MIT, UCLA, Pan Pacific, CLMBR, UCS, OURA, TONAL, Spartan Racing, and Paris Saint Germain. ", "one_liner": "Enabling health professionals to prescribe clinical-grade wellness…", "team_size": 70, "industry": "Healthcare", "subindustry": "Healthcare -> Healthcare Services", "launched_at": 1601260702, "tags": [ "Medical Devices", "Digital Health", "Telemedicine", "Diagnostics", "Primary Care" ], "tags_highlighted": [], "top_company": false, "isHiring": true, "nonprofit": false, "batch": "Winter 2019", "status": "Active", "industries": [ "Healthcare", "Healthcare Services" ], "regions": [ "Greece", "United States of America", "Europe", "America / Canada", "Remote", "Partly Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/pnoe", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2019/pnoe.json", "year_founded": 2016, "city": "Athens", "country": "GR", "linkedin_url": "https://www.linkedin.com/company/pnoe/mycompany/", "x_url": "https://twitter.com/Pnoe_fitness", "fb_url": "https://www.instagram.com/pnoe_analytics/?hl=en", "cb_url": "https://www.crunchbase.com/organization/pnoe", "github_url": null, "logo_url": null, "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": { "name": "Gustaf Alstromer", "url": "https://www.ycombinator.com/people/gustaf-alstromer" }, "founders": [ { "user_id": 291041, "full_name": "Apostolos Atsalakis", "title": "Founder", "founder_bio": null, "is_active": true, "linkedin_url": "https://www.linkedin.com/in/apostolos-atsalakis-953032a7", "x_url": null, "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/a91351e00efa2b7c2ba391547aca41aacbb9b9f5.jpg" }, { "user_id": 253082, "full_name": "Panos Papadiamantis", "title": "Founder", "founder_bio": "", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/ppapadia/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/7f94ccc3ff5fae3bca4f43195ce6458004c1d8e2.jpg" } ], "jobs": [ { "id": 32785, "title": "Senior Business Developer for Corporate Wellness/Health Insurance", "url": "https://www.ycombinator.com/companies/pnoe/jobs/79hlqPzaH-senior-business-developer-for-corporate-wellness-health-insurance", "location": "Remote / Remote", "type": "Contract", "role": "Sales", "role_type": null, "salary_range": "$150 - $200", "equity_range": "0.10% - 0.50%", "experience": "6+ years", "visa": "Will sponsor", "skills": [] } ], "news": [], "launches": [] }, { "id": 12077, "name": "Instapath Inc.", "slug": "instapath-inc", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/edbfa875f5b9593c4bbe89349b05b7a77c4bb9d6.png", "website": "http://instapathbio.com", "all_locations": "Houston, TX, USA", "long_description": "", "one_liner": "We built the world's first automated digital pathology lab.", "team_size": 6, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1541646306, "tags": [ "Medical Devices" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2019", "status": "Active", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/instapath-inc", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2019/instapath-inc.json", "year_founded": 2017, "city": "Houston", "country": "US", "linkedin_url": "", "x_url": "https://twitter.com/instapathbio", "fb_url": null, "cb_url": "https://www.crunchbase.com/organization/instapath-inc", "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/edbfa875f5b9593c4bbe89349b05b7a77c4bb9d6.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 222957, "full_name": "Mei Wang", "title": "Founder", "founder_bio": "I am the co-founder and CEO of Instapath Inc. ", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/mei-wang-34096858/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/a46d436fbef6131dca564b54b147ba120a05f5e3.jpg" }, { "user_id": 290685, "full_name": "Quincy Brown", "title": "Founder", "founder_bio": null, "is_active": true, "linkedin_url": "https://www.linkedin.com/in/j-quincy-brown-28b4288/", "x_url": null, "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/c0a44b468f8e9d9fd6b786a3b5b8db9e6b3760da.jpg" }, { "user_id": 288938, "full_name": "David Tulman", "title": "Founder", "founder_bio": null, "is_active": true, "linkedin_url": "https://www.linkedin.com/in/david-tulman-2aa38112a/", "x_url": null, "avatar_thumb_url": "/avatars/thumb/missing.png" } ], "jobs": [], "news": [], "launches": [] }, { "id": 12580, "name": "Voyage Biomedical", "slug": "voyage-biomedical", "former_names": [ "Voyage Biomedical Inc." ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/bc2de50e20e222a7884277e269a1efe34dfe261d.png", "website": "https://voyage.bio", "all_locations": "San Francisco, CA, USA; Berkeley, CA, USA", "long_description": "Acquired by Penumbra (NYSE:PEN).", "one_liner": "Using cooling to end brain damage during stroke.", "team_size": 3, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1556165412, "tags": [ "Hardware", "Neurotechnology", "Medical Devices" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2019", "status": "Acquired", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "United States of America", "America / Canada" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": true, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/voyage-biomedical", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2019/voyage-biomedical.json", "year_founded": 2018, "city": "San Francisco", "country": "US", "linkedin_url": "", "x_url": "", "fb_url": null, "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/bc2de50e20e222a7884277e269a1efe34dfe261d.png", "app_video_url": null, "dday_video_url": "https://bookface-images.s3.us-west-2.amazonaws.com/video_event/45/1566337814965-a8vfx0lzgvf-43db43432b5134b893a40c7759ed463d/421658c884fd278719f235a518bbe9ac.mp4?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIAQC4NIECABPQ2AHNW%2F20261020%2Fus-west-2%2Fs3%2Faws4_request&X-Amz-Date=20261020T022644Z&X-Amz-Expires=3600&X-Amz-SignedHeaders=host&X-Amz-Signature=d32d9c210c93e65c47e07118652225226ed2fde8a333c333c8805990d485f445", "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 276914, "full_name": "Justin Olshavsky", "title": "Founder", "founder_bio": "Founder of Voyage Bio (S19, acquired by Penumbra), founding partner of Pioneer Bio+Health Fund", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/jolshavsky/", "x_url": "https://twitter.com/olshav", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/8beae5cc238b762e5eeec94788aecd8ac75235f4.jpg" }, { "user_id": 288625, "full_name": "Robert Schultz", "title": "Founder", "founder_bio": "MD, heart surgery resident", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/robschultzmd", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/6bdc4435522c5847612abfc51ce6cd0dc067a0df.jpg" }, { "user_id": 349311, "full_name": "Bridget Vaughan", "title": "Founder", "founder_bio": "", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/bridgetcvaughan", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/eb0a10c54180e581d2ad33f6c97f8d6e3243ebfd.jpg" } ], "jobs": [], "news": [], "launches": [] }, { "id": 12611, "name": "AudioFocus", "slug": "audiofocus", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/dfd0e481274d2ce049ec8ba610428a947f18b71a.png", "website": "http://audiofocus.io", "all_locations": "San Francisco, CA, USA; Oakland, CA, USA", "long_description": "If we've learned anything in the last few years it's that spending time with our friends and family is essential to our well-being and happiness. Unfortunately, loud and noisy places like weddings and family gatherings hinder human connection, especially for the hearing impaired. In fact, the biggest unmet need in the entire hearing healthcare industry is hearing in noisy places. AudioFocus helps patients hear in these environments by only enhancing voices nearby the patients and ignoring ones farther away. We do this using acoustics informed machine learning and custom microphone array design.\r\n\r\nOur goal is to increase the adoption rate of 37M US adults with hearing loss, only 8M use hearing aids today.\r\n\r\nFounded by Auditory Neuroscientist & AI expert and a Hearing Aid hardware design expert.", "one_liner": "Hearing aids that work in noisy places, like restaurants, using ML.", "team_size": 4, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1556592393, "tags": [ "Deep Learning", "Hardware", "Medical Devices" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2019", "status": "Inactive", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "United States of America", "America / Canada" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/audiofocus", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2019/audiofocus.json", "year_founded": 2019, "city": "San Francisco", "country": "US", "linkedin_url": "", "x_url": "https://twitter.com/AudioFocus", "fb_url": null, "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/dfd0e481274d2ce049ec8ba610428a947f18b71a.png", "app_video_url": null, "dday_video_url": null, "company_photos": [ "https://bookface-images.s3.us-west-2.amazonaws.com/attachments/f90481475c68fe2cb1fba1051650c704218acd76.png" ], "primary_partner": null, "founders": [ { "user_id": 62073, "full_name": "Shariq Mobin", "title": "Founder", "founder_bio": "Machine Learning and Distributed Systems hacker. Accessibility advocate.", "is_active": false, "linkedin_url": "https://www.linkedin.com/in/shariqmobin", "x_url": "https://twitter.com/shariqmobin", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/c82eb01ac64fdb2b5a0f0a7812213707960af3fd.jpg" } ], "jobs": [], "news": [], "launches": [] }, { "id": 13118, "name": "Perceptive Technologies", "slug": "perceptive-technologies", "former_names": [ "Cyberdontics", "Cyberdontics", "Perceptive Technologies, Inc (formerly Cyberdontics", "Perceptive Technologies, Inc (formerly Cyberdontics)", "Perceptive Technologies, Inc" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/0af9298634a06fac205a5f21943eef3988141c14.png", "website": "https://www.perceptive.io", "all_locations": "Boston, MA, USA", "long_description": "Stealth-mode, rapidly scaling, venture-backed startup at the vanguard of automated robotic surgery revolution -- just closed our Series A round. We are improving access to dental care in underserved populations by combining novel imaging technology with AI and surgical robotics to automate surgery in the $452B dental industry. \r\n\r\nWe are bringing a new imaging modality to dentistry which can see inside teeth and below the gingiva all without the need for x-rays. AI is used to diagnose decay and plan treatment. Automated robotics reduces the time for surgery down to one minute, reducing patient discomfort and saving time and reducing cost for the dentist.\r\n\r\nYC 2020, Winner of the Forsyth DenTech 2021 CareCaptial award", "one_liner": "Automated tooth cutting for dentists using imaging, AI and robotics", "team_size": 25, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1587740005, "tags": [ "Robotics", "Health Tech", "Medical Devices", "AI" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2020", "status": "Active", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Growth", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/perceptive-technologies", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2020/perceptive-technologies.json", "year_founded": 2020, "city": "Boston", "country": "US", "linkedin_url": "", "x_url": "", "fb_url": null, "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/0af9298634a06fac205a5f21943eef3988141c14.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 414521, "full_name": "Chris Ciriello", "title": "Founder", "founder_bio": "Founder Perceptive Tech, developed biomarker thesis, first in motion OCT, AI OCT models, first human automated dental crown prep.", "is_active": false, "linkedin_url": "https://www.linkedin.com/in/christopher-ciriello/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/ffb629bd59d9a6c7c30987db0e510aa33aabed1b.jpg" }, { "user_id": 418205, "full_name": "Scott Phillips", "title": "Founder", "founder_bio": null, "is_active": false, "linkedin_url": "https://www.linkedin.com/in/scotthphillips/", "x_url": null, "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/0fda450e09adb59a4965d67e7abcbdec8402d92b.jpg" } ], "jobs": [], "news": [ { "title": "AI startup raises $30 million, including from Mark Zuckerberg’s dad", "url": "https://www.statnews.com/2024/07/30/dental-ai-robotics-startup-perceptive-ed-zuckerberg/", "date": "Jul 30, 2024" }, { "title": "Cyberdontics raises $15M for robotic root canals • TechCrunch", "url": "https://techcrunch.com/2022/10/17/cyberdontics-raises-15m-for-robotic-root-canals/", "date": "Oct 17, 2022" } ], "launches": [] }, { "id": 13338, "name": "twoplus fertility", "slug": "hannah-life-technologies", "former_names": [ "Hannah Life Technologies" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/766a16d49e6e5875f93d06424e0d5a962067f994.png", "website": "http://twoplusfertility.com", "all_locations": "Singapore, Singapore", "long_description": "We are making a new fertility treatment that infertile couples can order with a click of a\r\nbutton to help them conceive at home. Our technology increases the likelihood of pregnancy by guiding significantly higher number of sperms towards the ovum using a proprietary combination of surface features and microenvironment optimization.\r\n\r\nThe fertility treatments available today, such as in-vitro fertilization (IVF) and intra-uterine\r\ninsemination (IUI), are psychologically and financially draining and come with considerable treatment-associated risks. Furthermore, over 25 million women of reproductive age in the US\r\nhave limited nearby access to fertility treatment.", "one_liner": "An effective home-use fertility treatment for natural conception", "team_size": 18, "industry": "Healthcare", "subindustry": "Healthcare -> Consumer Health and Wellness", "launched_at": 1599762607, "tags": [ "Fertility Tech", "Medical Devices", "Telemedicine" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2020", "status": "Active", "industries": [ "Healthcare", "Consumer Health and Wellness" ], "regions": [ "Singapore", "Southeast Asia" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/hannah-life-technologies", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2020/hannah-life-technologies.json", "year_founded": 2019, "city": "Singapore", "country": "SG", "linkedin_url": "", "x_url": "", "fb_url": null, "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/766a16d49e6e5875f93d06424e0d5a962067f994.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 311581, "full_name": "Prusothman Raja", "title": "Founder", "founder_bio": "Medical device innovator with experience in new product development and navigating FDA.", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/prusothman-sina-raja-93881440/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/b738a45e76ea88be6fb2a5cffced75c8f8944300.jpg" }, { "user_id": 317425, "full_name": "Benjamin Tee", "title": "Founder", "founder_bio": "Spent a few good years in StanfordU dreaming up crazy ideas, and decided to make them real by starting companies. Stanford Biodesign Fellow and serial entrepreneur. Also an academic trying to help others dream and achieve things they never thought possible. Current 10 year goal: Make 1M babies with Hannah Life Technologies.", "is_active": true, "linkedin_url": "https://linkedin.com/in/benjamintee", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/008ff1f77168b7bf1a23970357027d5eb32df2ba.jpg" } ], "jobs": [], "news": [ { "title": "Y Combinator-backed SG fertility startup bags $5.1m funding", "url": "https://www.techinasia.com/hannah-life-pre-series-a-funding", "date": "May 10, 2022" }, { "title": "Fertility startup Hannah Life Technologies gets $5.15M Pre-Series A – TechCrunch", "url": "https://techcrunch.com/2022/05/09/fertility-startup-hannah-life-technologies-gets-5-15m-pre-series-a/", "date": "May 09, 2022" }, { "title": "Couple managed to conceive after using a £49 sperm-catching device | Daily Mail Online", "url": "https://www.dailymail.co.uk/health/article-10687621/Couple-managed-conceive-using-49-sperm-catching-device.html", "date": "Apr 05, 2022" } ], "launches": [] }, { "id": 13351, "name": "Morphle Labs", "slug": "morphle-labs", "former_names": [ "Morphle Technologies Private Limited", "Morphle" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/c76097b716ca7b82f6b26beb694f3ab12e87aab6.png", "website": "https://morphlelabs.com", "all_locations": "Bengaluru, KA, India", "long_description": "", "one_liner": "Robotic Automation for cancer diagnostics - Robotic Microscopes &…", "team_size": 65, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1584114914, "tags": [ "Hardware", "Robotics", "Health Tech", "Medical Devices", "Automation" ], "tags_highlighted": [], "top_company": false, "isHiring": true, "nonprofit": false, "batch": "Winter 2020", "status": "Active", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "India", "South Asia" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/morphle-labs", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2020/morphle-labs.json", "year_founded": 2017, "city": "Bengaluru", "country": "IN", "linkedin_url": "https://www.linkedin.com/company/morphle/", "x_url": "https://twitter.com/MorphleDigiPath", "fb_url": "https://www.facebook.com/morphlelabs", "cb_url": "https://www.crunchbase.com/organization/morphle", "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/c76097b716ca7b82f6b26beb694f3ab12e87aab6.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 215164, "full_name": "Rohit Hiwale", "title": "Founder", "founder_bio": "A product geek & a hard tech enthusiast solving unique problems in vision guide robotics starting with medical devices.", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/rohithiwale/", "x_url": "https://twitter.com/hiwalle", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/85216d449d71fe18457b0296f1ab3b2e28b39bd3.jpg" } ], "jobs": [ { "id": 67506, "title": "Senior Software Engineer", "url": "https://www.ycombinator.com/companies/morphle-labs/jobs/N2I8gal-senior-software-engineer", "location": "Bengaluru", "type": "Full-time", "role": "Engineering", "role_type": "Full stack", "salary_range": "₹2.5M - ₹4M INR", "equity_range": "", "experience": "3+ years", "visa": "US citizenship/visa not required", "skills": [ "Angular", "Django", "Java" ] } ], "news": [], "launches": [] }, { "id": 21816, "name": "VenoStent", "slug": "venostent", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/85c511b5b08466c9718931c1aafcb26b7bd9181b.png", "website": "https://www.venostent.com", "all_locations": "Houston, TX, USA", "long_description": "There are 10 million dialysis and bypass surgeries per year, but half of them fail. VenoStent saves lives with a wrap that goes around blood vessels during surgery so they don't fail.", "one_liner": "Absorbable wrap for blood vessels", "team_size": 17, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1593442656, "tags": [ "Medical Devices", "3D Printing" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2020", "status": "Active", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "United States of America", "America / Canada" ], "stage": "Growth", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/venostent", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2020/venostent.json", "year_founded": 2017, "city": "Houston", "country": "US", "linkedin_url": "https://www.linkedin.com/company/venostent", "x_url": "https://twitter.com/venostent", "fb_url": null, "cb_url": "https://www.crunchbase.com/organization/venostent", "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/85c511b5b08466c9718931c1aafcb26b7bd9181b.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": { "name": "Jared Friedman", "url": "https://www.ycombinator.com/people/jared-friedman" }, "founders": [ { "user_id": 300009, "full_name": "Tim Boire", "title": "Founder", "founder_bio": "President and CEO of VenoStent, Inc. I developed these novel smart polymeric biomaterials for vascular applications during my PhD at Vanderbilt University. Focus of the technology shifted to hemodialysis access applications after participating in the 2014 NSF I-Corps program. BS, Chemical & Biological Engineering and Biotechnology, Tufts University, 2008; PhD, Biomedical Engineering, Vanderbilt University, 2017. Worked in R&D at Genzyme Corporation, 2008 - 2011. Grew up in Nashua, NH.", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/timothy-boire-283bab10/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/099024dafa7c4a08edd4b77c7c900fae5ca42412.jpg" }, { "user_id": 101965, "full_name": "Geoffrey Lucks", "title": "Founder", "founder_bio": "Co-founder & COO of pivotal trial-stage therapeutic medical device company developing bioabsorbable wraps to improve vascular surgery. Vandy MBA, UPenn Masters of Bioethics, UW-Madison UG\n\nInterested in tech and culture. Reading: the classics, religion, economics, finance, politics, philosophy, history, social sciences, etc. Born mellow and everywhere harshed. ", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/geoffrey-lucks-0495a239/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/aa2ab7a7ca416d6b24531a28395ee4ab9e3bc0b9.jpg" } ], "jobs": [], "news": [ { "title": "VenoStent Completes $16M Series A Financing, Receives IDE Approval from FDA to Begin US Trial", "url": "https://finance.yahoo.com/news/venostent-completes-16m-series-financing-140400126.html", "date": "Jul 31, 2023" }, { "title": "VenoStent Technology Receives Breakthrough Device Designation by FDA | BioSpace", "url": "https://www.biospace.com/article/releases/venostent-technology-receives-breakthrough-device-designation-by-fda/", "date": "May 17, 2022" } ], "launches": [] }, { "id": 22206, "name": "Vena Vitals", "slug": "vena-vitals", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/d5e63e35879195913f15231bf23b59e4850803e2.png", "website": "http://venavitals.com", "all_locations": "Irvine, CA, USA", "long_description": "Vena Vitals makes a small sticker that monitors blood pressure continuously. We've shown that it works in the operating room and is as accurate as the best tools doctors have today, at a fraction of the cost. We're a team of health tech scientists with multiple past startups and exits, and we've built products that have scaled to over 2M users.", "one_liner": "A small sticker that monitors blood pressure continuously", "team_size": 9, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1597939819, "tags": [ "Hard Tech", "Nanosensors", "Health Tech", "Medical Devices", "Digital Health" ], "tags_highlighted": [], "top_company": false, "isHiring": true, "nonprofit": false, "batch": "Summer 2020", "status": "Active", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/vena-vitals", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2020/vena-vitals.json", "year_founded": 2019, "city": "Irvine", "country": "US", "linkedin_url": "https://www.linkedin.com/company/vena-vitals", "x_url": "", "fb_url": null, "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/d5e63e35879195913f15231bf23b59e4850803e2.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 472902, "full_name": "Ray Liu", "title": "Founder", "founder_bio": "- Two health tech exits (to Cigna & Vizient)\n- 15+ years leadership at GE Healthcare, Siemens, & startups (Ediom, Socialwellth)\n- Built multiple products/services from ground zero, some with 2M+ users\n- Set up quality system for factory in China that passed FDA inspection \n- MBA, Harvard Business School\n- MS Electrical Engineering, University of California at Berkeley \n- BS Electrical Engineering, University of Illinois at Urbana-Champaign\n", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/rayliu/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/f3e05b58b2316da94b5bb888ca74e77e3c10ac9b.jpg" }, { "user_id": 491064, "full_name": "Michelle Khine", "title": "Founder", "founder_bio": "Professor of Biomedical Engineering and Serial Entrepreneur", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/michelle-khine-a7111315/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/e8d71c149514027f92005a2e24336211dfc69f4c.jpg" }, { "user_id": 472936, "full_name": "Josh Kim", "title": "Founder", "founder_bio": "PhD - Materials Science and Engineering, University of California, Irvine\nMS - Materials Science and Engineering, University of California, Irvine\nBS - Chemistry, University of Illinois, Urbana-Champaign", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/joshkim599/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/1328932dd6ce247eeb64f13e993a164bac288aa6.jpg" } ], "jobs": [ { "id": 53885, "title": "R&D Algorithm Engineer – Health Technologies", "url": "https://www.ycombinator.com/companies/vena-vitals/jobs/RvD50Nt-r-d-algorithm-engineer-health-technologies", "location": "Irvine, CA", "type": "Full-time", "role": "Engineering", "role_type": "Data science", "salary_range": "$75K - $125K", "equity_range": "0.09% - 0.50%", "experience": "3+ years", "visa": "Will sponsor", "skills": [ "C", "C++", "D", "MATLAB", "Python", "TensorFlow", "Deep Learning", "Data Modeling", "Data Analytics", "Machine learning" ] }, { "id": 60986, "title": "Electrical Engineer ", "url": "https://www.ycombinator.com/companies/vena-vitals/jobs/mHg6rfQ-electrical-engineer", "location": "Irvine, CA, US", "type": "Full-time", "role": "Engineering", "role_type": "Electrical", "salary_range": "$70K - $150K", "equity_range": "", "experience": "3+ years", "visa": "Will sponsor", "skills": [ "Assembly", "C", "C++", "CAD Design", "Prototyping" ] }, { "id": 80286, "title": "R&D Process & Manufacturing Manager", "url": "https://www.ycombinator.com/companies/vena-vitals/jobs/qRFk4gc-r-d-process-manufacturing-manager", "location": "Las Vegas, NV, US", "type": "Full-time", "role": "Engineering", "role_type": "Engineering manager", "salary_range": "$60K - $120K", "equity_range": "0.10% - 0.50%", "experience": "3+ years", "visa": "Will sponsor", "skills": [ "MATLAB", "Chemistry", "Material science", "Wet lab" ] } ], "news": [], "launches": [] }, { "id": 22207, "name": "inSoma Bio", "slug": "insoma-bio", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/de0455624bad1e94310441869f841535ce28c99b.png", "website": "https://www.insomabio.com/", "all_locations": "Durham, NC, USA", "long_description": "", "one_liner": "Helping Plastic Surgeons Rebuild Fat", "team_size": 4, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1599762607, "tags": [ "Synthetic Biology", "Medical Devices" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2020", "status": "Active", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "United States of America", "America / Canada" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/insoma-bio", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2020/insoma-bio.json", "year_founded": 2018, "city": "Durham", "country": "US", "linkedin_url": "", "x_url": "", "fb_url": null, "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/de0455624bad1e94310441869f841535ce28c99b.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 470207, "full_name": "Stefan Roberts", "title": "Founder", "founder_bio": "", "is_active": true, "linkedin_url": "http://www.linkedin.com/in/stefan-roberts-1a2b6747", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/ed4fc434818989390ad974f605893c641d6a418d.jpg" }, { "user_id": 492178, "full_name": "Ashutosh Chilkoti", "title": "Founder", "founder_bio": "I am a professor of Biomedical Engineering at Duke University, and currently the Chair of the department. I work on genetically encoded biomaterials, drug delivery and point-of-care diagnostics. I have cofounded 5 companies — PhaseBio (NASDAQ: PHAS), Sentilus (acquired by Immucor in 2014), Gateway Bio, Isolere Bio and inSoma Bio,", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/ashutosh-chilkoti-2531193/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/d5934a4d0bcda882cf09f86fa762124b67506299.jpg" } ], "jobs": [], "news": [], "launches": [] }, { "id": 22934, "name": "Auricle", "slug": "auricle", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/3befcbf94e33a69c5d761a78d1ff81c267da6aff.png", "website": "https://auricle.com", "all_locations": "San Francisco, CA, USA; Oakland, CA, USA", "long_description": "Auricle is a medical device company building a breakthrough neurostimulation implant to restore hearing in millions of patients who no longer benefit from hearing aids, get less than 60% on a word recognition test, but aren't prepared to make the jump to a cochlear implant. \r\n\r\nOur approach preserves remaining natural hearing through a reversible and less invasive surgery, addressing the key concerns that hold most patients back from getting a cochlear implant (currently the only treatment option for these patients).\r\n\r\nThe company spun out of Stanford Biodesign having completed two acute human clinical studies demonstrating the approach will work. The team is now focused on developing their full implant system for their first clinical trial. \r\n\r\nAuricle addresses a currently unserved profile of hearing loss that affects a growing population of 3.5 million patients in the US and represents an immediately accessible $1.2B market opportunity with existing reimbursement.", "one_liner": "Neurostimulation implant to restore hearing & speech understanding", "team_size": 2, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1680287454, "tags": [ "Hard Tech", "Neurotechnology", "Health Tech", "Medical Devices", "Healthcare" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2021", "status": "Active", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/auricle", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2021/auricle.json", "year_founded": 2020, "city": "San Francisco", "country": "US", "linkedin_url": "https://linkedin.com/company/auriclehealth", "x_url": "https://twitter.com/auricleneuro", "fb_url": null, "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/3befcbf94e33a69c5d761a78d1ff81c267da6aff.png", "app_video_url": null, "dday_video_url": null, "company_photos": [ "https://bookface-images.s3.us-west-2.amazonaws.com/attachments/6bc38e9898ae09e2c3b05e814c12b5abf8211660.png" ], "primary_partner": null, "founders": [ { "user_id": 586540, "full_name": "Francis Wong", "title": "Founder", "founder_bio": "I'm Francis, a UK-trained surgeon who worked in the National Health Service as a surgeon for 5 years. In 2012 I moved to the Bay Area to get my MBA/MPH at UC Berkeley. I've worked in several product management roles at startups including 23andMe and Castlight Health. I also founded Outcomes, Inc., a digital health startup enabling the routine use of patient-reported outcomes. Prior to Stanford, I worked at Haven in Boston and co-founded Auricle out of the Stanford Biodesign Fellowship.", "is_active": true, "linkedin_url": "https://linkedin.com/in/loaded", "x_url": "https://twitter.com/packeted", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/a4ab023ff6e3e34ae20e78435ce77c1c8187b0f8.jpg" }, { "user_id": 589133, "full_name": "Jay Dhuldhoya", "title": "Founder", "founder_bio": "I am a medical device engineer and entrepreneur with a BA from Columbia and an MS from Rice in biomedical engineering. I have led R&D, quality, and manufacturing projects at Element Science, an SF-based Class 3 medical device start-up. I recently completed the Stanford Biodesign Innovation Fellowship where I co-founded Auricle.", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/jaydhuldhoya/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/92bae1341bd83a4509297cd91f514b366eb122d9.jpg" } ], "jobs": [], "news": [ { "title": "Our favorite startups from YC's Winter 2023 Demo Day — Part 1 | TechCrunch", "url": "https://techcrunch.com/2023/04/05/y-combinator-demo-day-favorites-part-one/", "date": "Apr 05, 2023" } ], "launches": [] }, { "id": 23597, "name": "Kilobaser", "slug": "kilobaser", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/e1ed33a936a43c8aace45a8383365d93d4620730.png", "website": "https://www.kilobaser.com", "all_locations": "Graz, Styria, Austria", "long_description": "We combined microfluidic chip technology and a reagent cartridge to create the first personal DNA synthesizer. Until now most life scientists had to rely on out-sourced DNA synthesis, causing stagnating research. Kilobaser empowers every life scientist to synthesize DNA on their benchtop.", "one_liner": "Desktop DNA Printer. The Nespresso Machine for DNA.", "team_size": 10, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1616246135, "tags": [ "Hard Tech", "Hardware", "Medical Devices" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2021", "status": "Active", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "Austria", "Europe" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/kilobaser", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2021/kilobaser.json", "year_founded": 2014, "city": "Graz", "country": "AT", "linkedin_url": "https://www.linkedin.com/company/kilobaser", "x_url": "https://www.twitter.com/DNAPrototyper", "fb_url": "https://www.facebook.com/kilobaser.DNA", "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/e1ed33a936a43c8aace45a8383365d93d4620730.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 591593, "full_name": "Alexander Murer", "title": "Founder", "founder_bio": "", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/alexander-murer-ab76aa97/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/1c8ddcf90043f4c41e6e6a60d87045cab2d28a7a.jpg" }, { "user_id": 595278, "full_name": "Martin Jost", "title": "Founder", "founder_bio": "Molecular Biologist / Biohacker / Developer (Full Stack)", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/martinjost/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/bd0300fae35e26405538bcf43b058ddd15c05497.jpg" }, { "user_id": 595287, "full_name": "Bernhard Tittelbach", "title": "Founder", "founder_bio": "Likes to have an ever more accurate model of the world. Interested in how things work. Likes to take apart, hack and create things, to understand them better. Interested in various frameworks that allow people to work together.\nSometimes Speaker at talks, helper at events and holder of workshops.\nLife Goal: Create net gain for everyone, leave the world a slightly better place and come out ahead as well.\nWould love for everyone to learn rationality and probability theory in school.", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/bernhard-tittelbach-a903a696/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/5336354bf31e0226872161c3bc0f403675d23f7e.jpg" } ], "jobs": [], "news": [], "launches": [] }, { "id": 24034, "name": "Ananya Health", "slug": "ananya-health", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/2b4784fe233f145657c210c4e6446866d8b1196b.png", "website": "https://www.ananya.health/", "all_locations": "San Francisco, CA, USA", "long_description": "Building a standard-of-care medical device to freeze abnormal cells before they become cervical cancer, in any clinic, anywhere in the world, at 1/10 the cost.\r\n--\r\nAnanya Health is building a portable cryoablation unit designed for every primary care clinic in the world. Our beachhead application is cervical cancer prevention -- even though cervical cancer is easy to screen for, 80% of clinics worldwide lack the infrastructure and specialized staff to treat at the earliest stages. Our platform technology allows nurses and lower level health workers to treat at the point of care for 1/10 the cost of traditional ablation, and is the only cryo device that will help us achieve the WHO target to eliminate cervical cancer in our lifetime.", "one_liner": "Portable cryoablation to prevent cervical cancer", "team_size": 8, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1625509180, "tags": [ "Hardware", "Health Tech", "Medical Devices" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2021", "status": "Active", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "United States of America", "America / Canada" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": true, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/ananya-health", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2021/ananya-health.json", "year_founded": 2020, "city": "San Francisco", "country": "US", "linkedin_url": "https://www.linkedin.com/company/ananya-health", "x_url": "", "fb_url": null, "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/2b4784fe233f145657c210c4e6446866d8b1196b.png", "app_video_url": null, "dday_video_url": "https://bookface-images.s3.us-west-2.amazonaws.com/video_event/54/1630623108079-sxpgxjvx2r-011a2860734371d7ae1e5e153f90ae55/9400c6f6227bba9229b6fe646a6c1497.mp4?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIAQC4NIECABPQ2AHNW%2F20261020%2Fus-west-2%2Fs3%2Faws4_request&X-Amz-Date=20261020T022657Z&X-Amz-Expires=3600&X-Amz-SignedHeaders=host&X-Amz-Signature=22a1aa55111ecd6dbd44c2701f2098c543716c0676b63b8ad8421d5223aa3966", "company_photos": [ "https://bookface-images.s3.us-west-2.amazonaws.com/attachments/0da36c27c332991897904237530243e14ec57f84.png" ], "primary_partner": null, "founders": [ { "user_id": 257454, "full_name": "Anu Parvatiyar", "title": "Founder", "founder_bio": "Cofounder & CEO at Ananya Health. I’m a medical device engineer turned public health technologist. I love building products that expand access to healthcare in emerging markets — from better data tools to improve childhood vaccination rates in Nigeria, to medical devices that allow nurses and midwives to deliver the same high-quality standard of medicine as specialized Ob/Gyns.", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/anuparvatiyar/", "x_url": "https://twitter.com/anu_par", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/1f9cf88c2c21e36cf9c5b6e34830aa95922dc7d7.jpg" } ], "jobs": [], "news": [], "launches": [] }, { "id": 24058, "name": "Zeit Medical", "slug": "zeit-medical", "former_names": [ "Zeit Medical Inc." ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/a099dfe2730e5df20958e5db106644c907772abb.png", "website": "https://www.zeitmedical.com/", "all_locations": "San Francisco, CA, USA; Redwood City, CA, USA", "long_description": "Zeit Medical leverages the power of AI and wearable sensors to deliver peace of mind for those affected by stroke. Zeit’s smart headband immediately detects the onset of stroke and notifies 911. Each year more than 90% of the one million strokes in the US go untreated, resulting in life-long disability and exploding medical costs north of $100b. The lack of timely treatment is the result of delays in alerting the emergency services. More than 10 million Americans with an elevated stroke risk live with constant fear that a stroke may go unnoticed for hours, while they are asleep or alone. The company was founded by Orestis Vardoulis PhD a biomedical & mechanical engineer and expert in digital health (EPFL/Stanford) and Urs Naber MD a critical care physician (Dartmouth/Stanford). They have both seen the devastating effects of stroke in their families and came up with the idea of addressing this unmet clinical need during their Stanford Biodesign Innovation Fellowship.", "one_liner": "Immediate stroke detection at home", "team_size": 2, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1627888729, "tags": [ "Sleep Tech", "Consumer Health Services", "Medical Devices" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2021", "status": "Inactive", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/zeit-medical", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2021/zeit-medical.json", "year_founded": 2019, "city": "San Francisco", "country": "US", "linkedin_url": "https://www.linkedin.com/company/zeitmedical/", "x_url": "https://twitter.com/zeitmedical", "fb_url": "https://www.facebook.com/zeitmed/", "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/a099dfe2730e5df20958e5db106644c907772abb.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 410475, "full_name": "Orestis Vardoulis", "title": "Founder", "founder_bio": "Maker, Breaker, Baker", "is_active": false, "linkedin_url": "https://www.linkedin.com/in/orestisvardoulis/", "x_url": "https://twitter.com/orestisvar", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/2c16224c0cb29f3df1e8d7b76098e1638ad5ea1d.jpg" }, { "user_id": 410790, "full_name": "Urs Naber", "title": "Founder", "founder_bio": "Growing up building and modding the gaming computers for all my friends, I had to pause my passion for tinkering during medical school, only to re-discover it in postgraduate training. I tried starting my first needle-free vein access device company during pediatrics residency. Although an early failure, I found the right mentorship, first at Dartmouth and then as a fellow at Stanford Biodesign Innovation Fellowship, where I learned the ins and outs of medical technology innovation. ", "is_active": false, "linkedin_url": "https://www.linkedin.com/in/urs-naber-2393b62a/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/b1bdca7d73ae599e76caab7d2e57ed1e89ae5257.jpg" } ], "jobs": [], "news": [ { "title": "Zeit secures $2M in seed funding for its stroke-detecting wearable – TechCrunch", "url": "https://techcrunch.com/2021/10/29/zeit-secures-2m-in-seed-funding-for-its-stroke-detecting-wearable/?tpcc=tcplustwitter", "date": "Oct 29, 2021" }, { "title": "Zeit’s early warning wearable for sleep strokes could save hours and lives – TechCrunch", "url": "https://techcrunch.com/2021/08/25/zeits-early-warning-wearable-for-sleep-strokes-could-save-hours-and-lives/", "date": "Aug 25, 2021" } ], "launches": [] }, { "id": 24095, "name": "Neodocs", "slug": "neodocs", "former_names": [ "Neodocs Technologies Pvt. Ltd." ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/957c00265cfe6ded7c38d77ca38c5e42c0cf9128.png", "website": "https://www.neodocs.in", "all_locations": "MH, India", "long_description": "Neodocs lets you perform instant lab tests on your smartphone. Our users are health optimizers and athletes who want to improve key nutritional markers for better performance.\r\n\r\nYou simply collect your sample, take a picture, and results are instantly generated.\r\n\r\n\r\nWe are the perfect team to build this. Anurag is a 3-time medical entrepreneur who’s built medical devices, Pratik has worked on AI/ML models for leading US banks, and Nikunj comes from a consulting background at Bain & Co.\r\n\r\nWe’re building your personal lab on your phone.", "one_liner": "Instant lab tests on your smartphone", "team_size": 20, "industry": "Healthcare", "subindustry": "Healthcare", "launched_at": 1628661815, "tags": [ "Consumer Health Services", "Medical Devices", "AI" ], "tags_highlighted": [], "top_company": false, "isHiring": true, "nonprofit": false, "batch": "Summer 2021", "status": "Active", "industries": [ "Healthcare" ], "regions": [ "India", "South Asia", "Remote", "Partly Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/neodocs", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2021/neodocs.json", "year_founded": 2020, "city": null, "country": "IN", "linkedin_url": "https://www.linkedin.com/company/neodocs/", "x_url": "https://twitter.com/neodocs", "fb_url": null, "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/957c00265cfe6ded7c38d77ca38c5e42c0cf9128.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 488589, "full_name": "Nikunj Malpani", "title": "Founder", "founder_bio": "Co-founder @ Neodocs | Ex-Bain & Co | IIT Bombay", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/nikunjmalpani/", "x_url": "https://twitter.com/nikunj_malpani", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/771d8dca29039dea6a74576af4193344b4e5bc55.jpg" }, { "user_id": 388476, "full_name": "Pratik Lodha", "title": "Founder", "founder_bio": "Hacker.\nPassionate about building products.", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/pratiklodha/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/944646d003b1fddd1f9e8462e2cadb57c5b02db8.jpg" }, { "user_id": 488840, "full_name": "Anurag Meena", "title": "Founder", "founder_bio": "I like building stuff. Worked across both hardware and software. \n\nPassionate about healthcare. Have built a data driven healthcare startup and a medical device design company previously. Always up for discussing the next Big things in technology. ", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/anurag-meena/", "x_url": "https://twitter.com/ianuragit", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/40fab4a87444231f1e9fb46e08a7f1c707c55131.jpg" } ], "jobs": [ { "id": 62272, "title": "Flutter Developer", "url": "https://www.ycombinator.com/companies/neodocs/jobs/DdBrlSA-flutter-developer", "location": "Mumbai, MH, IN", "type": "Full-time", "role": "Engineering", "role_type": "Frontend", "salary_range": "₹1.2M - ₹1.4M INR", "equity_range": "", "experience": "3+ years", "visa": "US citizen/visa only", "skills": [ "Android", "F#" ] } ], "news": [ { "title": "Pfizer offers grant and incubation support to 14 Indian health-tech startups under 'INDovation Program'", "url": "https://www.fortuneindia.com/business-news/pfizer-offers-grant-and-incubation-support-to-14-indian-health-tech-startups-under-indovation-program/130367", "date": "Feb 12, 2026" }, { "title": "Samsung R&D Institute Noida Ignites India’s Tech Future with 3rd Startup Summit – Samsung Newsroom India", "url": "https://news.samsung.com/in/samsung-rd-institute-noida-ignites-indias-tech-future-with-3rd-startup-summit", "date": "Jun 03, 2025" }, { "title": "IIT Bombay trio aims for Asia Book of Records with massive kidney screening drive - Express Healthcare", "url": "https://www.expresshealthcare.in/news/iit-bombay-trio-aims-for-asia-book-of-records-with-massive-kidney-screening-drive/448311/", "date": "Mar 12, 2025" }, { "title": "Neodocs secures $2M seed funding from Omidyar, Y-Combinator", "url": "https://yourstory.com/2024/02/neodocs-secures-2m-seed-funding-from-omidyar-yc", "date": "Feb 09, 2024" }, { "title": "Google launches seventh class for its startups accelerator programme", "url": "https://yourstory.com/2023/07/google-launches-seventh-class-for-its-startups-accelerator-programme", "date": "Jul 04, 2023" } ], "launches": [] }, { "id": 24108, "name": "V-Flow Medical", "slug": "v-flow-medical-inc", "former_names": [ "V-Flow Medical", "Inc" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/a4a2e2f2139d9baa80f30d05c72feb1978ae5906.png", "website": "https://www.vflowmedicalinc.com/", "all_locations": "San Clemente, CA, USA; Remote", "long_description": "Chronic pelvic pain is a debilitating condition, that impacts over 15 million US women and costs over $39 Billion each year to manage. V-Flow medical has developed a trio of products that target the root cause of chronic pelvic pain, allowing millions of women to avoid opioid use and restart living a normal, pain free life. \r\n\r\nThe V-Flow team has successfully scaled, multiple start-up medical device companies in various clinical disciplines with a combined exit value of over $4B. We have developed a broad IP portfolio covering both device design and method of application. A recent landscaping identified no competing IP for our indication of use. We have tested our beta prototypes and are initiating animal models ahead of a planned first in human investigation in Q1 2023. Following discussion with the NIH program advisors, we have been encouraged to apply for a phase 1 grant, call to action for the Heal initiative to find new diagnostic and non-drug treatments for chronic pelvic pain. \r\n", "one_liner": "Transforming the lives of millions of women suffering from chronic…", "team_size": 4, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1625059572, "tags": [ "Medical Devices" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2021", "status": "Inactive", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "United States of America", "America / Canada", "Remote", "Fully Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/v-flow-medical-inc", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2021/v-flow-medical-inc.json", "year_founded": 2019, "city": "San Clemente", "country": "US", "linkedin_url": "https://www.linkedin.com/company/71651179", "x_url": "", "fb_url": null, "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/a4a2e2f2139d9baa80f30d05c72feb1978ae5906.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 733200, "full_name": "Peter Balmforth", "title": "Founder", "founder_bio": "I'm a serial medTech entrepreneur, having developed my skill set from bench top to board room, giving me a unique perspective to the key elements of success. I have strong interpersonal skills, and success in building teams, engaging and retaining strong KoL relationships. I am a firm believer in developing long term strategy, with short term achievable goals, but with an open mind to reassess, adapt and execute change.", "is_active": false, "linkedin_url": "https://www.linkedin.com/in/peterbalmforth?lipi=urn%3Ali%3Apage%3Ad_flagship3_profile_view_base_contact_details%3BVXGI61CWQ1uAnVMiTMv9DQ%3D%3D", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/12fb3e33162a43b303348d6d72524944939d61d2.jpg" }, { "user_id": 735570, "full_name": "Rodney Brenneman", "title": "Founder", "founder_bio": "Rodney is a mechanical engineer by training with over 40 years of experience in medical device development, mostly in early stage start-up companies. His experience spans many specialties including general surgery, laparoscopy, interventional cardiology, peripheral vascular, emergency medicine, ENT, GI, urology and orthopedics. He has helped start over a half-dozen companies and loves the early stage energy. Rodney is a named inventor on over 100 patents. ", "is_active": false, "linkedin_url": "https://www.linkedin.com/in/rodney-brenneman-2652688/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/2bd3902a4b46b23f4a06a855e3fff6a07452987a.jpg" }, { "user_id": 735911, "full_name": "paul sobotka", "title": "Founder", "founder_bio": "Stanford-BS,, University of Illinois-MD., Internal Medicine-Michigan,, Cardiovascular diseases-Northwestern.Tenured in Medicine and Physiology at Loyola;Vice Chair, dept Medicine Wayne State, Chief Medical Officer St Mary Hospital. Chief Medical Officer of Ardian, CHF Solutions, Rox Medical; Entrepreneur in Residence, The White House. >200 published manuscripts.Interests: interaction of arterial compliance and venous capacitance congestion & HTN, regulation of splanchnic capacitance. ", "is_active": false, "linkedin_url": "Paul Alan Sobotka", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/04a1f5a6952d6c84115292627fcbcb1bc6e59ac3.jpg" }, { "user_id": 736911, "full_name": "Darren Spencer", "title": "Founder", "founder_bio": "", "is_active": false, "linkedin_url": "http://linkedin.com/in/darren-spencer-5922717", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/4aa109c82ee490536601aabedec7c00a7019d55d.jpg" } ], "jobs": [], "news": [], "launches": [] }, { "id": 24166, "name": "SafeBeat", "slug": "safebeat", "former_names": [ "SafeBeat Rx LLC", "SafeBeat Rx" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/acc0e68099b17b27bc8291119107847bd622a646.png", "website": "https://safebeat.com", "all_locations": "San Francisco, CA, USA", "long_description": "", "one_liner": "First ECG AI to go beyond diagnostics and recommend treatment", "team_size": 9, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1627411095, "tags": [ "AI-Enhanced Learning", "Medical Devices", "Digital Health", "Therapeutics" ], "tags_highlighted": [], "top_company": false, "isHiring": true, "nonprofit": false, "batch": "Summer 2021", "status": "Active", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/safebeat", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2021/safebeat.json", "year_founded": 2021, "city": "San Francisco", "country": "US", "linkedin_url": "https://www.linkedin.com/company/safebeatrx/", "x_url": "https://twitter.com/SafeBeat", "fb_url": null, "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/acc0e68099b17b27bc8291119107847bd622a646.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": { "name": "Jared Friedman", "url": "https://www.ycombinator.com/people/jared-friedman" }, "founders": [ { "user_id": 725686, "full_name": "Rachita Navara", "title": "Founder", "founder_bio": "Dr. Navara is an EP cardiologist and bioengineer internationally recognized for her contributions to heart rhythm research and medical innovation. While caring for patients in the hospital, she identified the need to expand access to patients starting heart drugs. To solve this problem, she assembled a multi-disciplinary team including heart rhythm physicians, data scientists, AI engineers, clinical trialists, and regulatory experts. Her passion is to use engineering to transform heart health.", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/rachita-navara-md-3b49551b8/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/1fbe360667725c7d96cd35e947d193aae2bce1c0.jpg" } ], "jobs": [ { "id": 76734, "title": "Sales Development Representative", "url": "https://www.ycombinator.com/companies/safebeat/jobs/5oIH4QQ-sales-development-representative", "location": "CA, US / Remote (US; San Francisco, CA, US; Atlanta, GA, US; Austin, TX, US; Chicago, IL, US; New York, NY, US; Miami, FL, US; Philadelphia, PA, US; Memphis, TN, US; Detroit, MI, US)", "type": "Full-time", "role": "Sales", "role_type": null, "salary_range": "$50K - $95K", "equity_range": "", "experience": "3+ years", "visa": "US citizen/visa only", "skills": [] }, { "id": 78442, "title": "Head of Growth", "url": "https://www.ycombinator.com/companies/safebeat/jobs/52A6Ozi-head-of-growth", "location": "San Francisco, CA, US / Remote (US)", "type": "Full-time", "role": "Operations", "role_type": null, "salary_range": "", "equity_range": "", "experience": "3+ years", "visa": "US citizen/visa only", "skills": [] }, { "id": 110259, "title": "Director of Customer Success and Strategic Partnerships", "url": "https://www.ycombinator.com/companies/safebeat/jobs/6XUT5uY-director-of-customer-success-and-strategic-partnerships", "location": "US / Remote (US)", "type": "Full-time", "role": "Operations", "role_type": null, "salary_range": "", "equity_range": "", "experience": "3+ years", "visa": "US citizen/visa only", "skills": [] } ], "news": [], "launches": [] }, { "id": 24188, "name": "Pirouette Pharma", "slug": "pirouette-pharma", "former_names": [ "Pirouette Medical, LLC.", "Pirouette Medical" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/6d5c45afdf23c42aacf00d8b2a17adc32893a852.png", "website": "https://www.pirouettepharma.com/", "all_locations": "Boston, MA, USA", "long_description": "At Pirouette, we have developed a low-profile, disk-shaped, rugged injection device with a patient-centric focus on affordability, portability, and usability. The patented device, based on extensive patient input, is designed to make administering an injection as easy as pushing a button. This allows individuals with limited or no training to easily and intuitively perform an injection on themselves or others.", "one_liner": "We make injections as easy as pushing a button!", "team_size": 9, "industry": "Healthcare", "subindustry": "Healthcare -> Drug Discovery and Delivery", "launched_at": 1624370517, "tags": [ "Health Tech", "Medical Devices", "Biotech", "Healthcare" ], "tags_highlighted": [], "top_company": false, "isHiring": true, "nonprofit": false, "batch": "Summer 2021", "status": "Active", "industries": [ "Healthcare", "Drug Discovery and Delivery" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Growth", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/pirouette-pharma", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2021/pirouette-pharma.json", "year_founded": 2017, "city": "Boston", "country": "US", "linkedin_url": "https://www.linkedin.com/company/pirouettepharma", "x_url": "https://twitter.com/pirouettepharma", "fb_url": "https://www.facebook.com/pirouettepharma", "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/6d5c45afdf23c42aacf00d8b2a17adc32893a852.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 718613, "full_name": "Conor Cullinane", "title": "Founder", "founder_bio": "Conor obtained a PhD in Medical Engineering & Medical Physics at MIT and Harvard Medical School in the Health Sciences and Technology Program, and a BS in aeronautical engineering from Clarkson University. He is interested in leading engineering teams to successful technology implementations, not by ordering action to be taken, but rather taking action and motivating others to do the same. He has expertise in human factors engineering, medical engineering, medical physics, and startups.", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/conorrcullinane/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/034c209c65374e7765742c18e55654004b64e568.jpg" }, { "user_id": 718651, "full_name": "Matthew Kane", "title": "Founder", "founder_bio": "Matthew received a B.S. in aeronautical and mechanical engineering from Clarkson University. He received a MSc in Aerospace Engineering from the University of Notre Dame. He is the COO of Pirouette Medical where he is primarily responsible for FDA Interactions, regulatory requirements, project management, quality management and design analysis. He has previous experience with fluid dynamics, turbomachinery, design, and testing. He loves learning and finding unique engineering solutions. ", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/matthew-kane-321423139/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/d4d9f37d667d51c1fdc8d5b7e787b287577dc3fb.jpg" }, { "user_id": 718644, "full_name": "Elijah Kapas", "title": "Founder", "founder_bio": "Eli received a dual BS in Mechanical and Civil engineering from Clarkson University. Experience in design as well as implementation allows for key insight to user interfaces and workability. Eli is the CTO for Pirouette Medical and is responsible for device design and intellectual property. He has worked across multiple industries in roles ranging from quality to supervision and knows how to leverage the key strengths of team members to be successful. ", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/eli-kapas-0b176366/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/0d5c131b5d9b2eed09dc17a0d1f153c6c9d0a1e7.jpg" } ], "jobs": [ { "id": 110564, "title": "Quality Systems & Compliance Lead", "url": "https://www.ycombinator.com/companies/pirouette-pharma/jobs/kwn8xnE-quality-systems-compliance-lead", "location": "Portsmouth, NH, US", "type": "Full-time", "role": "Science", "role_type": "Biotechnology", "salary_range": "$90K - $130K", "equity_range": "0.02% - 0.20%", "experience": "6+ years", "visa": "US citizen/visa only", "skills": [] } ], "news": [ { "title": "Pirouette Medical’s auto-injector wins 2024 Product of the Year - NH Business Review", "url": "https://www.nhbr.com/pirouette-medicals-auto-injector-wins-2024-product-of-the-year/", "date": "Dec 20, 2024" }, { "title": "Safar Partners Leads Pirouette’s Investment Round with $5M+ Raised, Extending Opportunity for Public to Invest Alongside Renowned Investors like Y Combinator", "url": "https://www.businesswire.com/news/home/20240507871732/en/Safar-Partners-Leads-Pirouette%E2%80%99s-Investment-Round-with-5M-Raised-Extending-Opportunity-for-Public-to-Invest-Alongside-Renowned-Investors-like-Y-Combinator", "date": "May 06, 2024" } ], "launches": [] }, { "id": 24445, "name": "Digistain", "slug": "digistain", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/ee811a143d9362213ecd8df87fca7780ce1945b8.png", "website": "https://digistain.co.uk/", "all_locations": "London, England, United Kingdom", "long_description": "In the global fight against breast cancer, Digistain stands at the forefront, offering a beacon of hope to millions. Our journey began at Imperial College London, where ground-breaking research gave birth to a technology poised to revolutionize breast cancer diagnostics.\r\n\r\nThe Challenge: Every year, breast cancer affects 2.3 million individuals globally. Post-surgery, 60% of patients are advised to undergo genomic testing, an expensive and time-consuming process monopolized by a single lab in the U.S., costing around $4,000 and taking nearly two months. Consequently, only 5% undergo this vital testing. The rest, unable to access this crucial diagnostic step, often resort to chemotherapy—a treatment that, in one in four cases, is more harmful than the cancer itself.\r\n\r\nOur Solution: Digistain addresses this critical gap. Our technology transforms the current diagnostic process by enabling hospitals to analyze patient samples in-house using existing equipment, supplemented with our innovative technology. This approach offers near-instantaneous decision-making data, a stark contrast to the existing month-long waits. Central to our technology is a proprietary algorithm that identifies a unique spectral fingerprint of the tumour in the infrared spectrum, providing a personalized risk score. This score guides oncologists in selecting the most effective, individualized treatment plans, potentially reducing unnecessary chemotherapy and its harmful side effects.\r\n\r\nImpact and Potential: Our solution not only challenges the status quo in technology but also in accessibility. In a landmark government-commissioned study, Digistain demonstrated clinical evidence on par with the market leader, but at a fraction of the cost and time. Already making waves in clinical practice globally, with insurance reimbursement at leading cancer centers, our technology represents a paradigm shift in cancer care.\r\n\r\nRecognized by the Institute of Physics, the Royal Society, and Imperial College for our innovative contributions, and supported by entities like the NHS, Y Combinator, and the European Investment Bank, Digistain is more than a company—it’s a movement towards equitable, effective cancer treatment. With the potential to democratize access to life-saving diagnostics, Digistain is not just envisioning a better future for cancer patients; we are actively creating it.\r\n ", "one_liner": "Pioneering Breast Cancer Diagnostics for a Healthier Tomorrow", "team_size": 40, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1624636740, "tags": [ "Medical Devices" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2021", "status": "Active", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "United Kingdom", "Europe" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/digistain", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2021/digistain.json", "year_founded": 2019, "city": "London", "country": "GB", "linkedin_url": "https://uk.linkedin.com/company/digistain", "x_url": "", "fb_url": null, "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/ee811a143d9362213ecd8df87fca7780ce1945b8.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 410138, "full_name": "Hemmel Amrania", "title": "Founder", "founder_bio": "Hemmel Amrania Ph.D, CEO has previously scaled several 7 figure businesses both in therapeutics and diagnostics. As a doctoral researcher he was awarded the Outstanding Research Prize at Imperial College London. He has also won several UK business awards including the Innovation & Entrepreneurship Challenge Imperial College and the Climate KIC Competition held by the Mayor of London. For Digistain he spear-headed the research out of the lab all the way through to clinical trials.\n", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/hemmel-amrania/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/d9f3ec4a24a122d7cb94bf65ef53a3cd13478559.jpg" }, { "user_id": 739775, "full_name": "Chris Phillips", "title": "Founder", "founder_bio": "Chris is an Imperial College Physics Professor, researching into photovoltaics, and biomedical imaging. He's spent the last few years, with Hemmel Amrania, developing the Digistain cancer diagnosis technology with Imperial medics.\n\nHe has won a number of prizes and has explained his research on invisibility caused by quantum optical effects to comedy legend Cleese on TV. He once rowed 500 miles non-stop from London to Paris. See https://en.wikipedia.org/wiki/Chris_Phillips_(professor)", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/chris-phillips-a650151b/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/484ecb78dede011ebb62e44c047cf5943c04f728.jpg" } ], "jobs": [], "news": [], "launches": [] }, { "id": 24450, "name": "Astek Diagnostics", "slug": "astek-diagnostics-inc", "former_names": [ "Astek Diagnostics LLC" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/0cc751641f3edca70063a728f7fc978cc2df8169.png", "website": "http://astekdx.com", "all_locations": "Baltimore, MD, USA", "long_description": "Astek Diagnostics is building a platform (Eugris) that guides physicians in prescribing appropriate antibiotics for patients with bacterial sepsis in one hour. It is done by detecting the oxygen consumption of the bacteria", "one_liner": "One-hour antibiotic sensitivity testing", "team_size": 5, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1625157553, "tags": [ "Microfluidics", "Medical Devices" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2021", "status": "Active", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/astek-diagnostics-inc", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2021/astek-diagnostics-inc.json", "year_founded": 2020, "city": "Baltimore", "country": "US", "linkedin_url": "", "x_url": "", "fb_url": null, "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/0cc751641f3edca70063a728f7fc978cc2df8169.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 698468, "full_name": "Mustafa Al-Adhami", "title": "Founder", "founder_bio": "Mustafa Al-Adhami Ph.D., CEO, Astek Diagnostics. He has long experience in customer discovery and diagnostics. He envisioned the technology behind Eugris while completing his PhD. As a doctoral student, he won the national Three Minute Thesis (3mt) competition, Baylor Business Plan, elevator pitch competition, and VentureWell’s BMEidea competition. Mustafa has raised over $5M for Astek to date to revolutionize antibiotic prescription. ", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/maladhami/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/c3d6e397e9c04bcafd4a4570763f1a8fd437a1e9.jpg" } ], "jobs": [], "news": [ { "title": "Y Combinator alum Astek wants to revolutionize antibiotics - Technical.ly", "url": "https://technical.ly/2022/01/18/astek-diagnostics-antibiotics-y-combinator/", "date": "Jan 18, 2022" } ], "launches": [] }, { "id": 24466, "name": "Makani Science", "slug": "makani-science", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/06492ded72b734cf66f1e107ab0974ffc480d989.png", "website": "http://makaniscience.net/", "all_locations": "Los Angeles, CA, USA", "long_description": "Makani Science is a medical device company based in Irvine, California. We have created the world's first wireless patch that can accurately and continuously monitor breathing. The company is co-founded by Dr. Michelle Khine and Dr. Michael Chu, two experts in the wearable monitoring space from the University of California, Irvine. \r\n\r\nThe Makani Science system will collect unique breathing waveforms from patients in everyday environments to create the first large database of respiratory patterns associated with different diseases. Data will be collected through systems sold to our initial beachhead market, where we will help improve monitoring safety in patients being sedated for medical procedures. Our long-term goal is to combine machine learning with this database to identify and predict respiratory complications for different patient populations. \r\n\r\nWe have a highly experienced team and will be FDA cleared in our beachhead market within a year. ", "one_liner": "Reinventing respiration monitoring", "team_size": 2, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1629402769, "tags": [ "Health Tech", "Medical Devices" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2021", "status": "Active", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/makani-science", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2021/makani-science.json", "year_founded": 2018, "city": "Los Angeles", "country": "US", "linkedin_url": "https://www.linkedin.com/company/makani-science", "x_url": "", "fb_url": null, "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/06492ded72b734cf66f1e107ab0974ffc480d989.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 730052, "full_name": "Michael Chu", "title": "Founder", "founder_bio": "Michael graduated, PhD, from the Department of Biomedical Engineering at the University of California Irvine, where he worked in Dr. Michelle Khine’s lab. His research focused on developing and using soft wearable sensors for noninvasive monitoring of physiologic vital signs. Michael has helped author over 10 peer reviewed papers and is also inventor of 3 patents submitted by the lab. His dissertation work served as the foundation for the Makani Science technology.", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/mchu8/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/6c2e345b9d120977b7bd1b61a1f2e83476b29c19.jpg" }, { "user_id": 491064, "full_name": "Michelle Khine", "title": "Founder", "founder_bio": "Professor of Biomedical Engineering and Serial Entrepreneur", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/michelle-khine-a7111315/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/e8d71c149514027f92005a2e24336211dfc69f4c.jpg" } ], "jobs": [], "news": [ { "title": "Makani Science Receives FDA Clearance for Groundbreaking Respiratory Monitor", "url": "https://www.prnewswire.com/news-releases/makani-science-receives-fda-clearance-for-groundbreaking-respiratory-monitor-302417666.html", "date": "Apr 07, 2025" } ], "launches": [] }, { "id": 24622, "name": "Caire Health", "slug": "caire-health", "former_names": [ "CAIRE" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/97361364dc226255ea7672c56e73b4967ef83a2e.png", "website": "http://cairehealthinc.com", "all_locations": "FL, USA", "long_description": "We believe that no emergency should have to wait. To make this a reality we build AI that instantly reads medical scans and enables critical care teams to make diagnoses better than radiologists. This saves lives by getting emergencies to treatment immediately and by discharging non-emergent patients quickly so the next emergency doesn’t have to wait either.\r\n", "one_liner": "Semi-Autonomous Diagnostics for Emergent Care", "team_size": 3, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1628310950, "tags": [ "Medical Devices", "AI" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2021", "status": "Active", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "United States of America", "America / Canada" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/caire-health", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2021/caire-health.json", "year_founded": 2021, "city": null, "country": "US", "linkedin_url": "https://www.linkedin.com/company/caire-health/about/", "x_url": "", "fb_url": null, "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/97361364dc226255ea7672c56e73b4967ef83a2e.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 256980, "full_name": "Anmol Warman", "title": "Founder", "founder_bio": "", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/anmol-warman-139820160/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/89333bcf97c52ed50b7a78c616ea6ec767b07a0d.jpg" }, { "user_id": 253683, "full_name": "Pranav Warman", "title": "Founder", "founder_bio": "", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/pranavwarman/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/33242076eb03baaf3d3921c554e66d394d8e270e.jpg" }, { "user_id": 470998, "full_name": "Roshan Warman", "title": "Founder", "founder_bio": "", "is_active": true, "linkedin_url": "", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/a33f7a088cae02bec2152730b13957ed646e56b7.jpg" } ], "jobs": [], "news": [], "launches": [] }, { "id": 24822, "name": "Luminate", "slug": "luminate-medical", "former_names": [ "Luminate Medical" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/9fe59dec0db5818a11a7306f36b67e952ee2c037.png", "website": "http://www.luminatemed.com", "all_locations": "Galway, County Galway, Ireland", "long_description": "", "one_liner": "We make cancer care at home possible.", "team_size": 55, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1625132011, "tags": [ "Hard Tech", "Consumer Health Services", "Medical Devices" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2021", "status": "Active", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "Ireland", "Europe" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/luminate-medical", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2021/luminate-medical.json", "year_founded": 2019, "city": "Galway", "country": "IE", "linkedin_url": "https://www.linkedin.com/company/luminate-medical", "x_url": "https://twitter.com/luminatemed", "fb_url": null, "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/9fe59dec0db5818a11a7306f36b67e952ee2c037.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": { "name": "Jared Friedman", "url": "https://www.ycombinator.com/people/jared-friedman" }, "founders": [ { "user_id": 690313, "full_name": "Aaron Hannon", "title": "Founder", "founder_bio": "Co-Founder and CEO of Luminate Medical. Software and electronic engineer with a passion for medical devices and a better citizen experience of medicine. Thiel Fellowship, Class of 2020.", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/aaronhannon/", "x_url": "https://twitter.com/AaronDHannon", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/1f4df18555f9257132e0bcb25793ca917e09f81c.jpg" }, { "user_id": 723249, "full_name": "Barbara Oliveira", "title": "Founder", "founder_bio": "Co-Founder and Clinical Lead of Luminate Medical, a start up medical device company based in Galway, Ireland working on empowering patients during their cancer & chemotherapy journey. Biomedical Engineer by background, with experience in leading first-in-human medical device clinical trials, and a passion for quality of life applications of medicine! ", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/barbaralolive/", "x_url": "https://twitter.com/barbaralolive", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/ee137668bdea95093442d21a0970dc2199f4b282.jpg" } ], "jobs": [], "news": [ { "title": "Luminate raises $2.5m in additional funding for cancer care products – The Irish Times", "url": "https://www.irishtimes.com/business/2024/12/04/luminate-raises-25m-in-additional-funding-for-cancer-care-products/", "date": "Dec 10, 2024" }, { "title": "Luminate's hair-saving chemo helmet nears release, as new funding goes toward home cancer care | TechCrunch", "url": "https://techcrunch.com/2024/09/18/luminates-hair-saving-chemo-helmet-nears-release-as-new-funding-goes-toward-home-cancer-care/", "date": "Sep 18, 2024" }, { "title": "Irish startup Luminate Medical picks up €4.7 million to tackle the side effects of cancer treatment | EU-Startups", "url": "https://www.eu-startups.com/2022/06/irish-startup-luminate-medical-picks-up-e4-7-million-to-tackle-the-side-effects-of-cancer-treatment/", "date": "Jun 27, 2022" }, { "title": "EXCLUSIVE: Meet The Irish Startup Preventing Hair Loss During Chemotherapy That Just Raised $5 Million", "url": "https://www.forbes.com/sites/igorbosilkovski/2022/05/30/exclusive-meet-the-irish-23-year-old-thiel-fellow-whose-startup-preventing-hair-loss-during-chemotherapy-just-raised-5-million/", "date": "May 30, 2022" }, { "title": "Luminate aims to make hair loss from chemotherapy a thing of the past – TechCrunch", "url": "https://techcrunch.com/2021/08/30/luminate-aims-to-make-hair-loss-from-chemotherapy-a-thing-of-the-past/", "date": "Aug 30, 2021" } ], "launches": [] }, { "id": 24926, "name": "Revolve Surgical", "slug": "revolve-surgical", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/3432070f3c596c704428f8721684045f22cb0714.png", "website": "https://revolvesurgical.com/", "all_locations": "Toronto, ON, Canada", "long_description": "Revolve is building the world’s only surgical robot designed for every operating room. Its simple yet powerful design makes it the only robot that can service the 1M+ abdominal surgeries performed outside of hospitals in the US every year.", "one_liner": "Surgical robotics for every operating room", "team_size": 8, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1628609381, "tags": [ "Hardware", "Medical Robotics", "Medical Devices" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2021", "status": "Active", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "Canada", "America / Canada" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/revolve-surgical", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2021/revolve-surgical.json", "year_founded": 2019, "city": "Toronto", "country": "CA", "linkedin_url": "https://linkedin.com/company/revolve-surgical", "x_url": "", "fb_url": null, "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/3432070f3c596c704428f8721684045f22cb0714.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": { "name": "Brad Flora", "url": "https://www.ycombinator.com/people/brad-flora" }, "founders": [ { "user_id": 769642, "full_name": "Peter Francis", "title": "Founder", "founder_bio": "Background in Mechatronics Engineering (undergrad) and surgical robotics (graduate-level). Engineer #2 at a medical robotics startup in the Bay area and worked on a CSA lunar rover.\n", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/peterfrancis19/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/2103b72c4e0a41062e302cd0e0fa4d507a87828c.jpg" }, { "user_id": 769547, "full_name": "Matthew Kang", "title": "Founder", "founder_bio": "I build stuff: MedTech, ML/CV, robots", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/matthew-kang/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/afd54366ab433fb30f2e03f6af7e9f1e4b558365.jpg" } ], "jobs": [], "news": [], "launches": [] }, { "id": 25151, "name": "Keylika", "slug": "keylika", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/bd12fc4dc5d053441f31a9c528579e0d16f3449e.png", "website": "https://www.keylika.com", "all_locations": "San Francisco, CA, USA; Walnut Creek, CA, USA", "long_description": "Keylika is an early stage biopharma startup developing metal-based drugs using a platform synthesis technology to treat unmet medical needs. We then administer these drugs using proven delivery technologies to effect the best clinical outcomes. \r\n\r\nOur first product is a small molecule iron drug (new molecular entity) delivered by a wearable skin patch to treat Iron Deficiency Anemia (IDA), with significantly higher safety, efficacy and tolerability over existing treatments. This is poised to be a best-in-class, potentially breakthrough therapy for treating iron deficiency without any GI side-effects (eg. nausea, constipation, diarrhea, etc.) typically associated with oral iron supplements, and without the risks, costs and side-effects associated with IV iron infusions. When approved, Keylika’s proprietary transdermal iron will be the world's first prescription iron patch. Iron deficiency is a hugely understated problem affecting about 1.6 billion people worldwide and more than 30 million in the US alone, translating to a $17B US market.", "one_liner": "Redefining the Standard of Care for Iron Deficiency Anemia", "team_size": 1, "industry": "Healthcare", "subindustry": "Healthcare -> Therapeutics", "launched_at": 1658519436, "tags": [ "AI-powered Drug Discovery", "Medical Devices", "Drug Delivery", "Nanotechnology", "Therapeutics" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2022", "status": "Active", "industries": [ "Healthcare", "Therapeutics" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": true, "app_answers": [ { "question": "Describe what your company does in 50 characters or less.", "answer": "We develop metallodrugs for unmet medical needs." } ], "question_answers": null, "url": "https://www.ycombinator.com/companies/keylika", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2022/keylika.json", "year_founded": 2022, "city": "San Francisco", "country": "US", "linkedin_url": "https://www.linkedin.com/company/keylika/", "x_url": "https://twitter.com/keylika_inc", "fb_url": null, "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/bd12fc4dc5d053441f31a9c528579e0d16f3449e.png", "app_video_url": null, "dday_video_url": "https://bookface-images.s3.us-west-2.amazonaws.com/video_event/58/1662662980325-y62ohje1s2-e76deefbbfbb2fb38de30a62b84546d9/714326f49aba38f91fda71a9c6d47471.mp4?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIAQC4NIECABPQ2AHNW%2F20261020%2Fus-west-2%2Fs3%2Faws4_request&X-Amz-Date=20261020T022701Z&X-Amz-Expires=3600&X-Amz-SignedHeaders=host&X-Amz-Signature=658b0a7fb2ce8bd68597d0a5076c7260b1d48c3c6ffdde07533bb121cf26ce6b", "company_photos": [], "primary_partner": { "name": "Jared Friedman", "url": "https://www.ycombinator.com/people/jared-friedman" }, "founders": [ { "user_id": 756768, "full_name": "Buddha Chaudhuri", "title": "Founder", "founder_bio": "Buddha spearheaded the technology development of a microneedle-based biosensor from lab-to-fab for a Series B stage medtech startup. Having worked across 3 continents and 6 countries, he has been instrumental in developing novel healthcare technologies in leading global research institutes and biotech companies, for the last 15 years. \n\nBuddha earned his PhD from Imec / KU Leuven in Belgium, in Drug Delivery Microsystems. He also pursued a Postdoc at UC San Francisco (UCSF) / UC Berkeley. ", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/buddhadevpc", "x_url": "https://twitter.com/buddhachaudhuri", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/8e4a1a5185f5455f05b9967fc8793797c729bd4c.jpg" }, { "user_id": 776586, "full_name": "Frederik Ceyssens", "title": "Founder", "founder_bio": "With a deep passion for diverse technologies, I'm a true multi-domain expert. My interest go from tiny moving machines to nuclear space rockets, from electrical circuits to medical devices and beyond. Next to Keylika, I founded ReVision, a neurotech company aiming at restoring sight in blind people, developing widely useful high-res neurotech in the process.\n\nI have an EE PhD, a MSc. in IC design as well as a BSc. in Medicine. ", "is_active": true, "linkedin_url": "http://linkedin.com/in/frederik-ceyssens-43b6ab5", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/20288d3198cb324772987da4da9b7f8137d8a725.jpg" } ], "jobs": [], "news": [ { "title": "Keylika Develops World's First Buccal Patch for Iron Deficiency Anemia (IDA) | Entrepreneur", "url": "https://www.entrepreneur.com/en-au/news-and-trends/keylika-develops-worlds-first-buccal-patch-for-iron/490791", "date": "Apr 29, 2025" }, { "title": "Keylika develops first Buccal Patch for Iron Deficiency Anemia (IDA) - Arabian Business: Latest News on the Middle East, Real Estate, Finance, and More", "url": "https://www.arabianbusiness.com/industries/healthcare/keylika-develops-first-buccal-patch-for-iron-deficiency-anemia-ida", "date": "Apr 25, 2025" }, { "title": "Bootstrapped Indian Startup Innovating Treatment for Eczema, Itch & Beyond | Entrepreneur", "url": "https://www.entrepreneur.com/en-in/news-and-trends/bootstrapped-indian-startup-innovating-treatment-for/490293", "date": "Apr 20, 2025" }, { "title": "TACKLING IRON-DEFICIENCY ANAEMIA: A LEAP FORWARD WITH A REVOLUTIONARY BUCCAL PATCH - ONdrugDelivery", "url": "https://www.ondrugdelivery.com/tackling-iron-deficiency-anaemia-a-leap-forward-with-a-revolutionary-buccal-patch/", "date": "Jun 17, 2024" }, { "title": "Bootstrapping in Biotech: How Keylika’s Founding Story Highlights Key Entrepreneurship Lessons", "url": "https://www.usatoday.com/story/special/contributor-content/2024/05/12/bootstrapping-in-biotech-how-keylikas-founding-story-highlights-key-entrepreneurship-lessons/73665473007/", "date": "May 12, 2024" } ], "launches": [ { "id": 64959, "title": "Keylika: Redefining the Standard of Care for Iron Deficiency", "tagline": "World's first prescription iron patch to treat Iron Deficiency Anemia", "body": "[Keylika](https://www.keylika.com) is combining its **metallodrug synthesis technology** with **optimized delivery methods** to obtain improved clinical outcomes. Our first product is a **novel iron drug** in a **wearable skin patch** with significantly improved safety, efficacy and tolerability to treat **Iron Deficiency Anemia (IDA).** When approved, Keylika’s proprietary transdermal iron will be the **world's first** prescription iron patch.\n\n### **The Problem**\n\n**Iron Deficiency Anemia (IDA) is a hugely understated, highly prevalent problem with subpar treatments.**\n\nIron deficiency (ID) affects **30 million** people in the US alone and about **1.6 billion** worldwide. Current treatments include oral iron supplements which are typically associated with low bioavailability and poor tolerability due to mild to severe gastrointestinal (GI) side-effects (constipation, nausea, stomach discomfort, diarrhea, etc.) often leading to patient non-compliance. Also, a significant number of patients just do not absorb iron taken orally.  The second line of treatment with intravenous (IV) iron infusions is more invasive, riskier, costlier and requires hospitalization due to the risk of anaphylactic shocks.\n\n### **Our Solution**\n\nOur first product is a **new small molecule (new molecular entity)**, an **iron-containing drug** designed for **transdermal** delivery by a wearable skin patch: **NistuFe**. It is a safe, highly bioavailable iron complex with higher efficacy. A therapeutically relevant dosage is administered through the skin directly into the systemic circulation, thereby circumventing the gastrointestinal tract and all associated adverse effects. Thus, we combine the benefits of both orals and IV iron, and without their respective downsides: a drug suitable for self-administration with no GI side effects and no required hospitalization that yields a superior treatment outcome from the convenience of a patient’s home. This is slated to be a potentially **best-in-class, breakthrough therapy**. Our preliminary proof-of-concept in vivo studies in rats have demonstrated excellent results.\n\n![uploaded image](/media/?type=post&id=64959&key=user_uploads/756768/c93eab67-c28a-45c2-8a20-42843bbd0d16)\n\n### **Our Science**\n\nAt our core is a **platform synthesis technology** we have developed for synthesizing mixed ligand metal complexes. We are using this platform to generate a range of drug candidates for treating therapeutic conditions in the fields of hematology, pain and inflammation, metabolic disorders, infectious diseases and oncology. We then administer these drugs using proven delivery technologies, to effect the best clinical outcomes. Positioned at the **intersection of drug development and drug delivery**, we customize the molecular structure of the drug and its formulation to optimize the therapeutic delivery per clinical requirements.\n\n### **Target Population**\n\nOur first indication being menorrhagia, our primary target population is **women of child-bearing age** in the US who suffer from severe to moderate ID, which has an estimated prevalence of 6 million. A wide range of other patient groups adds up to a potential **30 million** users in the US alone.\n\n### **Our Ask**\n\n1\\.     If you know anyone in your social circle suffering from Iron Deficiency, we would love to talk to them!\n\n2\\.     If you are connected to biopharma companies with interests in the hematology space, could you please introduce us?\n\nPlease follow us on [LinkedIn](https://www.linkedin.com/company/keylika/)!\n\nQuestions? Feel free to reach out: [founders@keylika.com](mailto:founders@keylika.com)", "url": "https://www.ycombinator.com/launches/Gtj-keylika-redefining-the-standard-of-care-for-iron-deficiency", "votes": 59, "created_at": "2022-07-28T02:09:46.908Z" } ] }, { "id": 25286, "name": "TYBR Health", "slug": "tybr-health", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/c304532e9fd526875c6649d4a940c41cd10d892b.png", "website": "https://www.tybrhealth.com/", "all_locations": "Houston, TX, USA", "long_description": "TYBR is developing a hydrogel to limit internal scarring after surgery. The naturally derived material is applied to coat tendons at the end of surgery to improve healing outcomes for the millions Americans who undergo tendon or ligament surgery each year.", "one_liner": "Natural hydrogel to keep internal organs scar-free after surgery", "team_size": 3, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1645907970, "tags": [ "B2B", "Medical Devices" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2022", "status": "Active", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "United States of America", "America / Canada" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/tybr-health", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2022/tybr-health.json", "year_founded": 2020, "city": "Houston", "country": "US", "linkedin_url": "https://www.linkedin.com/company/tybr-health/", "x_url": "", "fb_url": null, "cb_url": "https://www.crunchbase.com/organization/tybr-health", "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/c304532e9fd526875c6649d4a940c41cd10d892b.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 598249, "full_name": "Tim Keane", "title": "Founder", "founder_bio": "Tim Keane is a co-founder & CEO of TYBR Health. He has expertise in regenerative medicine and biomaterials and over 30 publications to support the science behind TYBR's technology. Prior to co-founding TYBR, Tim completed a Biodesign Fellowship at Texas Medical Center. He has a PhD in bioengineering from the University of Pittsburgh and completed post-doctoral fellowships at Imperial College London.", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/timjkeanejr", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/3acd5df96699ada6ba435dea5e9a212e6b4fbe06.jpg" }, { "user_id": 486196, "full_name": "Alex Smith", "title": "Founder", "founder_bio": "Alex is a cofounder and TYBR’s CTO. He has a BS and MEng in Biomedical Engineering from Texas A&M University and a PhD in Mechanical Engineering from University of Houston. He has nearly a decade of experience in medical device development for dialysis access, vaginal dilators, and ventricular assist pump design. At TYBR, he prototypes the delivery system for ECM spray, plans studies, and manages manufacturability & cost control of the delivery device.", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/palexsmith/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/48d909f471625089b950c1ce229144209c405c6c.jpg" } ], "jobs": [], "news": [ { "title": "TYBR Health Announces $30 Million Series A Financing to Expand Access to the B3 GEL® System", "url": "https://www.prnewswire.com/news-releases/tybr-health-announces-30-million-series-a-financing-to-expand-access-to-the-b3-gel-system-302830733.html", "date": "Jul 20, 2026" } ], "launches": [] }, { "id": 25327, "name": "Starling", "slug": "starling", "former_names": [ "Starling Medical" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/cdc25280245ff89ae883c07e3aa55cf751c7c285.png", "website": "https://starlingmedical.com/", "all_locations": "Houston, TX, USA", "long_description": "Starling is building a urine diagnostic remote patient monitoring platform that seamlessly integrates into anyone's bathroom routine. By detecting early changes in a patient's urine using our toilet indwelling mass spectroscopy device, our platform is aiming to prevent hospitalizations from numerous conditions like recurrent UTIs, BPH exacerbations, or diabetes. We do this while creating significant new annual revenues for our clinician partners from remote patient monitoring reimbursements without requiring any significant changes in a staff's day to day schedule. ", "one_liner": "AI enabling digital urine diagnostics in the home", "team_size": 5, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1644279781, "tags": [ "Machine Learning", "Medical Devices", "Digital Health" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2022", "status": "Active", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/starling", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2022/starling.json", "year_founded": 2019, "city": "Houston", "country": "US", "linkedin_url": "https://www.linkedin.com/company/starling-medical", "x_url": "https://twitter.com/StarlingMedical", "fb_url": null, "cb_url": "https://www.crunchbase.com/organization/starling-medical", "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/cdc25280245ff89ae883c07e3aa55cf751c7c285.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 739344, "full_name": "Drew Hendricks", "title": "Founder", "founder_bio": "I am a health-tech entrepreneur with a special interest in all things urine and diagnostic. My background in medicine and medical device design gives me a unique point of view while identifying major gaps in healthcare through regular patient interaction. ", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/drew-hendricks/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/65775c5df4a3bb77487be7d624a6c4646f77d8eb.jpg" }, { "user_id": 740020, "full_name": "Hannah McKenney", "title": "Founder", "founder_bio": "My experience within both the hospital and industry setting has developed my interest in emphasising the user-centered and human factors design of medical technologies to ensure accessibility and usability in all areas around the world. My skills are broadly in problem definition, upstream product development, and implementation of medical technologies (device and digital health) in the clinical setting. I am focused on ensuring Starling prioritises the user experience throughout our growth.", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/hmck96/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/59ec4cee30bd011012518f725abac51cd46d1d17.jpg" } ], "jobs": [], "news": [ { "title": "American Telemedicine Association announced telehealth innovators challenge vict", "url": "https://www.fiercehealthcare.com/telehealth/american-telemedicine-association-announced-12-telehealth-innovators-challenge-finalists", "date": "Mar 15, 2023" }, { "title": "Starling Medical’s new urine-testing device turns your toilet into a health tracker • TechCrunch", "url": "https://techcrunch.com/2023/01/27/starling-medical-urine-health/", "date": "Jan 27, 2023" }, { "title": "In conversation with Alex Arevalos and Sylvie Kalikoff, Starling Medical - Praxis Spinal Cord Institute", "url": "https://praxisinstitute.org/in-conversation-with-alex-arevalos-and-sylvie-kalikoff-starling-medical/", "date": "Feb 11, 2021" } ], "launches": [] }, { "id": 25330, "name": "Actipulse Neuroscience", "slug": "actipulse-neuroscience", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/549997d4f76fc2b7db6db7332ed77e361e12b98d.png", "website": "http://www.actipulseneuroscience.com", "all_locations": "Mexico City, CDMX, Mexico", "long_description": "Non-invasive brain stimulation is a widely-utilized, FDA cleared treatment used for patients diagnosed with depression, but is limited to a hospital setting due to the cost of the device, and complexity of treatment application.\r\n\r\nOur proprietary brain stimulation device allows patients to be treated directly from their home, with the same efficacy, and at a lower cost of treatment.\r\n\r\nCurrently in FDA pivotal phase for Major Depressive Disorder, and Pilot phase for Alzheimer's and Parkinson diseases. ", "one_liner": "Bringing non-invasive brain stimulation from the hospital to the home", "team_size": 38, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1643135801, "tags": [ "Mental Health Tech", "Neurotechnology", "Medical Devices" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2022", "status": "Active", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "Mexico", "Latin America", "Remote", "Partly Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/actipulse-neuroscience", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2022/actipulse-neuroscience.json", "year_founded": 2017, "city": "Mexico City", "country": "MX", "linkedin_url": "https://www.linkedin.com/company/actipulse-international", "x_url": "", "fb_url": null, "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/549997d4f76fc2b7db6db7332ed77e361e12b98d.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 404287, "full_name": "Adrien Châtillon", "title": "Founder", "founder_bio": "I am a serial entrepreneur (3+ startups), who has lived and worked in more than 8 countries.\nAs the CEO of a medical-tech company, my goal is to democratize access to better and more affordable mental health therapeutics. \n", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/adrienchatillon/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/d520c9e1a705af977ebcd1dbd42b1789b12fbb27.jpg" }, { "user_id": 496496, "full_name": "Gabriel Villafuerte", "title": "Founder", "founder_bio": "I am a MD/PhD in neuroscience. Passionate about applying technology to solve nervous system disorders. Frustrated (but self-taught!) engineer, industrial designer, and artist. ", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/gabriel-villafuertemdphd", "x_url": "https://twitter.com/neuro_gabo", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/5eceec48434877df4af81dcbc017fbfb4c5ce5a0.jpg" } ], "jobs": [], "news": [ { "title": "Actipulse Neuroscience Nominated for Best Medical Startup at the 2024 Prix Galien | AP News", "url": "https://apnews.com/press-release/ein-presswire-newsmatics/medical-technology-clinical-trials-medication-bb53b22badf94dc3eae3aa7f3ab1d7ce", "date": "Sep 24, 2024" }, { "title": "Innovative treatments: the new frontier for mental health", "url": "https://www.drugtargetreview.com/article/101847/innovative-treatments-the-new-frontier-for-mental-health/", "date": "Mar 10, 2022" }, { "title": "Y Combinator grants funding to neuro-tech startup working to improve mental healthcare accessibility - StartUp Beat", "url": "https://startupbeat.com/y-combinator-grants-funding-to-neuro-tech-startup-working-to-improve-mental-healthcare-accessibility/35642/", "date": "Feb 27, 2022" }, { "title": "Esta startup quiere llevar su tecnología de neuroestimulación a la casa de sus pacientes", "url": "https://www.forbes.com.mx/emprendedores-startup-quiere-llevar-tecnologia-neuroestimulacion-casa-pacientes/", "date": "Feb 16, 2022" }, { "title": " Adrien Châtillon, CEO de Actipulse Neuroscience: “América Latina es una región que consume salud, pero no innova” | AméricaEconomía | AméricaEconomía", "url": "https://www.americaeconomia.com/negocios-industrias/multilatinas/adrien-chatillon-ceo-de-actipulse-neuroscience-america-latina-es", "date": "Jan 24, 2022" } ], "launches": [] }, { "id": 25450, "name": "Corveus Medical", "slug": "corveus-medical", "former_names": [ "Caridian Medical" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/2b878b32eb3add0a7ae9da1e37fb4dcc337e6a8f.png", "website": "https://www.corveusmedical.com/", "all_locations": "Houston, TX, USA", "long_description": "Our device catheter-based device is able to safely perform a targeted nerve ablation in the upper abdomen. Cardiologists are concerned about collateral tissue damage in ablation procedures - our probe not only targets a very specific area, but also confirms that it’s done correctly.", "one_liner": "Catheter-based solution to treat chronic heart failure. ", "team_size": 3, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1645046316, "tags": [ "Medical Devices" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2022", "status": "Active", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/corveus-medical", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2022/corveus-medical.json", "year_founded": 2021, "city": "Houston", "country": "US", "linkedin_url": "https://www.linkedin.com/company/corveus-medical", "x_url": "", "fb_url": null, "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/2b878b32eb3add0a7ae9da1e37fb4dcc337e6a8f.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 783677, "full_name": "Tyler Melton", "title": "Founder", "founder_bio": "Medical Device | Biomedical Engineering | Business Strategy", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/tylermelton/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/8d9aeadededb3b420c4a23a5af90f867b48ef24f.jpg" } ], "jobs": [], "news": [], "launches": [] }, { "id": 25650, "name": "NearWave", "slug": "nearwave", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/f557afe1950ca98cfc34f200e929dacc1c441796.png", "website": "http://nearwave.co", "all_locations": "Austin, TX, USA; South Bend, IN, USA", "long_description": "NearWave makes a handheld imaging device that helps physicians select the right therapy for their breast cancer patients. This prevents patients from suffering through months of side effects caused by unsuccessful treatments. \r\n\r\n\r\n ", "one_liner": "Helping physicians select the right therapy for breast cancer patients", "team_size": 3, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1646924515, "tags": [ "Hard Tech", "Hardware", "SaaS", "Medical Devices", "AI" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2022", "status": "Active", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/nearwave", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2022/nearwave.json", "year_founded": 2022, "city": "Austin", "country": "US", "linkedin_url": "https://www.linkedin.com/company/nearwave/about/", "x_url": "https://twitter.com/NearWave/", "fb_url": "https://www.facebook.com/nearwave/", "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/f557afe1950ca98cfc34f200e929dacc1c441796.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 749007, "full_name": "Roy Stillwell", "title": "Founder", "founder_bio": "Roy Stillwell is the co-founder, CEO and chief engineer of NearWave, which he co-founded with Professor Thomas O'Sullivan in 2020. He has a PhD in electrical engineering, with a focus in biophotonics research. Originally from Colorado, Roy is a father, husband, technologist, gamer, boarder, and loves to build. \n", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/roy-stillwell-12448916/", "x_url": "https://twitter.com/stillwell_roy", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/fa6d624bf89f9bd5f64732bdf206bc741ce339ef.jpg" } ], "jobs": [], "news": [], "launches": [ { "id": 80934, "title": "NearWave - Realtime therapy efficacy for treating breast cancer patients", "tagline": "NearWave makes a new type of handheld imaging tech with AI that helps physicians select the right therapy for their breast cancer patients. ", "body": "**TL;DR We can tell within a week if chemotherapies in breast cancer are working or not, allowing physicians to stop or change therapies very quickly, rather than waiting 3-12 months. This saves patients months of side effects for the 70% of women that do not fully respond to cancer therapies, affecting the 4M women in the world diagnosed with invasive breast cancer each year. This will be the standard of care in the next 5 years.**\n\nHello to all my YC friends, I’m Roy and our team is building [NearWave.](https://nearwave.co/) Both my mother and grandmother are breast cancer survivors, as is my co-founder’s wife.  After going through the (often archaic) treatment process with them, we are on a personal mission to bring treatment relief for unnecessary side effects caused by ineffective and expensive treatments which currently costs the US health system $50B/yr. There is a nice video story [here](https://fightingfor.nd.edu/2023/fighting-for-breast-cancer-patients/).  We already have 4 systems sold to customers ($123k) and just received a letter that the FDA agrees with our regulatory pathway.\n\n**The Problem**\n\nOncologists have the difficult task of assessing the efficacy of chemotherapy drugs and proper dosing, with the majority of breast cancer patients not showing pathologic complete response (pCR). Imagine taking drugs that devastate your immune system, cause hair loss, nausea, later to find the treatment is ineffective. Further, it takes months to tell if a therapy is working. Those months are critical to survival for patients with aggressive disease progression.\n\n**Our Solution**\n\nNearWave's core imaging technology and accompanying prediction models have been shown in multi-center studies to predict pathologic complete response in breast cancer patients in as early as a week\\[[1](https://pubmed.ncbi.nlm.nih.gov/30338678/#:\\~:text=Notably%2C%20logistic%20regression%20based%20on,CI%3A%200.82%20to%201)\\]\\[[2](http://cancerres.aacrjournals.org/content/76/20/5933.short)\\]\\[[3](https://www.spiedigitallibrary.org/journals/journal-of-biomedical-optics/volume-29/issue-06/066001/Functional-hemodynamic-imaging-markers-for-the-prediction-of-pathological-outcomes/10.1117/1.JBO.29.6.066001.full#_=_)\\]. If oncologists knew efficacy in a few days, they would make real-time adjustments to therapy, personalizing care for each patient \\[[4](https://www.mendelspod.com/p/precision-oncology-at-the-community-544?utm_source=publication-search)\\].\n\n📸 Device and iPad app showing a tumor simulating phantom scanned with the system.\n\n![uploaded image](/media/?type=post&id=80934&key=user_uploads/749007/8f146342-1e4a-4bcb-a40f-639be01f52be)\n\nWhen a therapy is not showing a response, physicians can increase dosage, iterate to other therapies, or move to surgery much sooner, reducing side-effects for patients by as much as 50%, while reducing cost in direct-to-surgery cases. In the future we will expand our indication to cover benign/malignant lesion classification at the ob/gyn bed-side, where ½ the world population undergoes exams, a true **billion user** technology. \n\n**How it works**\n\nThe underlying technology uses [fdNIRS](https://nearwave.co/technology/fdnirs/), a form of near infrared spectroscopy which is deep tissue, non-invasive, does not require injectable contrast, and uses no ionizing radiation.  We measure the molecular absorption and scattering of light of biomarkers (blood, water, lipid) to monitor changes in metabolic and hemodynamic information in tissue \\[[5](https://opg.optica.org/boe/fulltext.cfm?uri=boe-12-11-7261&id=462776)\\]. Metabolic changes are an excellent indicator of therapy response, which our AI models use to categorize and predict the treatment outcomes. \n\n🌈 Here’s how light travels in tissue, and how it works with our system.\n\n![uploaded image](/media/?type=post&id=80934&key=user_uploads/749007/6ffa11ac-d114-48d8-a27b-8e50c0c1e2ab)\n\n🤖 Workflow for our AI model therapy response grading. Breast images are from a study patient responding to therapy.\n\n![uploaded image](/media/?type=post&id=80934&key=user_uploads/749007/2a7c993c-4938-4648-b042-61af9cdfe9f5)\n\n🤯 Here we visualize a 3d tumor, measured with our system on a physical tumor phantom of actual breast tissue properties.\n\n![uploaded image](/media/?type=post&id=80934&key=user_uploads/749007/e47ac6ad-99d0-4b3a-a421-9d535916dc28)\n\n**Asks**\n\nIf you know anyone affected by breast cancer that was a candidate for neoadjuvant chemotherapy, we’d love to talk to them to hear about their experience. Reach out to us [here](https://nearwave.co/company/contact/). \n\nIf you have 10 minutes to chat about what we’re doing, I’d be thrilled to book a time with you [here](https://calendly.com/roy-197/roy-15min?preview_source=et_card&month=2024-05&date=2024-05-20).  \n\nThank you. \n\nRoy & the NearWave Team", "url": "https://www.ycombinator.com/launches/L3O-nearwave-realtime-therapy-efficacy-for-treating-breast-cancer-patients", "votes": 42, "created_at": "2024-05-17T22:13:40.694Z" } ] }, { "id": 25864, "name": "Torpedo Therapeutics", "slug": "torpedo-therapeutics", "former_names": [ "Neural Dynamics Technologies LLC", "Neural Dynamics", "Neural Dynamics Technologies", "Neural Dynamics Technologies Inc." ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/29b16aa346e71b9adabcb4e4ad8246dc1ea325db.png", "website": "https://www.torpedotherapeutics.com", "all_locations": "Boston, MA, USA", "long_description": "We are building high-precision implantable neuromodulation devices that can sense and stimulate neural activity in the brain with the goal of transforming the efficacy and adoption of deep brain stimulation (DBS), an existing FDA-approved therapy used to treat Parkinson’s, essential tremor and epilepsy. \r\n\r\n\r\n", "one_liner": "High-precision, closed-loop neuromodulation devices", "team_size": 5, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1645109962, "tags": [ "Neurotechnology", "Medical Devices", "Biotech" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2022", "status": "Active", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "United States of America", "America / Canada" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/torpedo-therapeutics", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2022/torpedo-therapeutics.json", "year_founded": 2018, "city": "Boston", "country": "US", "linkedin_url": "https://www.linkedin.com/company/35666408", "x_url": "https://twitter.com/torpedotx", "fb_url": null, "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/29b16aa346e71b9adabcb4e4ad8246dc1ea325db.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 590688, "full_name": "Ingrid van Welie", "title": "Founder", "founder_bio": "Ingrid van Welie, PhD, is the Founder and CEO of Torpedo Therapeutics. Ingrid is a neuroscientist and biophysicist and is focused on developing and commercializing new technologies for sensing and modulating the electrical properties of neurons in the brain. ", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/ingrid-van-welie-28095423/", "x_url": "https://twitter.com/torpedotx", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/32c93f98a06464a37eebe6266bb9669f8ef82a38.jpg" } ], "jobs": [], "news": [], "launches": [] }, { "id": 26331, "name": "BBy", "slug": "bby", "former_names": [ "BBy, Inc" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/32ca3d94384fbaa3965d8340db4bd11c1c0bf860.png", "website": "http://www.bbymilk.com", "all_locations": "New York City, NY, USA", "long_description": "BBy's condensing device turns milk into a fine powder that spares the biome leaving it biologically and immunologically active. This allows hospitals to stop wasting precious nursing time defrosting milk for hours and milk wastage from discarding rules. Simply weigh the powder, add water, shake and serve. No more freezing, no more defrosting, only patient care. NICUs are time sensitive wards in the hospital, time is everything and yet nurses today continue to prepare frozen milk for infants in what's known as the milk shift. A shift where the nurse spends the day defrosting milk for the next shift of nurses. Our tech is now fully peer reviewed and published, yielding safe and reliable results in over 20 hospitals in the New York Tri-State. The company is headed by Vansh Langer MD, a physician (Windsor University, University of Chicago) and Blanca Aguilar Uscanga PhD, a Bioengineering/Food Science PhD (University of Guadalajara /Centro Universitario de Ciencias Exactas e Ingenierías (CUCEI)) team that has over 50 published works in the field between them and are experts in the science of infant nutrition. Vansh saw the immense need for a time critical solution in the NICU and helped solve the puzzle with Dra. Blanca and her team and decided to work together to: Nurture the Future.", "one_liner": "BBy powders breast milk that's immunologically active & lasts 6 months", "team_size": 70, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1643810815, "tags": [ "Health Tech", "Medical Devices", "Healthcare" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2022", "status": "Active", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Growth", "app_video_public": true, "demo_day_video_public": true, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/bby", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2022/bby.json", "year_founded": 2015, "city": "New York City", "country": "US", "linkedin_url": "http://www.linkedin.com/bby", "x_url": "http://www.twitter.com/bbycares", "fb_url": "http://www.facebook.com/bbycares", "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/32ca3d94384fbaa3965d8340db4bd11c1c0bf860.png", "app_video_url": "https://bookface-images.s3.us-west-2.amazonaws.com/bf-public_profile/26391/app_video.mp4?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=ASIAQC4NIECAPNM4H2ZD%2F20261020%2Fus-west-2%2Fs3%2Faws4_request&X-Amz-Date=20261020T022706Z&X-Amz-Expires=60&X-Amz-Security-Token=IQoJb3JpZ2luX2VjEHEaCXVzLXdlc3QtMiJIMEYCIQC39P4yQgLmT71RDgpP7SzleQQnonC709CIthldibwFEQIhAIaTmz7itB2BSOcbLvHSEqR5atrCru8331p2nxswpFPlKuUDCDoQABoMMDA2MjAxODExMDcyIgyIHFNA%2BoAC3h6UfhkqwgMWrnQPAwVxcPSn8YGKQ67Z0i8w7sabSqzPmNg6qiVIbYfg3K4FwKrIr3%2BTMgYX%2F%2BeX%2Bpa1NffuFltcS%2FaD5i3P1PA7HKH7LJyFtww7k%2BA5KO%2BhkePkfgEpsky%2B%2BePphwBgc9LL2ObqwtvM0EqR2dvmGwK0pOjv9X9%2BotFVgCBEydgR1IOnYN56T1k%2BOXenbO9d9Elhw1Z78OO2wXYiR75z4yo1s5wz6zr4twai2ELFmfsMX3W7R4ZZZe%2FltqATVqoeN%2FywW0mOfO0EHxXkvuMbE2ccH5poFJFhBb8IND4h0Y0gH2T23H64cQtXSV4AJYWTQ9iYcaV%2Bwd8ByovUNO3fYdg187s5BLUfU6Jqn%2By5CtTj18WZzbB9V4IJIDVws7aW1cDLr1nbZLZ69tv7aAhMwPgsaLz1uFXCVWijHk29oa4VVNLMHAyfE6%2FTVNP0MjolUOhxV9p7md%2BhVVj5DiVMg%2FtlzSKh2keTbpP3xzzrXmlnSljux%2BPIztNqkDf3jvu4gdCKV3knadzxbWZoxCCNtJ2mZf3hqB7qsmn0%2Fj2keORPeqosWjC%2BM1Yvo7staxmYofRhKRaufjshsfrZz9fARksw5%2F3a1gY6pAGKRpigvHO1ZInNRWL4VQjhyvyyI4jWG5oD9NiiTxRQkTVPRsVYZrMtNGSYxvbfyty52pgjuw%2FBLRGM361snatBfs2Y4YLb7qqHcAHDCD1xDcZbIqioGiGF6I0iKm%2Bj4lDuUpeY4bb92wwFFie%2FgZRgfL%2FkayhSZmr4ZeWf%2FGCpxzwDak8O1KvjgDMiuzmVtIhavK0gyCxgFPfLUd0luRL5fYuYrg%3D%3D&X-Amz-SignedHeaders=host&X-Amz-Signature=94da150ac99dd5dc1f443fae716c01c90a8c11b34e4591763417b50acb06ff5c", "dday_video_url": "https://bookface-images.s3.us-west-2.amazonaws.com/video_event/56/1648672214662-7towjw5fnx-71489e1bd7fcd71cbbeb1b490e27e4ff/0e16eb382d490be65003dc02d6a3b2f8.mp4?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIAQC4NIECABPQ2AHNW%2F20261020%2Fus-west-2%2Fs3%2Faws4_request&X-Amz-Date=20261020T022706Z&X-Amz-Expires=3600&X-Amz-SignedHeaders=host&X-Amz-Signature=c9c17a75cce50b40be7d5b361e004a44020993abe747a29fb94d704ccd0cc045", "company_photos": [], "primary_partner": null, "founders": [], "jobs": [], "news": [ { "title": "Shelf-Stable Breast Milk Powder: Interview with Dr. Vansh Langer, CEO at BBy | Medgadget", "url": "https://www.medgadget.com/2023/06/shelf-stable-breast-milk-powder-interview-with-dr-vansh-langer-ceo-at-bby.html", "date": "Jun 26, 2023" }, { "title": "New York-based BBy Raises $3M in Seed Funding to Reinvent Breast Milk Management in Hospitals", "url": "https://femtechinsider.com/bby-seed-round/", "date": "May 29, 2023" }, { "title": "Powdered Breast Milk Startups Are A Thing And This One Just Grabbed $3M In Funding", "url": "https://news.crunchbase.com/health-wellness-biotech/breastmilk-startups-venture-funding/", "date": "May 25, 2023" }, { "title": "BBy device turns breast milk into powder, helps NICU nurses avoid lengthy ‘milk shift’ | TechCrunch", "url": "https://techcrunch.com/2023/05/25/bby-breast-milk-powder-nicu-health/", "date": "May 25, 2023" }, { "title": "Powdered Breast Milk Startups Are A Thing And This One Just Grabbed $3M In Funding", "url": "https://news.crunchbase.com/health-wellness-biotech/breastmilk-startups-venture-funding/", "date": "May 25, 2023" } ], "launches": [] }, { "id": 26806, "name": "Illuminant Surgical", "slug": "illuminant-surgical", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/7d849bf884b530749e2b233bf2099f94506fbd24.png", "website": "https://www.illuminant.ai/", "all_locations": "Los Angeles, CA, USA", "long_description": "Illuminant Surgical is building a new way of seeing inside the human body.\r\n\r\nOur breakthrough platform, Skylight™, is the first real-time anatomical projection system, displaying images directly on the patient to give doctors an x-ray vision view for safer interventions.", "one_liner": "A new way of seeing inside the human body.", "team_size": 11, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1660310230, "tags": [ "Medical Robotics", "Augmented Reality", "Robotic Surgery", "Medical Devices", "Navigation" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2022", "status": "Active", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/illuminant-surgical", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2022/illuminant-surgical.json", "year_founded": 2021, "city": "Los Angeles", "country": "US", "linkedin_url": "https://www.linkedin.com/company/illuminant-surgical/", "x_url": "", "fb_url": null, "cb_url": "https://www.crunchbase.com/organization/illuminant-surgical", "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/7d849bf884b530749e2b233bf2099f94506fbd24.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 636938, "full_name": "Eldrick Millares", "title": "Founder", "founder_bio": "Co-Founder and Co-CEO at Illuminant Surgical\nStanford BS/MS EE", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/eldrickm", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/46c43000368b236419f48afa866b663d4a8ca559.jpg" }, { "user_id": 1004430, "full_name": "James Hu", "title": "Co-Founder, Co-Chief Executive Officer", "founder_bio": "Co-Founder, Co-CEO @ Illuminant Surgical\nStanford Bioengineering\nUCI Med ", "is_active": true, "linkedin_url": "http://linkedin.com/in/jameshu7", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/d625c5ed3192fff72c5608d5bea6542c88936eeb.jpg" } ], "jobs": [], "news": [], "launches": [ { "id": 65365, "title": "Illuminant Surgical: A new way of seeing inside the human body", "tagline": "Displaying images directly on the patient for safer, faster procedures", "body": "**💡TL;DR**\n\n* We give doctors X-ray vision without the need for headsets or monitors.\n* It works in any operating room, requires zero wearables, and seamlessly integrates into existing workflows.\n* We're starting with spine surgery, pain management, and interventional radiology - 11M+ annual procedures in the U.S.\n\n![uploaded image](/media/?type=post&id=65365&key=user_uploads/636938/0a341696-1b40-4543-b52f-2cc145a6579f)\n\n**❌ The Problem: Patient Access Is Stuck In The 1800s**\n\nEvery year, hundreds of millions of procedures require precise access to internal anatomy. Whether placing a screw in the spine, inserting a needle for a biopsy, or advancing a catheter, precision is critical. Yet surgeons still rely on outdated tools: fluoroscopy, “feel”, and mental reconstruction, leading to inefficiencies, complications, and billions in unnecessary healthcare costs.\n\nThis has serious consequences:\n\n* For patients – misplaced implants, vascular injuries, and nerve damage result in repeat procedures, extended hospital stays, and life-altering complications.\n* For hospitals – preventable surgical revisions cost tens of billions annually in unnecessary expenses\n* For surgeons – Cumbersome tools and methods that extend case time, increase cognitive load, and limit the number of patients they can treat.\n\nSpine surgery and interventional access are two of the fastest-growing segments and also among the most accuracy-dependent.\n\nIn the US alone:\n\n* 1.6 M spine surgeries where millimeters can mean the difference between mobility and disability.\n* 9.5 M interventional procedures that rely on accurate percutaneous access to treat and diagnose hundreds of different conditions and diseases.\n\n**This is a $10B+ unmet need.**\n\n**🔎 Our Solution: See Inside The Patient in Real Time, Directly On The Body**\n\nWe’ve built a new way of seeing inside the human body: Skylight is the first real-time anatomical projection system built to solve the problems with patient access. Instead of forcing doctors to look away at a screen, Skylight projects anatomy directly onto the patient, like an AR display—but without headsets, wearables, or extra steps.\n\n![uploaded image](/media/?type=post&id=65365&key=user_uploads/636938/8f98ebe8-aa8b-44e5-aac5-1b03d5105bfd)\n\nTo make this happen, we’ve developed a novel method of tracking the patient with sub-millimeter accuracy and we’ve built this system to be universally compatible with industry-standard tools and scanners to allow adoption without changing workflow.\n\n![uploaded image](/media/?type=post&id=65365&key=user_uploads/636938/d4213fc6-0747-4211-8bc3-56a309fd14c9)\n\n**Just as fiber optics revolutionized how we do laparoscopy and minimally invasive surgeries, anatomical projection will become the new standard for patient access.**\n\n**Who We Are:**\n\nWe’re James and Eldrick, two Stanford engineers who first met as freshman dormmates and have now worked together for over a decade.\n\n💉James: MD, bioengineer, scientist, and medical device builder.\n\n⚙️ Eldrick: Experienced deep-tech founder. Built chips at Apple and led hardware-software teams at a lidar startup.\n\nWe’ve assembled a world-class team of engineers, clinicians, and medical device experts to solve tough problems at the intersection of medicine, computer vision, graphics, and hardware development.\n\n![uploaded image](/media/?type=post&id=65365&key=user_uploads/636938/f5a0197a-718d-45cf-b2bd-f71769312830)\n\n**We’re looking for:**\n\n🩺 Clinicians → If you do spine, pain management, or IR, let’s talk.\n\n🏥 Hospital Partners → Want to be at the forefront of procedural navigation? Reach out.\n\n📰 Media → We’re redefining how doctors see. Let’s get the word out.\n\nEmail us [founders@illuminant.ai](mailto:founders@illuminant.ai) 💡", "url": "https://www.ycombinator.com/launches/H0H-illuminant-surgical-a-new-way-of-seeing-inside-the-human-body", "votes": 95, "created_at": "2022-08-15T12:19:47.391Z" } ] }, { "id": 27168, "name": "Relevium Medical", "slug": "relevium-medical", "former_names": [ "Relevium", "ReleviumBio" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/fe3f53ef710ec5758d984168f33594337d5df8ae.png", "website": "https://relevium-medical.com/", "all_locations": "Galway, County Galway, Ireland", "long_description": "Relevium Medical is developing an injectable gel for knee osteoarthritis. Approximately half the population will be diagnosed with this pain and progressive disease.\r\nRight now, patients have to undergo not only repeat injections to control their pain, but also have to take strong oral medications. Because the disease is progressive and only gets worse over time, many patients end up on highly addictive, high-dose opioids. \r\nTo date, we have secured $3.7 million in non dilutive funding and completed preclinical testing. We demonstrated that our drug is safe, selectively blocks nerves that transmit pain, and provides pain relief that lasts four times as long. \r\nInsurance currently pays $770 per six-monthly treatment for knee osteoarthritis. With 5 million patients in the US, this represents a $7.7 Bn market opportunity.\r\nThis platform biotherapeutic can also be used to treat other joints affects by osteoarthritis such as the hip and ankle, where the same problems exist in treatment care. ", "one_liner": "Platform injectable gel based therapeutic for osteoarthritis", "team_size": 5, "industry": "Healthcare", "subindustry": "Healthcare -> Therapeutics", "launched_at": 1653661401, "tags": [ "Medical Devices", "Healthcare", "Therapeutics", "Drug discovery" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2022", "status": "Active", "industries": [ "Healthcare", "Therapeutics" ], "regions": [ "Ireland", "Europe" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/relevium-medical", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2022/relevium-medical.json", "year_founded": 2019, "city": "Galway", "country": "IE", "linkedin_url": "https://www.linkedin.com/company/releviummedical/", "x_url": "", "fb_url": null, "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/fe3f53ef710ec5758d984168f33594337d5df8ae.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 896081, "full_name": "Alison Liddy", "title": "Founder", "founder_bio": "Alison is CEO and Founder at Relevium Medical. Alison holds qualifications in Chemistry and Biochemical Engineering (M.Sc. & Ph.D.). She has worked for major multinational companies including ROCHE, Cook Medical and Boston Scientific; and completed the BioInnovate Fellowship in the prestigious Stanford BioDesign-affiliated program at NUI Galway, Ireland. She is the named inventor on over 20 patent publications and the winner of the Science Foundation of Ireland’s €1 million innovation prize.", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/alison-liddy-ph-d-402155138/?originalSubdomain=ie", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/5b2a3ec2cb7d9a78b37837da2196318376af434d.jpg" } ], "jobs": [], "news": [ { "title": "Galway’s Relevium Medical gets €4.6m funding for knee osteoarthritis treatment | Business Post", "url": "https://www.businesspost.ie/news/galways-relevium-medical-gets-e4-6m-funding-for-knee-osteoarthritis-treatment/", "date": "Dec 11, 2024" } ], "launches": [ { "id": 65532, "title": "🚀🚀 Relevium Medical", "tagline": "Advancing Long-Lasting Solutions for Chronic Pain", "body": "**The problem:** The chronic pain condition Knee osteoarthritis (OA) affects over 250 million people globally, creating significant social and healthcare challenges, with **untreated pain being the #1 patient complaint**.  In the absence of effective long-term injectable treatments, millions of patients rely on damaging oral medications. \n\nCapsaicin, offers long-lasting, selective pain relief for chronic pain via molecular ablation of pain-sensing nerves only. Despite FDA approval and proven safety and efficacy, its adoption is limited by **intense burning pain** post-administration, requiring over **1.5 hours of clinic management and making it intolerable for many patients**. This has restricted the use of an otherwise highly effective treatment for chronic pain.\n\n**Our solution:** RM-010 was specifically developed to address the burning pain associated with Capsaicin. Relevium Medical has engineered an innovative drug delivery system that gradually releases Capsaicin into the knee joint, carefully maintaining concentrations **below the threshold that triggers burning pain** while sustaining levels high enough to achieve full nerve ablation. This breakthrough offers patients a highly tolerable, effective, and safe treatment, delivering long-lasting pain relief with a significantly improved experience. RM-010 is designed for seamless integration into clinical workflows, allowing physicians to administer the therapy in **5 minutes**. It provides a practical, patient-friendly solution for effectively managing knee osteoarthritis pain, setting a new standard in treatment care.\n\n![uploaded image](/media/?type=post&id=65532&key=user_uploads/896081/10efad73-299c-4cd5-9c87-0a4e0f19f1bb)\n\n**Who are are:** Relevium Medical, headquartered in Galway, Ireland, is a pioneering pharmaceutical company driven by a passionate team of chemists, neuroscientists, pharmacists, and industry experts. United by a shared mission, the team is dedicated to developing novel solutions to improve the lives of people living with chronic pain.\n\n**Interested in hearing more**: Get in contact at [info@Relevium-Medical.com](mailto:info@Relevium-Medical.com)", "url": "https://www.ycombinator.com/launches/H2y-relevium-medical", "votes": 18, "created_at": "2022-08-22T13:44:28.458Z" }, { "id": 64408, "title": "ReleviumBio - Life changing Innovation", "tagline": "ReleviumBio is developing a platform peptide gel-based therapy for Osteoarthritis", "body": "![uploaded image](/media/?type=post&id=64408&key=user_uploads/854295/770094dd-9ea7-4b87-96db-dfa446ca3b6e)\n\n[www.ReleviumBio.com](http://www.ReleviumBio.com)\n\n**Problem** \\\nThere has been no disruptive treatment for knee osteoarthritis (KOA) in over 50 years, with 80% of patients reliant on damaging medications. The shortcomings of the current injectable treatments leave 2 million US patients reliant on opioids for adequate pain relief. The number one KOA patient complaint is pain, with regenerative therapies to date failing to demonstrate a measurable patient outcome.\n\n**Solution** \\\nUp to recently, it was believed KOA was a disease of wear and tear. The latest scientific evidence however shows it to be a complex whole-organ disease, affecting multiple tissues and with different disease patterns for different patients. This evidence highlights the need for a multimodal approach to effectively treat this complex disease. PeptiFlex is the first multimodal injectable therapeutic developed for KOA that gives not only pain relief but also lubricates and preserves the joint.\n\n**How it works** \\\nOur novel multimodal therapeutic is based on a peptide component (315y) covalently bound to a polymer gel base. This patent-protected biotherapeutic achieves its effects through three complementary and synergistic effects. The biotherapeutic is injected directly into the knee joint to give immediate long-acting relief.\n\n**Pain Relief Effect**: PeptiFlex reduces pain nerve signalling by the action of peptide 315y which safely and consistently reduces pain signalling by a sodium channel block effect on neurons in the knee nerve fibres. Preclinical test data out to 7 weeks in a dedicated KOA model has shown successful translation of efficacy and safety with statistically significant effects on key pain endpoints.\n\n**Lubrication Effect**: The polymer base of PeptiFlex has unique viscoelastic properties acting as a substitute for healthy joint fluid and providing lubrication, cushioning, shock absorption, and improving the physical function of the joint.\n\n**Protection Effect**: PeptiFlex has proven to be extremely safe and protects joint structure by cartilage protecting actions of peptide 315y. The peptide interacts with cartilage-producing cells (chondrocytes) to cause proliferation and increased cartilage production. Tests have shown KOA joints treated with PeptiFlex were evaluated using the gold standard OARSI cartilage scoring system and showed improvement in terms of aggression and extent of disease compared to control.\n\n**The ask** \\\nIf you know any strategics interested in osteoarthritis or clinical trial groups interested in partnering with early-stage companies, we would really appreciate an introduction", "url": "https://www.ycombinator.com/launches/Gkq-releviumbio-life-changing-innovation", "votes": 12, "created_at": "2022-07-07T14:00:52.112Z" } ] }, { "id": 28853, "name": "Obento Health", "slug": "obento-health", "former_names": [ "Shopergo" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/90a0ab27f8e7fd19fa5150b5f3de4e0557c38fb0.png", "website": "https://www.getobento.com", "all_locations": "San Francisco, CA, USA", "long_description": "Obento Health is redefining the CRM experience for medical field sales. Designed specifically for healthcare, we are saving reps time from documentation and empowering reps to create more personalized interactions with their customers. ", "one_liner": "CRM Co-Pilot for Medtech Sales", "team_size": 2, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1690867347, "tags": [ "B2B", "Medical Devices", "Healthcare", "CRM", "AI" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2023", "status": "Active", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "United States of America", "America / Canada" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/obento-health", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2023/obento-health.json", "year_founded": 2023, "city": "San Francisco", "country": "US", "linkedin_url": "https://www.linkedin.com/company/95734316/", "x_url": "", "fb_url": null, "cb_url": null, "github_url": "https://github.com/obentohealth/", "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/90a0ab27f8e7fd19fa5150b5f3de4e0557c38fb0.png", "app_video_url": null, "dday_video_url": null, "company_photos": [ "https://bookface-images.s3.us-west-2.amazonaws.com/attachments/29789715c2d9dbf04c7c6671d2788c30c2f9231e.png", "https://bookface-images.s3.us-west-2.amazonaws.com/attachments/17a23dbc4c3545c04ba015f97285b670931071bf.png" ], "primary_partner": { "name": "Garry Tan", "url": "https://www.ycombinator.com/people/garry-tan" }, "founders": [ { "user_id": 898197, "full_name": "Naxin Wang", "title": "Founder", "founder_bio": "I stumbled into healthcare and haven’t looked back since. Currently building CRM for Medical Sales at Obento Health. Analyst by training at Google and built products at Verily Life Sciences, serving biopharma and medtech customers.", "is_active": true, "linkedin_url": "https://linkedin.com/in/naxinwang", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/f360423e259d137d944085f077a43c27deafb397.jpg" } ], "jobs": [], "news": [], "launches": [ { "id": 84090, "title": "Obento Health - CRM Co-Pilot for MedTech Sales", "tagline": "We use AI to help medical field sales build stronger relationships with healthcare providers and organizations.", "body": "**TLDR**\\\n[Obento Health](https://www.getobento.com/?utm_source=launchyc) is redefining the CRM experience for medical device sales. Designed specifically for healthcare, we are saving field reps time from activity tracking and empowering reps to create more personalized interactions with their customers.\n\n### **The love-hate relationship with a CRM**\n\nMedical device reps are constantly on the go, and our users have told us using CRM is a necessary evil for their job. A clunky CRM leads to inefficiencies in managing customer relationships and missing valuable follow-ups. More importantly, reps are spending hours a week doing admin work in their CRM instead of focusing on their customers, and management is missing key insights to drive strategic directions for their sales teams. \n\n![uploaded image](/media/?type=post&id=84090&key=user_uploads/898197/fe5a0beb-4b25-42e3-8f6c-eb9b8e7f22d1)\n\n### **Obento is taking the pain out of using a CRM**\n\nThe team at Obento has designed the perfect co-pilot for medical device reps. Our mobile-first platform allows reps to log visits using voice-to-CRM, access their rolodex at their fingertips with enriched domain-specific data, and a debrief mode that can help reps uncover more aha moments. By integrating seamlessly with existing CRM systems, Obento enhances rep productivity from day one.\n\n### **The team has dedicated two decades into building well-loved products**\n\nNaxin Wang and Rodrigo Gutierrez have 20 years of combined experience and have built products used by millions of people. Naxin was at Verily (fka Google Life Sciences) building products for biopharma and medtech companies, and Rodrigo joined as an early employee and led product engineering at Strava.\n\n![uploaded image](/media/?type=post&id=84090&key=user_uploads/898197/2e2d4510-a499-4472-96d8-9f7e9079899b)\n\nReach out to us at [naxin@obentohealth.com](mailto:naxin@obentohealth.com) to see how AI can transform your commercial team.", "url": "https://www.ycombinator.com/launches/LsI-obento-health-crm-co-pilot-for-medtech-sales", "votes": 28, "created_at": "2024-09-17T17:29:33.192Z" } ] }, { "id": 28859, "name": "MICSI", "slug": "micsi", "former_names": [ "MICSI (Microstructure Imaging, Inc)" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/29d35560d45b90c5227b12877556942576e43627.png", "website": "https://www.micsi.co/", "all_locations": "New York City, NY, USA", "long_description": "MICSI is introducing AI software that doubles resolution and halves scan time. This breakthrough enables imaging centers to significantly enhance their capacity and patient throughput, potentially saving countless lives and generating an additional $2 million of revenue per MRI scanner. Our initial offering serves as a stepping stone toward the company’s larger vision of transforming the MRI into a truly quantitative instrument that is capable of providing highly reproducible data for more accurate diagnoses and patient management. ", "one_liner": "Higher resolution MRI with faster scan times.", "team_size": 2, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1687381964, "tags": [ "Computer Vision", "Medical Devices", "Healthcare" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2023", "status": "Active", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "United States of America", "America / Canada" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/micsi", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2023/micsi.json", "year_founded": 2018, "city": "New York City", "country": "US", "linkedin_url": "https://www.linkedin.com/company/microstructure-imaging-inc/", "x_url": "", "fb_url": null, "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/29d35560d45b90c5227b12877556942576e43627.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 1352304, "full_name": "Gregory Lemberskiy", "title": "Founder", "founder_bio": "Gregory Lemberskiy (CEO) co-founded MICSI with goal of bringing cutting edge image processing tools, that he encountered in the research setting into clinical practice. His PhD work (2019) focused on algorithm development for image enhancement and biophysical modeling of the MRI signal. His methods have been used to enable high-end quality on low field MRI systems through noise reduction (MICSI’s first product) and use MRI to characterize the physical properties of prostate glandular lumen.", "is_active": true, "linkedin_url": "https://linkedin.com/in/gregory-lemberskiy", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/83bae6427877568348313403492a3c5c90b7ff0c.jpg" }, { "user_id": 1352419, "full_name": "Benjamin Ades-Aron", "title": "Founder", "founder_bio": "I got my PhD in electrical engineering in 2022 from NYU, where I specialized in developing machine learning based computer vision algorithms for the visualization of MRI data. I specialize in developing software to process and route diffusion and functional MRI data, with a goal of improving image signal, reducing noise, and producing clinically viable diagnostic imaging biomarkers.", "is_active": true, "linkedin_url": "https://linkedin.com/in/benjamin-aron-b0313349", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/894ba3227d1a30f75b7086a428e64dbf24f4a090.jpg" } ], "jobs": [], "news": [], "launches": [ { "id": 96226, "title": "MICSI-PET: Anatomical Positron Emission Tomography", "tagline": "Making PET imaging fast, anatomical, and scalable for Alzheimer’s care.", "body": "TLDR; MICSI-PET makes PET imaging fast, anatomical, and scalable for Alzheimer’s care.\n\n![uploaded image](/media/?type=post&id=96226&key=user_uploads/1352304/a5488138-be4b-4093-86c1-1b2663488117)\n\n**Problem:** **PET is the bottleneck capping the entire Alzheimer’s market.**\n\n![uploaded image](/media/?type=post&id=96226&key=user_uploads/1352304/40ba7516-1b46-454a-9a26-98fb91fe3169)\n\nDisease modifying Alzheimer’s drugs like Leqembi and Kisunla are here, and they are projected to generate $5-8B/year by 2030. However, to get these drugs, patients need a positive amyloid PET scan.\n\nThis is an ambitious figure that is limited by the fact that there are only 2500 PET/CT scanners in the US, where the average age is 14 years old. PET scanners have a predictable 4-5% drop in sensitivity (or detected count rate) per year \\[Watanuki et al. Ann Nucl Med. 2010\\], suggesting a loss of half of the sensitivity since its initial install. Operationally, this sensitivity loss forces centers to lengthen acquisitions or increase dose just to preserve image quality, reducing throughput or margins right as amyloid PET demand is exploding. It’s also unrealistic to assume that the existing PET fleet is built for imaging Alzheimer’s at scale. PET systems are also heavily utilized for oncology, cardiology, infection, and presurgical planning, where 74% of all PET scans use FDG, a general purpose tracer for cellular metabolism. \n\n**Solution: Transform aging PET fleets into Anatomical PET with MICSI-PET.**\n\n![uploaded image](/media/?type=post&id=96226&key=user_uploads/1352304/be3b873c-3dd7-4326-8447-316161d179db)\n\nMICSI-PET is a turnkey upgrade that dramatically enhances PET image quality by using the MRI as an anatomical guide. This process does not require any additional imaging as all patients should have received an MRI prior to amyloid PET imaging. Operationally, this upgrade removes the primary barrier for scaling Alzheimer’s therapies by (1) enabling high-end PET imaging on low-end or aging PET scanners; (2) enabling shorter PET examinations leading to greater throughput; (3) minimizing ambiguity of positive/negative amyloid PET imaging by showing clearer boundaries between gray and white matter:\n\n![uploaded image](/media/?type=post&id=96226&key=user_uploads/1352304/90dd7722-405d-4a4f-967b-4ec6df183ff6)\n\n**Figure:** Coregistered conventional PET and MICSI-PET amyloid images across a range of amyloid burdens, highlighting differences in apparent cortical sparing: **left, amyloid-negative** with strong gray/white contrast; **right, amyloid-positive** with reduced gray/white contrast.\n\n**Addressing the Radiologist Workforce Crisis:** Scaling Alzheimer's care isn't just a hardware problem; it's a workforce problem. AD imaging is about to become a high-volume modality layered onto a nuclear medicine workforce where 54% of radiologists already report burnout.\n\nBeyond anatomical PET, MICSI-PET is designed to streamline diagnosis through automatic SUVR/Centiloid reporting with built-in QC.\n\n![uploaded image](/media/?type=post&id=96226&key=user_uploads/1352304/b48c9a16-d7b6-4fe9-bf74-509653e159dd)\n\nFast and anatomical PET is just the start. The same MR-guided upgrade would generalize across tracers, and eventually across doses, elevating the global standard of PET toward a new default: molecular imaging that’s both specific and anatomically precise. \n\nOur first product, MICSI-RMT, is already FDA-cleared and in the market. MICSI-PET is currently in clinical validation and we are preparing our FDA submission.\n\n**Ask:** We are expanding pre-FDA clearance pilot collaborations to validate MICSI-PET across sites and workflows, and we are closing a seed extension to support multi-center validation and early installs. If you lead a PET imaging program or invest in medical imaging and Alzheimer’s care, we would love to connect.  \n\n**Email Us:** \n\n[**Gregory.Lemberskiy@micsi.com**](mailto:Gregory.Lemberskiy@micsi.com)\n\n[**Benjamin.Adesaron@micsi.com**](mailto:Benjamin.Adesaron@micsi.com)", "url": "https://www.ycombinator.com/launches/P22-micsi-pet-anatomical-positron-emission-tomography", "votes": 16, "created_at": "2025-12-16T00:02:25.484Z" }, { "id": 73719, "title": "MICSI (Microstructure Imaging)", "tagline": "Higher resolution MRI acquired faster", "body": "TLDR; MICSI is introducing an innovative image processing algorithm to decrease MRI scan time, increase image resolution, and unlock new diagnostic capabilities using Microstructure Imaging.\n\n![](https://lh4.googleusercontent.com/166C-4hbfRCmiC20D9EbOVhdubPqEE3tuTb-ZvNh8bnOXts8Rf9ZfhssNQ8ptJsGYAFqtkSt6w9Cu-aRvnBDBoKesDzc1ou7ddUVUZqTZ0knq8MmlZsbLWYY4rpGoFqUmrbmjEeSjfMx7KMKRdEngWA)\n\n**Problem: MRI Centers are overbooked.**\n\nIf you've ever had an MRI, you've probably waited weeks for an available slot and then spent a long time in the scanner. These long scan times inconvenience patients, create hospital backlogs, and delay appointments. Delays like these can critically impact conditions that require prompt diagnosis and intervention, inflate healthcare costs, increase patient anxiety, and potentially compromise treatment strategies. Why the wait? An MRI of the whole brain can be acquired in [**seconds**](https://mriquestions.com/echo-planar-imaging.html)!\n\n**Compromise: Why is your MRI an hour long?**\n\nMost of the scan time is spent on preserving signal-to-noise ratio (SNR) to produce images of the highest quality. These standard SNR preserving methods include:\n\n* Line-by-line acquisitions: These are fax-machine-like acquisitions that read the image one line at a time, where the time spent on each line is equivalent to the time that could have been spent acquiring the whole image.\n* Averaging: To boost SNR, images may be reacquired and averaged together. However, SNR improves slowly as a square root of scan time (ie 4 images are required to double the SNR).\n\nAn additional compromise is related to the spatial resolution, since MRI is acquired in 3D with “voxels”, doubling the resolution in each dimension from (2x2x2 mm3 to 1x1x1 mm3) would require the SNR to increase by **8x**, which even after 50 years of innovation, seems near impossible.\n\n![](https://lh4.googleusercontent.com/y1p1DzihqAvnmKvtoSJAbVSBrInECVUP2GvzVc5TFmLNqwTQ1hevnLgcPX7iplxNhKchrjAAQq8L8WlPbLNVWX31jAN-VIg6dSJ7Nzv-lKMUTvy8xsUIlzfFOZLlgSoGL0ZAC1lk8xqtYL2V4Q1caJk)\n\n**The MRI exam is full of compromise.**\n\n* Long scan times means fewer patients can be scanned by a given radiology center.\n* Lower resolution means a compromise in anatomical accuracy, where pathologies that could have otherwise been detected at an earlier stage would need to progress further to be MR visible.\n\nWe believe that the ultimate compromise is that MRI is not being used to its fullest potential for microstructure imaging, where MRI could be used to [**image cellular properties non-invasively**](https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/nbm.3998).\n\n**Solution: Boosting SNR over the MRI exam using MICSI-RMT.**\n\nOur patented approach (pending FDA510k clearance in Q4-2023) uses a self-supervised AI method to learn the noise properties of the MRI exam and remove noise uniformly across all images of the dataset. Our algorithm, MICSI-RMT, can be described as a smart averaging approach, whereby many images of the MRI exam are combined while preserving their unique image properties and discarding the noise. This boost in SNR would be approximately, sqrt(M/P), where M is the number of images included in the dataset, whereas P describes how different the images are (physical properties: proton density, T1, T2, diffusion, etc + artifacts: motion, errors, etc).\n\nMICSI-RMT is the commercial implementation of the MP-PCA algorithm that was developed by our research group led by Drs. Dmitry S. Novikov and Els Fieremans of NYU Radiology’s Center for Biomedical Imaging.\n\nMP-PCA is the most popular denoising approach in the MRI community:\n\n* The [**original paper**](https://pubmed.ncbi.nlm.nih.gov/27523449/) introducing the approach has achieved over 1300 citations since November 2016.\n* Denoising of [**task-based FMRI**](https://pubs.rsna.org/doi/full/10.1148/radiol.2020200822) for presurgical planning of Neurosurgery\n* Enabling low field [**0\\.55T prostate diffusion**](https://pubmed.ncbi.nlm.nih.gov/37222526/) MRI\n\nWith MICSI-RMT, MRI centers will not only be able to provide higher quality imaging but also drastically reduce the scan time (up to [50%](https://pubs.rsna.org/doi/full/10.1148/radiol.2020200822)). This improved efficiency allows centers to scan more patients per day, enhancing their operational capacity and throughput. Financially, this increase in capacity translates into a significant boost in revenue for every MRI center. By doubling the number of patients scanned daily, we estimate an additional $2 million in annual revenue per MRI scanner. Furthermore, the improved image quality and resolution could lead to more accurate diagnoses, early disease detection, and reducing overall healthcare costs in the long run.\n\n**Who we are - Greg and Ben**\n\n![](https://lh6.googleusercontent.com/F5FGyVn85R_Oxvkgw_uEOhvkKUEg_2VemnSso8p1nBfc7vgYVd1q1Vnt2BgIJrm2CRenojq9RkwoxbuP0lebYfKIcs6anX6wQEPQj0T-yaTJGLBOvqqzsw4JL4ftzrHLozX-QX592SesWUotkt92ZCw)\n\nWe are scientists and engineers who have spent the last decade developing machine learning software to both improve the quality diagnostic utility of MRI. [**Gregory Lemberskiy, PhD**](https://www.linkedin.com/in/gregory-lemberskiy/) is an [**experimental physicist**](https://scholar.google.com/citations?user=_TvugCIAAAAJ&hl=en). He discovered how to use MRI to measure the diameter of the [**prostate glandular lumen**](https://www.frontiersin.org/articles/10.3389/fphy.2018.00091/full), which may obviate the need for tissue biopsy to detect prostate cancer progression. [**Benjamin Ades-Aron, PhD**](https://www.linkedin.com/in/benjamin-aron-b0313349/) is an [**electrical engineer**](https://scholar.google.com/citations?user=xNhHFuAAAAAJ&hl=en) who developed and deployed the [**DESIGNER**](https://pubmed.ncbi.nlm.nih.gov/30077743/) open-source image processing pipeline, which is the global gold standard of diffusion MRI image processing. He has also developed a number of novel neural network architectures to aid in the denoising of compressed sensing MRI data, to facilitate brain mapping for functional neurosurgery of Epilepsy and brain tumor.\n\nTogether, the MICSI team owns over a dozen approved patents and has a clear vision for the future of MRI. The goal of MICSI is to use our patented denoising and parameter estimation technologies to make MRI quantitative and reproducible for the first time, creating a new category in diagnostic healthcare and improving patient satisfaction and outcomes.\n\n**Our Ask**\n\n* Do you know anyone in private practice, hospitals, or in large academic centers who may be interested in our approach? We want to talk to them.\n* Questions, comments, feedback? We want to hear from you!\n\n**Email us:**\n\n[**Gregory.Lemberskiy@micsi.com**](mailto:Gregory.Lemberskiy@micsi.co)\n\n[**Benjamin.adesaron@micsi.com**](mailto:Benjamin.adesaron@micsi.co)", "url": "https://www.ycombinator.com/launches/JB1-micsi-microstructure-imaging", "votes": 23, "created_at": "2023-08-02T17:20:50.834Z" } ] }, { "id": 29008, "name": "Andromeda Surgical", "slug": "andromeda-surgical", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/ad29152e507992c17de56b3d0a62d1fd6769fd3b.png", "website": "http://www.andromedasurgical.com", "all_locations": "San Francisco, CA, USA", "long_description": "We're building autonomous robots to make surgery safe, easier and more efficient. Robots currently perform about 1/4 of surgeries but only help with the physical aspects. We use AI to make surgery cognitively easier. This has far greater potential to improve outcomes and reduce costs. Founded by 3x founders from medtech and autonomous vehicles, we're on track to be the fastest surgical robot to market of all time. First indication is prostate enucleation.", "one_liner": "Autonomous surgical robots", "team_size": 12, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1684515035, "tags": [ "Hard Tech", "Machine Learning", "Medical Robotics", "Medical Devices", "AI" ], "tags_highlighted": [], "top_company": false, "isHiring": true, "nonprofit": false, "batch": "Summer 2023", "status": "Active", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "United States of America", "America / Canada" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/andromeda-surgical", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2023/andromeda-surgical.json", "year_founded": 2023, "city": "San Francisco", "country": "US", "linkedin_url": "http://linkedin.com/company/andromeda-surgical", "x_url": "https://twitter.com/andromedasurg", "fb_url": "http://facebook.com/andromedasurgical", "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/ad29152e507992c17de56b3d0a62d1fd6769fd3b.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": { "name": "Garry Tan", "url": "https://www.ycombinator.com/people/garry-tan" }, "founders": [ { "user_id": 4171, "full_name": "Nick Damiano", "title": "Founder", "founder_bio": "First YC medtech founder and only 2x YC medtech founder; \nCo-founder & CEO @ Andromeda Surgical S23;\nFounder & CEO @ Zenflow W15 - treated > 300 patients so far, Class 3 FDA approval, raised > $100M;\nCo-founder & CTO @ Avail MedSystems (f.k.a. Nurep, acq. by Mendaera) - launched in 1000 hospitals, raised $120M;\nVenture Partner @ Pioneer Fund;\nStanford Biodesign Innovation Fellow & Stanford MS/BS;\nGeneralist/SW engineer;\nDad to two daughters;\nSemicolon enthusiast;", "is_active": true, "linkedin_url": "https://linkedin.com/in/nickdamiano", "x_url": "https://x.com/nickdamian0", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/d66722f33e37245caa7dd8f7da2e5ab43158e9a5.jpg" }, { "user_id": 37368, "full_name": "Kartik Tiwari", "title": "Founder", "founder_bio": "Background in robotics\n3x technical founder, 2x YC founder\nLed the team at Starsky Robotics to become the first in the world to have a driverless truck on a public road", "is_active": true, "linkedin_url": "https://www.linkedin.com/profile/public-profile-settings?trk=prof-edit-edit-public_profile", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/a6e5d0daa20f47f66ea411a42df32eb0df8fac6a.jpg" } ], "jobs": [ { "id": 62175, "title": "Robotics Controls Engineer", "url": "https://www.ycombinator.com/companies/andromeda-surgical/jobs/EiC4MLO-robotics-controls-engineer", "location": "South San Francisco, CA, US", "type": "Full-time", "role": "Engineering", "role_type": "Robotics", "salary_range": "$150K - $250K", "equity_range": "0.10% - 0.50%", "experience": "Any (new grads ok)", "visa": "Will sponsor", "skills": [ "C++", "Python" ] }, { "id": 66541, "title": "Senior Software engineer", "url": "https://www.ycombinator.com/companies/andromeda-surgical/jobs/0NF6Ie3-senior-software-engineer", "location": "South San Francisco, CA, US", "type": "Full-time", "role": "Engineering", "role_type": "Backend", "salary_range": "$150K - $250K", "equity_range": "0.10% - 0.50%", "experience": "3+ years", "visa": "Will sponsor", "skills": [] }, { "id": 80395, "title": "UX Designer", "url": "https://www.ycombinator.com/companies/andromeda-surgical/jobs/dTs6gll-ux-designer", "location": "South San Francisco, CA, US", "type": "Full-time", "role": "Engineering", "role_type": "Robotics", "salary_range": "$150K - $250K", "equity_range": "0.10% - 0.50%", "experience": "3+ years", "visa": "Will sponsor", "skills": [] }, { "id": 83839, "title": "Lead Hardware Engineer", "url": "https://www.ycombinator.com/companies/andromeda-surgical/jobs/93sD4oD-lead-hardware-engineer", "location": "South San Francisco, CA, US", "type": "Full-time", "role": "Engineering", "role_type": "Robotics", "salary_range": "$140K - $200K", "equity_range": "0.10% - 0.50%", "experience": "3+ years", "visa": "Will sponsor", "skills": [ "Arduino", "Python", "Linux", "CAD Design" ] }, { "id": 108088, "title": "Machine Learning Engineer", "url": "https://www.ycombinator.com/companies/andromeda-surgical/jobs/l9lWEvX-machine-learning-engineer", "location": "South San Francisco, CA, US", "type": "Full-time", "role": "Engineering", "role_type": "Machine learning", "salary_range": "$150K - $250K", "equity_range": "0.10% - 0.50%", "experience": "3+ years", "visa": "Will sponsor", "skills": [ "Python", "Torch/PyTorch", "Machine Learning", "Data Modeling" ] } ], "news": [], "launches": [ { "id": 74646, "title": "Andromeda Surgical: Autonomous surgical robots 🦾🏥", "tagline": "Autonomous robots that use AI to elevate every surgeon to world expert level and deliver consistently great patient outcomes", "body": "tl;dr: We’re [Andromeda Surgical](https://andromedasurgical.com/) and we’re building autonomous surgical robots. We’re a team of two 3x founders and 2x YC founders from medtech and autonomous vehicles. Our AI-assisted robots will empower every surgeon to operate at world expert level for every procedure, every time, with minimal training. We’re starting with a proven urologic procedure that can treat over half a million patients per year in the US alone.\n\n \n\n**About Us**\n\nHi everyone, we’re Nick and Kartik, the co-founders of Andromeda Surgical. Nick has founded medtech companies collectively worth over $1 billion whose products are used in over 1,000 medical facilities. Kartik led the team that built and launched the world’s first autonomous truck to operate driverless on US highways. We were both YC alums before this batch, Nick with Zenflow (W15) and Kartik with Starsky Robotics (S16). We met through [YC Co-Founder Matching](https://www.ycombinator.com/cofounder-matching) and realized we could apply the same principles underlying self-driving vehicles to fundamentally change how surgery is performed.\n\n![uploaded image](/media/?type=post&id=74646&key=user_uploads/4171/baf84b2c-4724-43aa-b88d-fc1980e4a389)\n\n\n**Problem**\n\nHuman mental and physical capabilities limit surgical outcomes. Existing surgical robotics companies focus almost exclusively on solving the physical challenges, making surgical movements more ergonomic and precise. These improvements alone have revolutionized surgery and spawned a large and fast-growing industry, led by [Intuitive Surgical](https://www.intuitive.com/en-us) ($108 billion market cap). Surgeons love to use these products and patients eagerly sign up for robotic procedures.\n\nDespite the proliferation of robotics in surgery, the clinical need to reduce complication rates remains largely unmet. Almost one third of patients undergoing surgery experience complications, and 8% experience major complications \\[1\\]. Many surgeons have told us they blame themselves for sub-optimal outcomes, and this adds significant stress to their lives. As AI becomes more powerful, it offers tremendous potential to improve surgical decision making and reduce complication rates.\n\n**Our Solution**\n\nAndromeda uses AI to augment surgeons’ mental and cognitive faculties. We’re starting with a common prostate procedure that can treat over half a million patients per year and has better outcomes than all alternatives. Its steep learning curve limits the number of urologists who can perform it. The procedure is algorithmically simple, but it’s hard for urologists to know exactly where they are and what they’re seeing, resulting in mistakes and delays. We’ve designed a GPS-like location system to help surgeons accurately orient themselves and perform the best possible action in every moment.\n\n![uploaded image](/media/?type=post&id=74646&key=user_uploads/4171/e37dbeac-932f-42bc-b896-954c0c4c0fcb)\n\nAfter launching, we’ll expand into other urologic procedures and then beyond. Whereas most surgical robots focus on multi-port laparoscopic procedures, we’re starting with natural orifice procedures that tend to be less mechanically complex. We’re a hardware-lite company and built our simple yet versatile robot in just three months. The main value we’ll provide is in our software. Our long-term vision is to enhance all surgeons’ abilities with AI, empowering them to perform a broad range of procedures at expert level and deliver consistently optimal outcomes to patients.\n\n**Asks**\n\n·      We’re hiring robotics and HRI/industrial design engineers\n\n·      We’re looking to meet urologists who can partner with us on data collection and future clinical trials\n\nPlease reach out at [info@andromedasurgical.com](mailto:info@andromedasurgical.com) if you’re interested to help us build the future of surgery.\n\n\\[1\\] ", "url": "https://www.ycombinator.com/launches/JPy-andromeda-surgical-autonomous-surgical-robots", "votes": 46, "created_at": "2023-09-06T13:49:39.308Z" } ] }, { "id": 29313, "name": "Selera Medical", "slug": "selera-medical", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/3093de2ebffff30f196a9a5caee36a78c8971282.png", "website": "http://www.seleramedical.com", "all_locations": "San Francisco, CA, USA", "long_description": "Heart failure impacts millions worldwide and is associated with poor quality of life and high mortality rates. Because the heart cannot pump efficiently, fluids buildup around the body. Fluid overload is the main driver behind patient symptoms (shortness of breath, fatigue, chest pain, etc.) and hospitalizations. Our minimally invasive device leverages the body's innate fluid management system to offload trapped fluid and prevent subsequent rounds of buildup. The one-time procedure has sustained effect -- keeping patients healthier, happier, and out of the hospital.", "one_liner": "One-time, device-based treatment for heart failure", "team_size": 2, "industry": "Healthcare", "subindustry": "Healthcare -> Medical Devices", "launched_at": 1709140378, "tags": [ "Medical Devices", "Healthcare" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2024", "status": "Inactive", "industries": [ "Healthcare", "Medical Devices" ], "regions": [ "United States of America", "America / Canada" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/selera-medical", "api": "https://devasheeshg.github.io/yc-api/batches/winter-2024/selera-medical.json", "year_founded": 2023, "city": "San Francisco", "country": "US", "linkedin_url": "https://www.linkedin.com/company/selera-medical/", "x_url": "", "fb_url": null, "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/3093de2ebffff30f196a9a5caee36a78c8971282.png", "app_video_url": null, "dday_video_url": null, "company_photos": [], "primary_partner": null, "founders": [ { "user_id": 1135677, "full_name": "Stacie Arechavala", "title": "Founder", "founder_bio": "Founder & CEO of Selera Medical, developing paradigm-shifting technology for heart failure patient management. Previous experience includes Innovation Fellow at Stanford Biodesign, CoS running internal operations at a healthtech startup, R&D engineer developing cardiovascular devices at Medtronic. Masters in biomedical engineering and engineering management from Duke.", "is_active": false, "linkedin_url": "https://www.linkedin.com/in/staciearechavala/", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/0eaf4b86c5d393849997a0e114c5f9a67284140d.jpg" }, { "user_id": 1165114, "full_name": "Kevin Bui", "title": "Founder", "founder_bio": "Kevin is co-founder and CTO of Selera Medical, a medical device startup developing a minimally invasive therapy for congestive heart failure. Prior to this, he was an Innovation Fellow in the Stanford Byers Center for Biodesign. Kevin received his undergraduate bioengineering degree from Stanford and his PhD in bioengineering from the University of Pennsylvania, where he conducted research at the intersection of robotics, stroke rehabilitation, and cognitive neuroscience. ", "is_active": false, "linkedin_url": "https://linkedin.com/in/kevindbui", "x_url": "", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/3d02037686733d187da63fe2f2fccc776a238182.jpg" } ], "jobs": [], "news": [], "launches": [ { "id": 78866, "title": "Selera Medical: Disrupting the heart failure treatment paradigm ❤️‍🔥", "tagline": "Device-based approach to better heart failure patient care", "body": "Selera is developing a device to treat fluid overload in heart failure patients with a one-time, minimally invasive procedure.\n\n### **Backstory 📖**\n\nHello! 👋 We ([Stacie](https://www.linkedin.com/in/staciearechavala/) & [Kevin](https://linkedin.com/in/kevindbui)) are engineers who met at Stanford Biodesign, where we shadowed clinical cases and identified unmet needs in hospitals across the Bay Area. We observed first-hand the limited and ineffective treatment options available to heart failure patients, which led to poor quality of life and frequent hospitalizations. With Kevin’s Ph.D. in bioengineering, Stacie’s medical device + ops/strategy industry experience, and a shared vision to improve healthcare outcomes, Selera was born.\n\n![uploaded image](/media/?type=post&id=78866&key=user_uploads/1135677/0a02856b-5a46-48f1-ac7a-0e7e890bf775)\n\n### **Problem 💔**\n\nOver 6.5 million people in the US suffer from heart failure, which is when the heart can no longer pump blood efficiently to the rest of the body. As the disease progresses, symptoms get worse, quality of life tanks, and hospital time skyrockets. It’s terrible for patients and their loved ones, as well as a huge burden to the healthcare system.\n\nOver 90% of symptoms and hospitalizations are driven by fluid buildup around the body (think: fluid in the lungs → patient can’t breathe → hospital). Standard of care medications to manage fluid hasn’t changed in over 60 years, have adverse side effects, require significant provider time, and become ineffective over time. As a result, patients are trapped in a cycle: fluid builds up, symptoms worsen, hospitalization, discharge, repeat. Post-hospitalization, the survival rate is similar to some stage 4 cancers – only 50% at 2 years – and reduces with each admission.\n\n### **Approach 🎯**\n\nWe are taking a brand new approach by harnessing the body’s own fluid management mechanisms to remove excess fluid, alleviate symptoms, and reduce hospitalizations.\n\nWith the heart not pumping blood as well as it should be, it causes backups in the blood vessels (like a highway when there’s construction). This forces fluid with important nutrients to leak out (detour) into the interstitial space, which is the space between organs and tissues. Normally, this fluid is collected and brought back to the bloodstream by the lymphatic system (a parallel highway with roads all over the body). However, the lymphatic system is overwhelmed by the extra fluid produced in heart failure due to the backups (when Maps reroutes everyone and the seemingly better alternative also has traffic). Without any other way out, fluid is trapped in the interstitial space, leading to the symptoms behind hospitalizations, such as swelling and chest pain depending on where the fluid is stuck. Our technology ‘untaps’ the fluid stuck in the interstitial space by offloading the lymphatic system so that it can work more efficiently (like opening up more lanes to reduce traffic).\n\nWith our one-time procedure, minimally invasive lymphatic offloading (MILO) provides long-term treatment and breaks the fluid overload hospitalization cycle for patients.\n\n![uploaded image](/media/?type=post&id=78866&key=user_uploads/1135677/54435770-1a47-441b-93c5-206d14826845)\n\n### **Connect 🤝**\n\nWe’re looking to connect with cardiologists and interventional radiologists interested in partnering with us on product testing and future clinical trials.\n\nIf you’d like to learn more about what we’re working on or get involved, reach out to us at [founders@seleramedical.com](mailto:founders@seleramedical.com).", "url": "https://www.ycombinator.com/launches/KW2-selera-medical-disrupting-the-heart-failure-treatment-paradigm", "votes": 35, "created_at": "2024-02-28T20:56:05.210Z" } ] }, { "id": 30673, "name": "Nexa Labs", "slug": "nexa-labs", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/489fd97ad45ee1d6d874c7a99792bf1552ebddc2.png", "website": "https://nexa.farm/", "all_locations": "San Francisco, CA, USA", "long_description": "Nexa is developing the solution for cattle monitoring, leveraging implantable microchips that collect more comprehensive biometrics than anything else on the market. Our accompanying AI-driven animal health engine empowers farmers with early disease detection, reproductive insights, GPS tracking, and more. \r\n\r\nWe're saving farmers time and money while collecting the world's largest cattle health dataset. We believe that cattle farming should be a science, not an art - this will secure the world's food supply and increase economic output that billions of people depend on.", "one_liner": "Implantable microchips and AI for cattle monitoring", "team_size": 3, "industry": "Industrials", "subindustry": "Industrials -> Agriculture", "launched_at": 1755009056, "tags": [ "Livestock Health", "Medical Devices", "Agriculture", "AI", "Biotechnology" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2025", "status": "Acquired", "industries": [ "Industrials", "Agriculture" ], "regions": [ "United States of America", "America / Canada" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": [ { "question": "How did your company get started? (i.e., How did the founders meet? How did you come up with the idea? How did you decide to be a founder?)", "answer": "We all met as undergrads at Caltech. Before becoming co-founders, we became close friends. We are brought together by a shared desire to build technology that impacts real people in America and beyond." } ], "url": "https://www.ycombinator.com/companies/nexa-labs", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2025/nexa-labs.json", "year_founded": 2025, "city": "San Francisco", "country": "US", "linkedin_url": "https://www.linkedin.com/company/nexafarm", "x_url": "", "fb_url": null, "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/489fd97ad45ee1d6d874c7a99792bf1552ebddc2.png", "app_video_url": null, "dday_video_url": null, "company_photos": [ "https://bookface-images.s3.us-west-2.amazonaws.com/attachments/2300cc908a88477ba3d0333b549e0c55584ccdfd.png" ], "primary_partner": { "name": "Diana Hu", "url": "https://www.ycombinator.com/people/diana-hu" }, "founders": [ { "user_id": 2198327, "full_name": "Zarif Azher", "title": "Founder/CEO", "founder_bio": "Previously built medical devices, biosensors, and AI for healthcare. Now building microchips for cattle monitoring! ", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/zarif-azher-260b401bb/", "x_url": "https://x.com/ZarifAzher", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/8780345b330950408619a690b45f87e77adcd24c.jpg" }, { "user_id": 2852618, "full_name": "Kenneth Chan", "title": "Founder", "founder_bio": "Prev @ Caltech. Now building the future of livestock health monitoring.", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/kenneth-chan-340a6032a", "x_url": "https://x.com/kennychan256", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/49841de0f9346c82b1774acbb96c5444b2460071.jpg" } ], "jobs": [], "news": [], "launches": [ { "id": 92930, "title": "Nexa Labs: Implantable Microchips for Cattle Monitoring", "tagline": "We empower cattle farmers with early disease detection and reproductive insights.", "body": "**TLDR:** Nexa builds implantable “FitBits” + AI for cattle monitoring. We empower farmers with early disease detection and reproductive insights that save them time and money.\n\nhttps://youtu.be/goioQTngpSU\n\n**Problem**\n\nEfficiently monitoring cattle health and reproduction is critical to maintain farm profitability. But the traditional practice of manually inspecting animals doesn’t scale - labor costs add up, while farms miss disease outbreaks and breeding cycles. Disease alone causes \\~$100 billion in losses yearly for cattle farms globally.\n\nExisting tech for monitoring cattle includes external wearables like collars and ear-tags. Being outside thick cattle skin, these can’t accurately track useful biometrics beyond “activity” (a glorified step-count). There’s also boluses, pill-shaped devices that sit in the cow stomach. But these are super expensive, have short battery life, and can’t be used for beef cattle.\n\n**Solution**\n\nNexa is building implantable microchips that go underneath the skin in the ear of cattle. We analyze vital biometrics - like temperature, heart rate, blood oxygen, activity, GPS location, and more - that other systems miss, to empower farmers with early disease detection and reproductive insights. And because our electronics operate at millimeter scale, we benefit from low production costs and pricing up to 70% cheaper than current solutions.\n\nOur hardware also enables collection of the world’s largest cattle health dataset - so, we can develop foundation models that can unlock new possibilities in farm management and livestock pharma. \n\nWe’re currently launching our dairy pilot program - if you know any dairy farmers based in the USA, please send them our way at [admin@nexa.farm](mailto:admin@nexa.farm) :)\n\n**About Us**\n\nWe’re a team of Caltech dropouts with backgrounds in bioengineering, electrical engineering, CS, math, and physics. We want to build technology that makes a tangible impact on the lives of real people in America and beyond.  \n\n![uploaded image](/media/?type=post&id=92930&key=user_uploads/89898/0ae16cce-d4d4-40c1-b80d-7079d433d8e6)\n\n", "url": "https://www.ycombinator.com/launches/OAs-nexa-labs-implantable-microchips-for-cattle-monitoring", "votes": 24, "created_at": "2025-08-12T15:36:19.597Z" } ] }, { "id": 32193, "name": "Floracene", "slug": "floracene", "former_names": [ "TareRx" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/4083ec47b697a352249164c76574e273a5fa75d7.png", "website": "https://www.floracene.com/", "all_locations": "New York City, NY, USA", "long_description": "Floracene lets any healthcare operator describe the internal tool they need and deploy it in one click - connected to production data, with read and write access scoped by the user. Think Lovable or Retool, except purpose-built for the needs of healthcare business that has no engineering team.\r\n\r\nThe bottleneck in healthcare isn't building anymore. Anyone can vibecode an 80% solution in an afternoon, custom to their own workflow, with people already on staff. The tool then dies locally on the builder’s computer, because IT (correctly) won't let anyone deploy a tool touching PHI without first-class authentication and permissioning. Our first customer had multiple employees who had each built useful tools and dashboards locally, but couldn’t actually share these with coworkers or connect to their core practice data. Within weeks of implementing Floracene, they were able to consolidate their BI tooling into Floracene and shipped 4 net-new to production.\r\n\r\nA staggering ~$200B is spent on administrative software in healthcare every year in the US. Tens of thousands of those companies still run core operations on spreadsheets, and we're at the top of the first inning of AI adoption.\r\n\r\nAsaph and Jonah met on the hospitals team at Palantir two years ago, and have each spent the last four years in the plumbing of US healthcare: claims, eligibility, and payor contracting. Asaph was an early PM at Garner. Jonah was a founding engineer at Metriport (YC S22) after starting his own fax-automation startup for fertility clinics.", "one_liner": "Vibecode + deploy HIPAA-compliant internal tools, no eng team needed", "team_size": 2, "industry": "Healthcare", "subindustry": "Healthcare", "launched_at": 1783448694, "tags": [ "Health Tech", "Medical Devices", "Digital Health", "Enterprise Software", "Healthcare IT" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2026", "status": "Active", "industries": [ "Healthcare" ], "regions": [ "United States of America", "America / Canada" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": null, "url": "https://www.ycombinator.com/companies/floracene", "api": "https://devasheeshg.github.io/yc-api/batches/summer-2026/floracene.json", "year_founded": 2026, "city": "New York City", "country": "US", "linkedin_url": "", "x_url": "", "fb_url": null, "cb_url": null, "github_url": null, "logo_url": "https://bookface-images.s3.amazonaws.com/small_logos/4083ec47b697a352249164c76574e273a5fa75d7.png", "app_video_url": null, "dday_video_url": null, "company_photos": [ "https://bookface-images.s3.us-west-2.amazonaws.com/attachments/5ccdb13884880d40ad27da646bb9675f961c4c61.png" ], "primary_partner": { "name": "Harshita Arora", "url": "https://www.ycombinator.com/people/harshita-arora" }, "founders": [ { "user_id": 3605405, "full_name": "Asaph Kupferman", "title": "Founder/CEO", "founder_bio": "Founder / CEO at Floracene (YC S26). Previously Hospitals team at Palantir and early employee at Garner Health. \n\nRobotics / Electrical Engineering from Penn. Amateur chef.", "is_active": true, "linkedin_url": "https://www.linkedin.com/in/aa-kup/", "x_url": "https://x.com/KupfermanAsaph", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/0a9703d8fcfaefb7b743105e311c4f6d9cc654b8.jpg" }, { "user_id": 1225540, "full_name": "Jonah Kaye", "title": "Founder/CTO", "founder_bio": "Founder / CTO at Floracene (YC S26). Previously Tech Lead at Palantir (Hospitals) and Founding Engineer at Metriport (YC S22). \n\nCS and Philosophy @ UChicago. Brazilian Jiu Jitsu Purple Belt.", "is_active": true, "linkedin_url": "https://linkedin.com/in/jonah-kaye-875a051b2", "x_url": "https://x.com/JonahKaye2", "avatar_thumb_url": "https://bookface-images.s3.us-west-2.amazonaws.com/avatars/303600cd0aa2a45efd8dee5820b815f081eca32a.jpg" } ], "jobs": [], "news": [], "launches": [] } ]